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Abstract 
 
The thymus generates multiple T cell populations from an early common CD4(-) 
CD8(-) double negative (DN) progenitor. Conventional αβ T cells, such as CD4(+) 
and CD8(+) T cells undergo thymic positive selection on partial agonist 
interactions with self-peptide/MHC, whereas unconventional TCRαβ(+)CD8αα(+) 
intraepithelial lymphocytes (IELs) and regulatory T cells (Tregs), are thought to 
require full agonist interactions. By contrast, very little is known about how γδ T 
cells undergo selection. While it has been suggested that IL-17A-secreting γδ T 
cells rely on strong TCR signals resulting from potential interactions with a 
ligand, several studies have led to opposite conclusions. This thesis 
investigates the role of TCR signal strength during the early stages of 
thymocyte development, and how this dictates subsequent T cell fate. 
We show that FVB/n mice have relatively few unconventional 
TCRαβ(+)CD8αα(+) IELs in comparison to C57Bl/6 animals. This depleted IEL 
compartment correlated with reduced thymic IEL progenitors, an inefficient 
preTCR-driven DN-to-DP transition, and a relatively increased expression of full 
length pTαa transcripts in CD44(-)CD25(+) DN3 cells. Transgenic over-expression 
of pTαa in the absence of pTαb transcripts mimicked the phenotype of FVB/n 
animals. CD5 levels on DN3 cells from pTαa transgenic mice indicate that 
preTCR signalling was weaker than in C57Bl/6 mice, suggesting that signal 
strength at the β-selection checkpoint may influence subsequent selection of 
mature T cell populations. Consistent with this, we show that OT-II mice, which 
express a transgenic TCRαβ from an early DN stage of thymocyte 
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development, and which have high levels of CD5 on DN3 cells, have a relatively 
increased unconventional TCRαβ(+)CD8αα(+)IEL compartment. For γδ T cell 
development, we also show that weakening signal strength impairs the 
development of IL-17A-secreting γδ T cells. However, increasing signal 
strength, through the use of a cross-linking antibody, does not favour their 
development as predicted. These seemingly paradoxical observations are 
explored further. 
Taken together, these data suggest that the quality or quantity of TCR-mediated 
signals early in T cell development have fundamental consequences for 
subsequent T cell selection events that differentially generate distinct T cell 
subsets.   
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PIP2 Phosphatidylinositol (4,5)-bisphosphate 
PIP3 Phosphatidylinositol (3,4,5)-trisphosphate 
pITAM Phosphorylated Immunoreceptor Tyrosine-based Activation Motif 
pMHC Peptide MHC complex 
Pre TCR Pre T Cell Receptor  
pTα Pre T cell receptor α 
RAG Recombination Activating Genes 
Ras-GRP RAS-Guanyl-Nucleotide-Releasing Protein  
RNA Ribonucleic Acid 
RORγt RAR-related orphan receptor γt 
RSS Recombination Signal Sequence 
S1P Sphingosine-1-Phosphate  
S1P1 Sphingosine-1-Phosphate Receptor 1 
SCID Severe Combined Immune Deficiency 
SD Standard Deviation 
SH2 Src-Homology 2 domain 
SLC Stem cell Leukemia 
SLP-76 SH2-domain-containing Leukocytes protein of 76kDa 
SOS  Son of Sevenless  
SP Single Positive (CD4(+) or CD8(+) T cell) 
SSC Side Scatter  
STAT Signal Transducer and Activation of Transcription. 
SYK Spleen Tyrosine Kinase 
TAP Transporter Associated with Antigen Processing  
TCR T Cell Receptor 
TDC Thymic Dendritic Cells 
Tdt Terminal Deoxynucleotidyl Transferase 
TEC Thymic Epithelial Cells 
TGF-β Transforming Growth Factor β 
TH T helper cells 
TLR Toll-Like Receptor 
TNF Tumour Necrosis Factor 
TNFR Tumor Necrosis Factor Receptor 
TRAF6 TNF receptor associated factor 6  
Tregs Regulatory T cells 
TRIM T Cell Receptor - Interacting Molecule 
VCAM Vascular Cell Adhesion Molecule  
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WT Wild Type  
Zap-70 ζ-chain-Associated Protein Kinase of 70 KDa 
β2-m Beta 2 Micro-globulin 
CFSE Carboxyfluorescein Succinimidyl Ester 
PMA Phorbol Myristate Acetate 
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Chapter 1  
Introduction  
 
1.1 The immune system 
All living organisms have an immune system capable of identifying and killing 
potentially harmful foreign pathogens that may cause disease. The immune 
system is conventionally divided into two branches; the innate and adaptive 
immune systems, which communicate tightly with each other via cell/cell contact 
and the secretion of mediators (cytokines, chemokines) (Cooper and Alder, 
2006).  
 
1.1.1 The innate immune system 
The innate (from the latin “innasci” meaning “to be born in”) immune system 
constitutes the first line of defence against an infectious pathogen and is shared 
by both simple and complex organisms. The identification of infectious agents 
and the initiation of a fast (minutes to hours) immune response occurs following 
the recognition of pathogen-conserved structures - also known as pathogen-
associated-molecular patterns (PAMPS); such as flagellin or lipopolysaccharide 
(LPS) (Table 1.1). Granulocytes (Neutrophils, Eosinophils, Basophils), dendritic 
cells (DC) and macrophages are the principal cellular components of the innate 
immune system and all share a common myeloid progenitor. The main purpose 
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of the innate immune system is to control the early phase of infection while 
recruiting a more specific and robust branch of the immune system that can fully 
eradicate the infection; the adaptive immune system.  
 
Table 1.1 Representative characteristics of the innate and adaptive immune 
system. 
 
1.1.2 The adaptive immune system  
In contrast to the innate immune system, the adaptive immune system 
appeared with the jawed vertebrates and is thus not found in all organisms. The 
adaptive immune system has the ability to recognize numerous and diverse 
pathogen-derived antigens with great specificity. It can also acquire an 
immunological memory enabling a faster and more robust response in 
subsequent infections by the same pathogen. Lymphocytes are the central 
component of the adaptive immune response and are divided into two main 
families; the T and B lymphocytes, which share a common lymphoid progenitor. 
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T cells are so called because of their thymic origin, whereas B lymphocytes 
were named after the bursa of fabricius of birds from where they were first 
discovered in 1956 (Miller, 1994). While T cells provide the bulk of the cell-
mediated arm of the adaptive immune response, B cells are a key mediator of 
the humoral immune response through the secretion of antibodies.  
 
The work presented subsequently in this thesis focuses on one component of 
the adaptive immune system; T cells. Thus, this introduction concentrates on 
reviewing T cell function, development and signalling.  
 
1.2 T cells are the central components of the adaptive immune 
system  
T cells are an indispensable component of a healthy body. Indeed, a lack of T 
cells leads to severe combined immunodeficiencies (SCID), which may result in 
death in the first year of life unless appropriate treatment is given. The 
importance of T cells can also be illustrated in human immunodeficiency virus 
(HIV) infection; as viral load increases, the numbers of a particular subset of T 
cells (helper T cells also known as CD4(+) T cells; introduced subsequently) 
decrease over time to eventually fall below 200 cells/mm3 of blood (normal 
range is: 500 to 1200 cells/mm3 for adults) resulting in a dramatically weakened 
adaptive immune response. This corresponds to the establishment of acquired 
immune deficiency syndrome (AIDS) where common infections, usually of no 
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threat for healthy individuals, are no longer controlled, leading to the death of 
the patient (Figure 1.1) (Klatzmann et al., 1984).  
 
 
Figure 1.1 Helper T cell depletion after HIV infection. During an HIV infection, 
numbers of CD4(+) T cells drop gradually over time reaching a point where the T cell 
compartment cannot deal with opportunistic infections leading eventually to the death 
of the patient. Adapted from (Simon and Ho, 2003)  
 
1.2.1 αβ and γδ  T cells 
T cells are characterised by the expression of a membrane-bound T cell 
receptor (TCR) and can be broadly divided into two subsets according to the 
type of TCR they express. αβ T cells display a TCRαβ consisting of a TCRβ 
chain bound to a TCRα chain, and are mainly found in blood, lymphoid organs 
and tissues. They represent the largest subset of T cells being more than 90-
95% of peripheral blood T cells. By contrast, γδ T cells express a TCRγδ 
composed of a TCRγ and a TCRδ chain, and represent only about 1 to 5% of 
peripheral blood T cells, being predominantly found in the body’s tissues 
  
31 
 
(Carding and Egan, 2002). γδ T cells can be further segregated by usage of 
certain variable domains (“V” regions) of either TCRγ or TCRδ. For example, in 
mouse, γδ T cells are often sub-divided based on the use of one of seven Vγ 
regions, which correlates with a specific tissue tropism (Carding and Egan, 
2002; Krecko and Tonegawa, 1989). Vγ5(+) cells, also known as dendritic 
epithelial T cells (DETC) are found in the mouse skin while Vγ6(+) cells are 
principally found in the lining of the genital tract, peritoneal cavity and the 
tongue. The Vγ7(+) subset is principally found in the gut. Vγ4(+) and Vγ1(+) T cell 
are found in blood, spleen and lymph nodes (Table 1.2) (Carding and Egan, 
2002).   
 
Table 1.2 γδ  T cells can be characterised by the variable region of their TCRγ  
chain (Vγ). Vγ5 migrate exclusively to the skin while Vγ6 T cells preferentially go to 
the lining of the genital tract, the peritoneal cavity and the tongue. Vγ7 T cells 
preferentially populate the gut while Vγ4 and Vγ1 T cells are found in the spleen, 
lymph nodes and blood.  
 
1.2.2 Structure of the TCR complex  
The TCR is a disulfide-linked heterodimer, and member of the immunoglobulin 
super-family. Encoded by three loci, four different TCR chains can be 
generated; TCRα, TCRβ, TCRγ and TCRδ. Each TCR chain shares some 
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structural features; an extracellular portion composed of two Ig-loop structures 
forming the variable (V) and the constant (C) regions; a cysteine residue 
essential for the establishment of a disulphide bond between the two chains; a 
hydrophobic transmembrane domain; and a short intracellular tail (Figure 1.2) 
(Wood and Tonegawa, 1983).  The ligand-binding region of the TCR, encoded 
by the V region, contains three hyper-variable regions (or complementarity 
determining regions (CDR1-3)) with CDR3 largely dictating the binding affinity of 
the TCR to the antigen (Davis and Bjorkman, 1988).  
A fully signalling-competent TCR complex is composed of four CD3 (CD3δ, 
CD3γ or CD3ε) and two TCRζ (TCRζ  or Fcε Receptor I γ (FCεRIγ)) signalling 
molecules (Letourneur and Klausner, 1992). The various pairs of CD3 subunits 
(CD3εγ, CD3ζδ) lack autonomous kinase activity but instead contain 
immunoreceptor tyrosine-based activation motifs (ITAMs) involved in signal 
transduction, which share a consensus sequence of two pairs of leucine and 
tyrosine residues, such as (D/E)xxYxxL(x)6-8YxxL (Letourneur and Klausner, 
1992; Reth, 1989). CD3γ, δ, and ε contain a single ITAM while CD3ζ has three 
providing altogether ten ITAMs through which signal transduction can be 
initiated.  
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1.2.3 TCR gene-rearrangement; the source of great TCR diversity  
The adaptive immune system generates millions of T cells that each has a 
unique TCR specificity that is capable of recognising a distinct antigen. Clearly, 
such diversity in TCR recognition cannot be inherently encoded in our genome 
of 20-25,000 genes. Instead, TCR diversity is generated by a process of 
 
Figure 1.2 Schematic representation of the structure of a T cell receptor αβ . 
TCRαβ is composed of a TCRα chain interacting with a TCRβ chain by disulphide 
bonds generated by cysteine residues. Each TCR chain is composed of two Ig-loop 
structures stabilised by interactions between cysteine residues and represents the 
variable domain (V) and constant domain (C). The V region encodes the binding region 
involved in the recognition of MHC-presented peptides.  Interaction between the TCR 
chains occurs through the transmembrane domain. 
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somatic recombination. This mechanism involves the random selection of 
certain DNA segments from the TCR loci that are cut and pasted together, while 
unwanted intervening segments are removed from the genome. It has been 
estimated that about 1012 different TCRs can be produced throughout our 
lifespan. This process takes place mainly in the thymus and is known as “TCR 
gene rearrangement” (Arstila et al., 1999). 
1.2.4 Organisation of the TCR loci 
Analysis of genomic organisation revealed that all TCR loci are composed of at 
least three families of gene segments; variable (V), joining (J) and constant (C) 
regions with TCRβ and TCRγ containing an extra set; the diversity (D) regions 
(Figure 1.3) (Wood and Tonegawa, 1983).  
 
 
Figure 1.3 Organisation of the murine TCRβ , TCRγ , TCRα  and TCRδ  loci. Each 
TCR locus is composed of at least three types of gene segments; the variable (V), the 
junction (J), the constant (C) segments and the diversity (D) segments are an extra set 
found in the TCRβ and TCRγ loci.   
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Interestingly, the TCRδ locus is entirely contained within the TCRα locus 
resulting in its deletion during TCRα rearrangement (Figure 1.3). The TCRβ 
locus is composed (in mouse) of thirty-one V-regions, followed by two clusters 
containing a D-region, twelve J-regions, and a C-region (Giudicelli et al., 2005).  
Generation of a TCRβ chain occurs first by juxtaposition of one Dβ and Jβ 
region and then of one Vβ to the DJβ (Alt et al., 1984). Following transcription, 
the intron between the Cβ region and the rearranged VβDβJβ segment is 
spliced out from the RNA molecule, giving rise to a unique type of TCRβ mRNA 
and TCRβ protein (following translation). By contrast, the TCRα locus has far 
more V-regions than TCRβ (between 75 and 100 Vα segments) but lacks 
diversity regions. During rearrangement, Vα and Jα regions are first assembled 
before transcription takes place and RNA splicing leads to the fusion of the Cα  
region with VαJα resulting in a TCRα protein after translation (Figure 1.4). 
 
Specific rearrangement and correct orientation between two types of segments 
are ensured by the presence of 28bp or 39bp long Recombination Signal 
Sequences (RSS). These are composed of palindromic heptamers found 
adjacent to a V, D or J segment, and are separated from a nonamer by a 
spacer of 12bp or 23bp. Gene rearrangement is said to follow the “12/23bp” rule 
where a RSS containing a spacer of 12bp will only associate with one that has 
a spacer of 23bp (Figure 1.5) (Krangel et al., 2004). This event is orchestrated 
by two lymphocyte-specific genes: Recombination Activating Genes (RAG) 1 
and RAG-2 (Lacomini et al., 1992).  
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Figure 1.4 Schematic representation of TCRα  and TCRβ  rearrangement. During 
TCRβ rearrangement, the D and J regions are fused first before the addition of a V 
region. The rearranged DNA molecule is transcribed and RNA splicing allows the C 
region to be juxtaposed to the VDJ segment. Due to the lack of D regions in the TCRα 
locus, fusion of V and J happens first. Once the genes have been rearranged, 
transcription will take place and translation will follow to give rise to the TCRα or TCRβ 
protein.  
 
Figure 1.5 TCR rearrangement follows the 12/23bp rule. V, D, J regions are 
juxtaposed to a recombination signal sequence (RSS) composed of either 39bp or 
28bp. Each RSS is composed of a heptamer (in pink) and a nonamer (in blue) 
palindromic sequences separated by a spacer of 12bp or 23bp. Juxtaposition of two 
gene segments results from the association of a RSS containing a 12bp spacer with 
another RSS containing the 23bp spacer ensuring the correct orientation of the gene 
segment. 
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RAG proteins recognise and associate with the RSS allowing two segments 
(e.g. Vα and Jα) to be brought into proximity. Cleavage of the DNA occurs 
through hydrolysis of the DNA strand separating the coding segment from the 
RSS. Once cleaved, the two DNA strands associate leading to the formation of 
a hairpin intermediate structure (Oettinger et al., 1990). Binding of Ku proteins 
(Ku70, Ku80) and DNA dependent protein kinase (DNA-PK) to the DNA triggers 
phosphorylation and activation of Artemis, the terminal deoxynucleotidyl 
transferase (Tdt), the DNA repair protein XRCC4 and the ligase IV. Artemis is 
thought to be responsible for opening up the hairpin structure creating “sticky 
ends” (or DNA overhang), which once repaired, produce palindromic sequence 
(also known as P-nucleotides) (Figure 1.6) (Ma et al., 2002). Finally, Tdt adds 
random nucleotides (N-nucleotides) at the joins, which together with the P-
nucleotides further extend the sequence diversity of the VDJ or VJ regions and 
essentially makes the theoretical number of rearrangement possibilities infinite 
(Mansilla-Soto and Cortes, 2003; Villartay et al., 2003). 
 
Although TCRγ and TCRδ loci contain fewer V-segments than the TCRα or 
TCRβ loci with only seven Vγ and six Vδ segments (in mouse), the TCRγδ still 
possesses a great potential for diversity as the TCRδ chain can incorporate two 
D regions as opposed to TCRβ which only uses a single D region. This extra D 
creates an extra join, hence a further opportunity for the inclusion of P and N 
nucleotides (Michael, 2006).  
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Figure 1.6 TCR gene rearrangement is initiated by RAG1 and RAG2. RAG1/2 
associate with the RSSs bringing into proximity two segments (here Vα and Jα) to 
cleave the DNA. The DNA-PK/Ku70/80 complex is subsequently recruited where 
Artemis gets activated and is responsible for opening up the hairpin structure creating 
“sticky ends”. XRCC4 and ligase IV subsequently mediate the repair and ligation of the 
sticky ends creating palindromic sequences while Tdt is responsible for the addition of 
N nucleotide. RAG, Recombination Activating Gene; Tdt, Terminal deoxynucleotidyl 
transferase; RSS, Recombination Signal Sequences; 
 
1.2.4 Major pathways in T cell receptor signalling  
The TCR translates extracellular stimuli into cytoplasmic and nuclear signals via 
a highly complex network of proteins that is critical for cell survival, proliferation 
and of particular interest to this thesis, differentiation. For simplicity, only the 
major T cell receptor signalling pathways are reviewed in this section. 
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1.2.4.1 Proximal TCR signalling  
  a. Lck signalling 
The lymphocyte-specific protein tyrosine kinase (Lck) belongs to the src-family 
kinase and contains two phosphorylation sites, Y394 and Y505, which when 
phosphorylated, dictate the activity of the kinase (active and inactive 
respectively) (D'Oro et al., 1996). Lck activity represents the initial step of TCR 
signalling and is critical for signal transduction through the TCR (van Oers et al., 
1996). Lck is negatively regulated by the phosphatase CD45 and the C-terminal 
src-kinase (CSK) (Autero et al., 1994). There has been some debate regarding 
how Lck triggers TCR signalling. It was shown that Lck can be found in a 
constitutively active state in the cytoplasm at steady state, as shown by a high 
proportion of phosphorylated Y394 Lck in jurkat and CD4(+) human T cells (Nika 
et al., 2010). However, this did not trigger T cell activation, and CD3-dependent 
stimulation of T cells did not increase the proportion of phosphorylated Y394 
Lck (Nika et al., 2010). By contrast, inhibition of active Lck through the use of an 
inhibitor of the Lck chaperon protein Hsp90, severely impaired phosphorylation 
of the CD3ζ chains, suggesting that basal amounts of active Lck are required 
for successful TCR signalling (Nika et al., 2010). Thus it is thought that Lck can 
be found in a constant active state and that it is its recruitment to the 
membrane, as a result of TCR engagement, probably through remodelling of 
the cytoskeleton, that triggers signal transduction (Acuto et al., 2008; Nika et al., 
2010; Tan et al., 2014). Alternatively, the kinetic segregation model of TCR 
triggering suggests that interactions between the TCR and the peptide-MHC 
complex creates a zone of close contact where large phosphatases like CD45 
are excluded, allowing Lck to adopt an activated state and phosphorylate 
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downstream signalling molecules (Davis and van der Merwe, 2006). However, 
this model is not fully compatible with a ligand-independent signalling 
mechanism (Figure 1.7).  
b. Zap-70 signalling 
Phosphorylation of the CD3 ITAMs by Lck creates docking sites for SH2-
domain-containing-proteins such as the ζ-chain-associated protein kinase of 70 
KDa (Zap-70) (Straus and Weiss, 1993; Wang et al., 2010; Wange et al., 1993). 
Zap-70 is composed of two SH2-domains, two inter-domains (A and B), a 
carboxy-terminal kinase domain and five phosphorylation sites (Y292, Y315, 
Y319, Y492, Y493) (Kong et al., 1996).  Binding of Zap-70 to phosphorylated 
ITAMs results in its phosphorylation by Lck at site Y493 followed by 
autophosphorylation of site Y492 both located in its kinase domain (Chan et al., 
1995; Kong et al., 1996). This enhances its kinase activity that results in Zap-70 
phosphorylating linker of activation of T cells (LAT) and SH2-domain-containing 
leukocytes protein of 76kDa (SLP76) (Figure 1.7) (Mege et al., 1996). This 
establishes an important foundation for the activation of numerous downstream 
signalling pathways.  
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Figure 1.7 The signalosome. Signal initiation is thought to start with the 
phosphorylation of Lck, which phosphorylates in turn the ITAMs located on the CD3 
signalling molecules creating a docking site for Zap-70. Zap-70 subsequently 
phosphorylates LAT, which represents a “hub” for TCR signalling. PLCγ-1 associates to 
LAT and cleaves PIP2 into IP3 and DAG. DAG stimulates the RASGRP pathway 
leading to the activation of the ERK pathway (Ras-Raf-Mek-ERK cascade) and 
activation of nuclear transcription factors. DAG also activates PKC-Ɵ resulting in NFKB 
activation. IP3 binds to IP3R on the ER and triggers release of Ca(2+) which is sensed by 
CRAC, which in turn allows an influx of Ca(2+) resulting in the activation of calcineurin. 
Calcineurin dephosphorylates NFAT allowing it to translocate into the nucleus. All 
these pathways are critical for cell proliferation, differentiation and survival. Lck, 
lymphocyte-specific protein tyrosine kinase; Zap-70, Zeta-chain-associated protein 
kinase 70; LAT, linker for activation of T cells; PLC, phospholipase Cγ1; PI3K, 
phosphoinositide 3-kinase; PIP3, Phosphatidylinositol-3,4,5-triphosphate; IP3, Inositol 
1,4,5-triphosphate; DAG, diacylglycerol; PIP2, Phosphatidylinositol 4,5-bisphosphate;  
ER, endoplasmic reticulum; ERK, Extracellular signal-regulated kinases; NFAT, 
nuclear factor of activated T cells; NFκB, nuclear factorκB;  
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c. LAT signalling 
LAT represents a central hub for the propagation of TCR signals and plays a 
critical role in the activation of several downstream signalling pathways (Zhang 
et al., 1998). Deficiency in LAT severely impairs T cell receptor signalling 
(Zhang et al., 1999). Structurally, LAT is a transmembrane protein with nine 
tyrosine sites conserved between human and mice, five of which can undergo 
phosphorylation (Y127, Y132, Y171, Y191, and Y226) (Paz et al., 2001). Once 
phosphorylated, they constitute major docking sites for multi-protein complexes 
regulating transcription, cytoskeletal reorganization, and cell adhesion 
(Sommers et al., 2001). Experimental mutation of these tyrosine residues to 
phenylalanine revealed that phosphorylation of Y132 recruits phospholipase-C-γ 
(PLC-γ), which can subsequently mediate the Ca(2+)-dependent activation of the 
nuclear factor of activated T cells (NFAT), and the activation of the extracellular-
signal-regulated kinase (ERK)/MAPK pathway through Ras-guanyl nucleotide-
releasing protein (RasGRP) (Lin and Weiss, 2001; Paz et al., 2001). Y171, 
Y191, and Y226 are recognised by growth factor receptor-bound protein 2 
(Grb2)-family members (Grb2, Gads, and Grap) and are critical for recruiting 
SLP76 and son of sevenless 1 (SOS1) (Zhang et al., 1998). Finally, distal 
signalling pathways are recruited with, for instance, activation of the nuclear 
factor-kappa B (NFκB) cascade through a SLP76-PKC-θ axis or the 
phosphoinositide 3-kinase (PI3K)- activator protein 1 (AP1) pathways, which are 
further reviewed below (Paz et al., 2001; Zhang et al., 2000).  
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1.2.4.2 Distal signalling and signal diversification  
a. Calcium/NFAT signalling  
Recruitment of lipase PLC-γ1 to LAT and SLP-76, followed by its activation via 
interleukin-2-inducible T cell kinase (ITK) permits PLC-γ1 to hydrolyse 
phosphatidylinositol-4,5-bisphosphate (PIP2) to diacylglycerol (DAG) and 
inositol-1,4,5-trisphosphate (IP3)(Min et al., 2009). IP3 binds to its receptor 
(IP3R) on the ER membrane allowing the release of Ca(2+). The decrease of 
Ca(2+) within the ER is sensed by stromal interaction molecule 1 (STIM 1), which 
has been hypothesised to translocate to the plasma membrane to activate 
calcium‑release‑activated calcium (CRAC) channels, which triggers a further 
influx of Ca(2+) (Bootman, 2012; Zhang et al., 2005). This increased intracellular 
Ca(2+) binds to calmodulin which in turn activates the calmodulin-dependent 
enzyme, calcineurin. The latter promotes the translocation of NFAT into the 
nucleus by dephosphorylating its regulatory domain (or NFAT-homology region; 
NHR) (Bootman, 2012). Indeed The NHR contains several serine residues, 
which are phosphorylated under steady state (Macián, 2005; Macián et al., 
2001). Once in the nucleus, NFAT acts in synergy with other partners to 
regulate the transcription of target genes and one of its principal partners is the 
activating protein 1 (AP1) complex composed of FOS and JUN (Macián, 2005). 
This pathway is also regulated by the RAS/MAPK pathway (reviewed below).  
b. ERK/MAPK signalling 
The PLC-γ1-mediated hydrolysis of PIP2 also generates DAG that can activate 
RAS-guanyl-nucleotide-releasing protein (RasGRP), which regulates Ras 
activity. It has been postulated that TCR signal strength would 
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compartimentalise Ras within the cell (Harding et al., 2005). TCR signalling 
triggers Ca(2+) and DAG release which are responsible for activating RasGRP 
and the golgi-associated form of Ras through guanine exchange (GDP to GTP), 
while at the same time negatively regulating membrane-associated Ras (Bivona 
et al., 2003). Work in vitro undertaken on Jurkat cells have shown that low-
grade signals preferentially activate golgi-associated ERK while strong TCR 
signals target membrane-associated ERK (Chiu et al., 2002; Daniels et al., 
2006; Perez de Castro et al., 2004). Ras subsequently activates the 
MAPK/ERK pathway via Raf and MEK. Once activated, ERK has several 
targets including the AP1 complex (Minden et al., 1994).  
b. PI3K signalling  
The PI3K family of kinases phosphorylate the D3 position of phosphoinositides 
resulting in the generation of lipid second messengers (Okkenhaug and 
Vanhaesebroeck, 2003). The PI3K family can be divided into three subclasses 
(Class I, Class II, Class III) according to structural similarities (Okkenhaug and 
Vanhaesebroeck, 2003). Class I PI3Ks have been largely implicated in 
lymphocyte signalling and therefore will be the only class reviewed in this 
introduction (Okkenhaug and Vanhaesebroeck, 2003). Class I PI3Ks are 
divided into two groups: Class IA PI3Ks are found downstream of tyrosine-
kinase-associated receptors such as the TCR. They consist of a heterodimeric 
complex composed of a regulatory subunit (p85α, p85β or p55γ) and a catalytic 
subunit with kinase activity (p110α, p110β or p110δ) (Okkenhaug and 
Vanhaesebroeck, 2003). There is a single known member of the class IB PI3K 
family; PI3Kγ that is found downstream of G-coupled protein receptors such as 
chemokine receptors. PI3Kγ is a heterodimeric protein composed of a 
  
45 
 
regulatory subunit p101 and a catalytic subunit p110γ. Importantly, while p110α 
and p110β are expressed in a variety of cell types, p110δ and p110γ are 
restricted to leukocytes (Okkenhaug et al., 2002; Okkenhaug and 
Vanhaesebroeck, 2003). Class I PI3Ks phosphorylate PIP2 to produce 
phosphatidylinositol-(3,4,5)-trisphosphate (PIP3) at the inner part of the 
membrane which in turn constitutes the binding site for various Pleckstrin-
Homology (PH) domain-containing proteins such as AKT that has been shown 
to be critical for cell proliferation, growth, and survival (Harriague and Bismuth, 
2002; Hemmings and Restuccia, 2012). Although PI3K has been shown to be 
essential for signalling in lymphocytes, it remains uncertain how it is linked to 
the TCR. The p85 isoform contains two SH2-domains and one SH3-domain 
allowing interactions with other signalling molecules. It has been shown that 
SLP-76 and LAT were required for the activation of PI3K probably through the 
interaction with VAV1 (Reynolds et al., 2002; Shim et al., 2011). Alternatively, 
the TCR-interacting molecule (TRIM), which gets phosphorylated following 
activation (probably by Zap-70), has been proposed to activate PI3K (Bruyns et 
al., 1998). Finally, the CD28 co-stimulatory protein has been shown to 
associate with p85 and can activate PI3K signalling (Okkenhaug and 
Vanhaesebroeck, 2003; Pages et al., 1994; Prasad et al., 1994).  
 
  c. NFκB signalling 
The NFκB family consist of five transcription factors; RelA (p65), Relb , c-Rel, 
p50 (NFΚB1) and p52 (NFΚB2), which are found as inactive dimeric complexes 
(p50/p65, Relb/p50 or p52/Relb) in the cytoplasm where they are sequestered 
by inhibitors IΚB (p100 or p105) (reviewed in (Bonizzi and Karin, 2004). 
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Activation of NFΚB signalling occurs through a wide range of stimuli delivered 
by various types of receptor such as the tumour necrosis factor receptor 
(TNFR), Toll-like receptor (TLR) or the antigen receptor (BCR or TCR). NFΚB 
signalling is commonly divided into canonical and non-canonical pathways. 
TCR signalling was shown to activate the canonical signalling pathway through 
protein Kinase C (PKC) and the CMB complex (including CARD11, Bcl10, 
Carma1 and MALT-1) as deletion of any of the CMB proteins led to a major 
block in T cell activation following TCR stimulation by cross-linking of CD3 
molecules (Paul and Schaefer, 2013; Pomerantz et al., 2002; Sommer et al., 
2005; Sun, 2010; Wang et al., 2002). Signalling through the TCR or cytokine 
receptors induces phosphorylation and activation of an IKKα:IKKβ complex that 
also includes the regulatory subunit NEMO (also known as IKKγ) possibly in a 
TNF receptor-associated factor 6 (TRAF6) dependent manner (Paul and 
Schaefer, 2013). This activated IKK complex then phosphorylates IΚB targeting 
it for destruction via ubiquitination. This enables the NFΚB hetero-dimer 
(p50/p65) to translocate to the nucleus where it can alter gene expression. By 
contrast, certain receptors such as the lymphotoxin-β receptor (LTβ-R) trigger 
both the canonical and non-canonical NFΚB branches. Signalling through LTβ-
R results in NIK and IKKα phosphorylation, which in turn phosphorylate the 
p100-Relb dimer resulting in the partial degradation of p100 into p52 (Heusch et 
al., 1999). The p52-Relb dimer then translocates to the nucleus to again 
regulate a set of target genes (Figure 1.8) (Gerondakis et al., 2006).  
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Figure 1.8 The canonical and non-canonical NFΚB pathways. Signalling through 
the TCR triggers the NFΚB canonical pathway. IKKα, which is part of a complex 
containing Nemo and IKKβ, gets phosphorylated and in turn phosphorylates IΚB. 
Phosphorylated IΚB is targeted for degradation freeing up the p50-p65 heterodimer to 
translocate to the nucleus. Activation of the non-canonical pathway phosphorylation of 
an IKKα dimer result in the phosphorylation, ubiquitination and degradation of the p100 
to p52. The p52/Relb heterodimer is then translocated to the nucleus where it can 
modulate gene transcription (Oeckinghaus et al., 2011). 
 
 
1.2.5 Conventional and unconventional T cells 
T cells can also be broadly divided into conventional or unconventional subsets 
according to; their capacity to recognise and respond in a non-detrimental 
manner to self-antigen; their location in the body (secondary lymphoid organs 
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versus tissues); and their development; all of which will be introduced 
subsequently in this thesis.  
1.2.5.1 Conventional T cells  
 
Conventional T cells mainly include cytotoxic T cells (CTLs) and helper T cells 
(TH cells), which express along with TCRαβ, a heterodimeric CD8αβ co-
receptor, or the monomeric CD4 co-receptor, respectively. CTLs constitute a 
fairly homogeneous subset of T cells and exhibit cytotoxic activity allowing them 
to directly induce apoptosis in target cells. TH cells are mainly implicated in the 
recruitment and direction of the humoral and cell-mediated branches of the 
immune system through the production of cytokines. They can be divided into 
several further subsets depending on the cytokine environment in which they 
are generated, the effector function they exhibit, and the type of pathogens 
against which they are most effective. For simplicity, only three TH subsets will 
be discussed here.  
a. T helper cell subsets 
Upon infection, antigen-presenting cells (APCs) such as dentritic cells (DC) 
migrate from the site of infection to lymphoid organs and present pathogen-
derived products to naïve CD4(+) T cells through MHC-II, which represents the 
initial step of T cell activation (referred as signal 1). In order to become fully 
activated, naïve T cells require two additional signals; interaction between 
CD28 and CD80/CD86 co-stimulatory molecules present on T and DC 
respectively (signal 2), and cytokines produced by DCs (signal 3). T cells 
activation triggers cell division and differentiation of naïve CD4(+) T cell into 
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effector TH subsets. Differentiation into a TH1 phenotype is dependent on 
interleukin 12 (IL-12) while polarisation into a TH2 or TH17 phenotype is driven 
by IL-4 or a combination of transforming growth factor β (TGF-β) and IL-6, 
respectively (Figure 1.9) (Hsieh et al., 1993; Mosmann et al., 1986).  Each TH 
subset is also characterised by the expression of certain “master” transcription 
factors and the major cytokines they produce. TH1 cells produce interferon γ 
(IFN-γ) and express the transcription factor T-bet. TH2 cells are producers of IL-
4 and express GATA3. Finally, differentiation into IL-17-secreting TH17 cells is 
dependent on the transcription factor RORγt. Each TH subset performs a 
specific function in the adaptive immune response. TH1 cells promote the cell-
mediated branch of the adaptive immune system and are involved for instance 
in the clearance of intracellular pathogens. By contrast, TH2 cells promote the 
humoral immune response that is important for controlling parasitic infections. 
Finally, TH17 cells have a pro-inflammatory role and are implicated in clearing 
extra-cellular pathogens, particularly extracellular bacteria. TH17 cells are also 
often implicated in autoimmune conditions.  
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b. CD8(+) T cells  
Conventional CD8(+) T cells have a central role in eradicating intracellular 
infections and tumours. During an immune response, intra-cellular pathogens or 
tumour-associated antigens undergo proteosomal degradation within the 
infected/transformed cell. The resulting antigens are transported to the 
endoplasmic reticulum (ER) by ABC transporters antigen processing (TAP) 1 
and TAP2, which mediate the loading of the antigen onto the major 
 
Figure 1.9 CD4(+) T cells can be polarised into at least three TH subsets. 
Differentiation of naïve CD4(+) T cells into an effector TH subset is dependent on the 
cytokine milieu in which activation takes place. It occurs in lymph nodes following 
interaction with pathogen-derived antigens presented by antigen presenting cells 
(APCs) such as dendritic cells (DC). Each TH subset can be characterised by a 
“master” transcription factor and a secreted cytokine signature. TH1 cells express Tbet 
and produde IFN-γ. TH2 cells express GATA3 and secerete cytokine IL-4. TH17 cells 
express RORγt and secrete IL-17.  
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histocompatibility complex class I (MHC-I) peptide-binding groove with the help 
of the chaperon molecule Tapasin. The peptide/MHC complex is then 
transported to the surface of the cell to allow interaction between TCRαβ and 
peptide/MHC-I complex resulting in the activation of the CD8(+) T cell and the 
acquisition of a cytotoxic phenotype (Williams et al., 2002). Two additional 
models have been proposed to describe the mechanism by which CD8(+) T cells 
get activated and they both involve CD4(+) T cells which  would cooperate to 
provide “extra” help during activation. In one model, CD4(+) and CD8(+) T cells 
interact simultaneously with the same DC (Bennett et al., 1997). Activation of 
the CD4(+) T cell results in the secretion of interleukin 2 (IL-2) thought to be 
responsible for driving the expansion of CD8(+) T cells (Bennett et al., 1997). 
Alternatively, CD4(+) T cells can interact and trigger activation of DCs through 
the CD40/CD40L axis endowing them with increased ability to activate CD8(+) T 
cells (Ridge et al., 1998). In all models, activation of the CD8(+) T cell results in 
clonal expansion and subsequent secretion of granzymes and perforins which 
induce lysis of infected/transformed cells. Moreover, CD8(+) T cells can release 
inflammatory cytokines (IFN-γ and TNF) responsible for recruiting additional 
immune cells and driving disease clearance (Barth et al., 1991). 
1.2.5.2 Unconventional T cells 
 
Unlike conventional T cells, unconventional T cells reside mainly in peripheral 
tissues, have a relatively high affinity for self-antigens, and have a poorly 
understood developmental pathway. They often, but not always, express a TCR 
with limited diversity and display innate-like functions. These unconventional T 
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cells mainly consist of γδ T cells, intra-epithelial lymphocytes (IELs), natural 
killer T cells (NKT) and arguably include regulatory T cells (Tregs) (Figure 1.).  
 
a. γδ T cells 
γδ T cells are prototypic unconventional T cells that are thought to straddle the 
innate and adaptive immune systems. They display innate-like functions such 
as rapid effector function to infections, a preferential tropism to epithelial 
tissues, the expression of innate-like receptors such as natural killer group 2D 
(NKG2D) and the expression of a TCRγδ with reduced diversity. γδ T cells 
mediate immunity against pathogens and are potent mediators of tumor 
immunosurveillance (Street et al., 2004). Indeed, γδ T cell recognition of 
tumours occurs through TCRγδ and NKG2D receptors, triggering a potent 
cytotoxic phenotype and the production of high levels of cytokines such as 
 
Figure 1.10 The unconventional T cell family. Unconventional T cells undergo a 
different mechanism of selection, are often found in tissues, and display innate-like 
features. The prototypic unconventional T cell is the γδ T cell, but also includes natural 
killer T cells, and TCRαβ(+)CD8αα(+)IELs. 
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tumour necrosis factor (TNF) and IFNγ (Gao et al., 2003). In agreement with 
this, mice deficient for γδ T cells (TCRδ-deficient animals) are significantly more 
susceptible to chemically-induced, transplantable and spontaneous tumours 
(Girardi et al., 2001).  
γδ T cells can be segregated into two functionally distinct subsets depending on 
expression of the TNF-superfamily receptor CD27 (Ribot et al., 2009). IFN-γ-
producing γδ T cells express CD27 (γδ( 27+)) whereas absence of CD27 
describes an IL-17A-producing γδ T cell subset (γδ(27-)), which mainly consists of 
Vγ4(+) and the Vγ6(+) cells (Cai et al., 2011; Hamada et al., 2008; Ribot et al., 
2009; Sumaria et al., 2011).  
b. Unconventional intraepithelial lymphocytes (IELs) 
Intraepithelial lymphocytes (IELs) are a large heterogeneous population of T 
cells that can be members of either the γδ or αβ lineage. They display anti-
inflammatory and anti-microbial responses, while tolerating commensal bacteria 
and controlling epithelial homeostasis. This thesis focuses on IELs located in 
the epithelial layer of the ileum that along with TCRαβ express the homodimeric 
form of CD8α (Gangadharan and Cheroutre, 2004). Unconventional 
TCRαβ(+)CD8αα(+) IELs display abundant cytotoxic function through the 
expression of granzymes, perforins and FAS-ligands but produce low amounts 
of IFN-γ despite an activated phenotype (as demonstrated by high levels of 
CD69) (Shires et al., 2001). Their precise role in the gut has yet to be fully 
described but expression of NK-like activatory markers DAP12, 2B4, or 
inhibitory Ly49, implicate them as a stress-sensing population essential for 
epithelial immune surveillance (Denning et al., 2007; Shires et al., 2001). 
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Finally, they have been implicated in immune regulation due to expression of 
immune regulators such as lymphocyte activation gene 3 (LAG3), TGF-β and 
fibrinogen-like 2 (FGL2) (Cheroutre et al., 2011). Indeed, transfer of 
TCRαβ(+)CD8αα(+) IELs to a colitis model prevented induced-intestinal 
inflammation (Poussier et al., 2002).  
c. NKT cells  
NKT cells represent only 0.5% of all blood T cells but constitute a major 
component of tumour immunity. They are found in blood, spleen, liver, and 
lymph nodes and express a TCRαβ. They can be divided into two main 
categories in mouse according to the co-receptors they express, their TCRαβ 
specificity, the diversity of their TCR and the presenting molecules they 
recognise. Type I NKT cells express NK1.1 and a TCRαβ repertoire composed 
of a TCRα chain using Vα14–Jα18 and a TCRβ chain using Vβ8.2/7/2, which 
has been shown to have high affinity for α-galactosylceramide (α-GalCer) 
presented in the context of CD1d. The second category of NKT cells express 
CD4 or none of the co-receptors and a semi-variable TCRαβ, characterised by 
frequent pairing of Vα3.2–Jα9 TCRα chains with Vβ8 TCRβ chains and their 
reactivity is unclear (Kronenberg and Gapin, 2002).  
 
d. Regulatory T cells  
Regulatory T cells (Tregs), are not involved in the clearance of infections but 
instead suppress unwanted immune responses. In addition to expressing 
TCRαβ and the co-receptor CD4, the major population of Tregs express the α-
chain of the IL-2 receptor, CD25, the transcription factor forkhead box P3 
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(foxp3), and mediate their suppressive functions through a variety of 
mechanisms that include cell-contact-dependent mechanism and the production 
of IL-10 or TGF-β. Foxp3(+) Tregs can be divided into naturally-occurring Tregs 
(nTregs) arising from the thymus and inducible Tregs (iTregs) that develop in 
the periphery from naïve CD4(+) T cells in the specific cytokine milieu of TGF-β. 
Inducible Tregs are often divided into two additional subsets with Tr1 Tregs 
secreting large amounts of IL-10 and Th3 Tregs preferentially producing TGF-β. 
Their suppressive functions were first described in a seminal study in which 
transfer of CD4(+) T cells depleted of CD4(+)CD25(+) T cells into athymic mice 
triggered the development of auto-immunity. Transfer of CD4(+)CD25(+) T cells 
successfully prevented the appearance of the symptoms in a dose-dependent 
manner (Sakaguchi et al., 1995). Thus, Tregs represent an important subset for 
controlling unwanted immune responses and maintaining peripheral tolerance. 
 
Collectively, this section describes the significant heterogeneity of the T cell 
family. Nonetheless, despite displaying diverse effector functions, sites of action 
and method of activation, all T cells develop from a common thymic progenitor 
and are indispensable for a healthy immune system. One of the central 
questions of the lab focuses on understanding how this heterogeneity in T cell 
phenotype is achieved in development.  
1.3 T cell development  
T cell development principally takes place in the thymus, an organ located in 
the upper part of the chest above the heart. Despite being identified as the 
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lymphocyte-producing organ by Sir Peter Medawar and Sir James Learmonth 
Gowans, its pillar immunological role was only demonstrated by Jacques Miller 
in 1962 through the use of thymectomised mice (Miller, 1961). It has been 
suggested that some unconventional T cells develop extra-thymically. Indeed, 
the presence of TCRαβ(+)CD8αα(+) IELs or NKT cells in athymic mice supports 
the idea that these cells could develop in localized structures found in the 
periphery (Guy-Grand et al., 2003; Kikly and Dennert 1992; Makino et al., 
1993). However, numbers and proportions of these cells were highly reduced in 
athymic mice highlighting the importance of the thymus for a full T cell 
compartment. Thus, this thesis concentrates on thymic T cell development. 
 
1.3.1 Structure of the thymus 
The thymus is composed of two lobes and is divided into a cortex, 
corresponding to the outer layer of the organ, and a medulla that constitutes the 
core. The cortex is itself divided into four regions with region one being more 
proximal to the medulla and region four found in the sub-capsular region or 
outer cortex (Blackburn and Manley, 2004). The thymus involutes with age as a 
result of stromal atrophy, mainly consisting of fat by the time an individual 
reaches adulthood (Figure 1.11) (Dorshkind and Montecino-Rodriguez, 2009). 
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Figure 1.11 A schematic representation of the structure of the thymus.  The 
thymus is conventionally divided into the cortex, constituting the outer layer of the 
organ and the medulla constituting the core. The cortex is further divided into four 
regions with region 1 being more centrally localised, near the cortico-medullary junction 
than region 4, that is found near the capsule. 
 
1.3.2 An overview of αβ T cell development 
T cell development is commonly divided into two main phases based on the 
expression of the CD4 and CD8 co-receptor molecules; the Double Negative 
(DN) phase in which immature thymocytes lack surface expression of both co-
receptors and the Double Positive (DP) phase where both CD4 and CD8 are 
expressed (Germain, 2002). The DN phase is further divided into four stages 
(DN1-DN4) based on cell surface expression of CD44, CD25 (α chain of the IL2 
receptor) and c-Kit. T cells develop sequentially through the DN1 
(CD44(+)CD25(-)c-Kit(+)), DN2 (CD44(+)CD25(+)c-Kit(+)), DN3 (CD44(-) CD25(+)c-
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Kit(-)), and DN4 (CD44(-)CD25(-)c-Kit(-)) stages (Figure 1.12) (Godfrey et al., 
1993). 
 
The DN1 subset is very heterogeneous and is believed to retain the potential to 
give rise to T cells, B cells or NK cells (Porritt et al., 2004). Full commitment of 
DN1 cells to the T cell lineage is dependent on signalling through the 
transmembrane glycoprotein Notch-1. Indeed, Radtke and co-workers showed 
that conditional ablation of Notch-1 in mice caused DN1 cells to acquire a B cell 
phenotype (Radtke et al., 2000).  
 
A high proportion of DN2 cells proliferate and display some features indicative 
of T cell lineage commitment. Indeed, CD3, TCRζ, the invariant protein pTα and 
Lck can be detected (Wilson and MacDonald, 1995). Moreover, the expression 
of RAG-1 and RAG-2 is initiated in DN2 cells, which drives TCR rearrangement. 
However, foetal thymic cultures (FTOC) revealed that DN2 thymocytes still 
retain potential to adopt alternative non-T cell lineage fates such as B, NK or 
macrophages lineages when cultured in different conditions (Balciunaite et al., 
2005; Yui, 2010).  
 
DN3 thymocytes are fully committed to the T cell lineage and mark the first 
major T cell developmental checkpoint; the β-selection checkpoint. This stage 
also correlates to when thymocytes adopt either a γδ or αβ fate (this is 
discussed subsequently). Expression of the pre-T cell receptor (preTCR; the 
invariant pTα chain paired to TCRβ) allows DN3 cells to survive, proliferate and 
differentiate to the subsequent DN4 stage. Two populations within the DN3 
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subset can be identified, which correspond to pre-β-selected thymocytes (DN3S 
also known as DN3a), and post-β-selected thymocytes (DN3L, DN3b) that are 
fully committed to an αβ T cell fate. DN3S thymocytes are not yet proliferating 
as shown by their arrest in the G1 phase of the cell cycle, and are considerably 
smaller than DN3L cells (hence their nomenclature) (Hoffman et al., 1996). 
Although DN3S cells express high levels of RAG proteins, suggesting that 
rearrangement of TCRβ has been initiated, only 33% of TCRβ chains are found 
to be rearranged in-frame. This is because only one of the possible reading 
frame of TCRβ makes functional protein, and the rearrangement process 
essentially produces equal numbers of rearranged TCRβ chains in each of the 
three frames (Alt et al., 1984). By contrast, most DN3L thymocytes express in-
frame TCRβ chains as only TCRβ(+) cells (or γδ cells) can traverse the β-
selection checkpoint. DN4 cells are also enriched in cyclin A and CDK2 
indicative of entry into the cell cycle (Hoffman et al., 1996). 
 
DN4 thymocytes represent an intermediate subset from which thymocytes 
transit to an “Immature Single Positive” (ISP) phenotype, expressing low levels 
of the co-receptor CD8 but no CD4 (Miyazaki, 1997). CD4 up-regulation rapidly 
follows allowing cells to reach the DP stage. DP cells start to rearrange their 
TCRα locus in an attempt to generate a mature TCRαβ (Mombaerts et al., 
1992). Interactions between MHC/self-peptide molecules and TCRαβ triggers 
cell surface expression of CD5, CD69 and termination of TCRα gene 
rearrangement, allowing DP cells to develop as either naïve TCRαβ(+)CD4(+) or 
TCRαβ(+)CD8(+) single positive cells (SP) (Azzam et al., 1998; Yamashita et al., 
1993).  
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Figure 1.12 An overview of thymic T cell development. A progenitor enters the thymus with a double negative (DN) phenotype due to lack of 
CD4 and CD8 expression. The DN stage is conventionally divided into five DN steps: DN1 (CD44(+)CD25(-)cKit(+)), DN2 (CD44(+)CD25(+)cKit(+)), 
DN3s (CD44(-)CD25(+)cKit(-)),  DN3L (CD44(-)CD25(+)cKit(-)pre TCR(+)), and DN4 (CD44(-)CD25(-)cKit(-)pre TCR(+)). At the DN3s stage, expression of 
preTCR will drive the cell towards an αβ fate whereas expression of TCRγδ will drive commitment towards the γδ T cell lineage. Progression from 
the DN4 stage leads to the immature single positive (ISP) stage followed by the double positive (DP) stage, from which single positive (SP) 
TCRαβ(+)CD4(+) and  TCRαβ(+)CD8(+) thymocytes are generated.  
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1.3.3 Intra-thymic migration 
Thymic T cell development involves maturation of cells as they migrate within 
the thymus, a journey that relies on expression of integrins and chemokine 
receptors, and their respective ligands on thymic epithelial cells (TEC) of the 
thymic stroma (Petrie, 2003). TEC can be subdivided into cortical thymic 
epithelial cells (cTEC) and medullary thymic epithelial cells (mTEC) (Lucas et 
al., 2003; Takahama, 2006). Hematopoietic progenitors enter the thymus at the 
cortico-medulla junction and subsequently migrate to the sub-capsular region. 
From there they move inwards towards the medulla to finally egress the thymus 
via blood vessels found in the medulla. Importantly, colonization of the thymus 
is said to be a “gated” phenomenon, in which T cell precursors are recruited 
periodically and populate the thymus in waves (Foss et al., 2001).  
 
Seeding of the thymus by hematopoietic progenitors starts at embryonic day 
11.5 (E11.5) in mice, and at week 8 of gestation in humans. It is thought that 
this can occur in a vasculature-independent manner through the combined 
action of chemokine ligand 21 (CCL21) and CCL25 on progenitor-expressed 
chemokine receptors 7 (CCR7) and CCR9 respectively (Liu et al., 2006; Liu et 
al., 2005; Misslitz et al., 2004). T cell progenitors are recruited to the outer 
cortex by CCR7, CCR9 and C-X-C chemokine receptor type 4 (CXCR4). 
However, although, CCR9-deficient animals show aberrant distribution of DN3 
thymocytes within the cortex it did not result in a defect in T cell development 
(Figure 1.13) (Benz et al., 2004). Progression through the β-selection 
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checkpoint is dependent on CXCR4, which acts as a co-stimulatory signal (Ara 
et al., 2003; Plotkin et al., 2003; Trampont et al., 2009).  
Finally, positively selected double positive (DP) thymocytes progress towards 
the medulla following a CCL19/21 gradient (CCR7 ligands) and up-regulate the 
G-coupled protein Sphingosine-1-Phosphate Receptor 1 (S1P1) (Kurobe et al., 
 
Figure 1.13 Schematic representation of intra-thymic migration. A hematopoietic 
progenitor enters the thymus at the corti-medulla junction via blood vessels. Migration 
of DN progenitors to the cortex is dependent on CCR7, CCR9 and CXCR4. Positive 
selection of DP thymocytes takes place in the cortex as peptides are presented by 
cTEC. CCR7 expression allows them to progress to the medulla once positively 
selected where their TCRαβ will be further tested for self-reactivity by mTEC. Egress of 
the thymocytes relies on the expression of S1P1.  DN, CD4(-)CD8(-); CXC4 CX-
chemokine receptor 4; CCR7, CC-chemokine receptor 7; CCR9,CC-chemokine 
receptor 9; DP, CD4(+)CD8(+); DC, Dendritic cells; cTEC, cortical thymic epithelial cells; 
mTEC, medullary thymic epithelial cells;  sphingosine-1-phosphate receptor 1 (S1P1). 
Adapted from (Takahama, 2006) 
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2006; Ueno et al., 2004). Because concentrations of Sphingosine-1-Phosphate 
(S1P) are low in the perivasculature cells but high in blood vessels connected to 
the thymus, thymocytes are attracted to follow this gradient and egress the 
thymus (Matloubian et al., 2004; Reinhardt et al., 2014; Schwab et al., 2005; 
Spiegel and Milstien, 2011)  
 
1.3.4 Thymic T cell selection – a fundamental checkpoint for αβ T cell 
development 
1.3.4.1 Positive and negative selection of conventional T cells  
 
The DP stage is the first point at which developing αβ T cells express a newly 
generated TCRαβ complex. Importantly, releasing self-reactive T cells in the 
periphery represents an obvious threat to health due to their ability to trigger 
autoimmune diseases. Thus, during a filtering process, known as T cell 
selection, TCRαβ self-reactivity to self- antigens is assessed ensuring that only 
DP thymocytes with low self-reactivity develop into naïve conventional CD4(+) 
and CD8(+) T cells and egress the thymus. As highly motile DP thymocytes (3 to 
8µm.min-1) migrate throughout the thymic medulla, they halt to interact with self-
peptides presented by mTECs (Bousso et al., 2002). Indeed, mTECs have the 
ability to display tissue-specific self-antigens due to the expression of the 
transcriptional factor autoimmune regulator (AIRE) (McCaughtry et al., 2008; 
Ramsey, 2002).  The strength of TCRαβ signal received by DP progenitors 
instructs the developmental outcome of (death or survival) and is proportional to 
the affinity between TCRαβ and self-peptide/MHC. High affinity interactions (i.e. 
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full agonist) result in negative selection via induction of apoptosis. This prevents 
the maturation of self-reactive T cells and is often termed “central tolerance”. 
Alternatively, a medium affinity interaction (i.e. a partial agonist) generates a 
positively selecting signal resulting in the survival and differentiation of DP cells 
(about 5% of all DPs) into CD4(+) or CD8(+) T cells. Finally, failure of a TCRαβ to 
recognise self-peptide/MHC leads to a process known as “death by neglect” in 
which “useless” TCRαβ are purged from the T cell repertoire (Figure 1.14) 
(Palmer, 2003; Stefanová et al., 2002). It has been estimated that as many as 
75% of DP thymocytes that have initiated selection fail to mature and complete 
this process (Sinclair et al., 2013; Yates, 2014).  
 
Figure 1.14 Central tolerance. DP thymocytes expressing a TCRαβ which 
recognises self-peptide MHC with medium affinity undergo positive selection and 
are allowed to differentiate into TCRαβ(+)CD4(+) and  TCRαβ(+)CD8(+) T cells. TCRs 
with high affinity towards peptide/MHC will be negatively selected resulting in their 
apoptosis. Finally, TCRs unable to recognise peptide/MHC will undergo death by 
neglect. 
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1.3.4.2 Agonist selection of unconventional αβ T cells 
 
Unconventional αβ T cells follow an alternative method of selection in that they 
appear to undergo agonist-driven positive selection in which strong affinity 
between TCRαβ and self-peptide-MHC is required for DP cells to acquire an 
unconventional phenotype (Figure 1.15) (Jordan et al., 2001; Leishman et al., 
2002).  
 
Figure 1.15 Agonist selection for unconventional αβ  T cells. Conventional αβ T 
cells develop following interactions with weak affinity self-peptide MHC. By contrast,  
unconventional T cells are thought to be selected on stronger affinity interactions with 
self-peptide/MHC. Failure to recognise self-peptide or strong affinity binding with self-
peptide result in death by neglect or negative selection respectively.  
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- Agonist selection of regulatory T cells   
Agonist selection of regulatory T cells was demonstrated in a landmark study, 
which used the MHC-II-restricted TCRαβ transgenic 6.5 system (also known as 
TSI TCR) recognising hemagglutinin of the influenza (HA) virus (Jordan et al., 
2001). Crossing of these mice with a HA-expressing transgenic animal resulted 
in a striking increase of CD4(+) CD25(+) T cells, indicative of regulatory T cells, 
amongst CD4(+) thymocytes  (Jordan et al., 2001). When the TSI transgenic 
TCR was mutated to bind HA with weaker affinity, regulatory T cell development 
was no longer favoured (Jordan et al., 2001).  
- TCRαβ(+)CD8αα(+) IELs 
Data suggests that TCRαβ(+)CD8αα(+) IELs also undergo agonist selection 
driven by self-peptide.  Indeed, male mice transgenic for a TCRαβ recognising 
the male specific antigen HY (that is presented on MHC-I) were shown to have 
a greater proportion of HY-specific TCRαβ(+)CD8αα(+) IELs compared to 
conventional HY-specific αβ T cells. The authors concluded that 
TCRαβ(+)CD8αα(+) IELs must be developing via agonist selection in the thymus 
(Cruz et al., 1998). In another study, co-culture of HY-TCR-bearing thymocytes 
with stromal cells from female thymuses (i.e. that lack the H-Y antigen) and 
supplemented with increasing concentrations of agonist HY peptide, showed an 
increased generation of CD8(+) T cells with a TCRαβ(+)CD8αα(+) phenotype 
when compared to conventional cytotoxic T cell progenitors (Yamagata et al., 
2004). Similar results were obtained when OT-I transgenic T cells, recognising 
an ovalbumin peptide presented by MHC-I, were supplemented with increasing 
dose of peptide or when the MHC-II restricted 5CC7 TCR transgenic cells 
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recognising cytochrome c preferentially adopted a TCRαβ(+)CD8αα(+) 
phenotype in the presence of high dose of cytochrome c (Leishman et al., 
2002). Thus, supplementation of agonist peptide in three different TCR 
transgenic models correlated with gradual disappearance of conventional 
TCRαβ(+)CD8αβ(+) cells and appearance of TCRαβ(+)CD8αα(+) cells (Yamagata 
et al., 2004).  
 
It remains unclear why some DP thymocytes undergo conventional selection 
based on medium affinity TCRαβ/self-peptide/MHC interactions to become 
conventional naïve CD4(+) and CD8(+) T cells, while other DP cells that receive 
an agonist signal develop as unconventional T cells. It may suggest that the DP 
stage consists of a heterogeneous subset of cells, which do not have equal 
potential to become conventional or unconventional T cells. This leads to some 
interesting questions; How is this heterogeneity achieved? And why do some 
DP cells survive strong signals and develop into unconventional T cells while 
others undergo apoptosis? These questions form a basis for the work 
presented in this thesis. 
1.3.4.3 Major signalling pathways implicated in T cell selection  
 
Differing affinities of interaction of TCRαβ with self-peptide/MHC during T cell 
selection trigger qualitatively different intracellular signals that result in DP cell 
survival or death. This raises the question of how signalling through a single 
receptor (here TCRαβ) leads to opposing developmental outcomes. This can be 
principally explained by engagement of qualitatively different signalling 
pathways. Indeed, the affinity and length of interaction between TCRαβ and 
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self-peptide/MHC during positive selection dictates the frequency of Ca(2+) 
oscilliations and likely influences downstream MAPK pathways including those 
that engage ERK, JNK and p38; weak affinity interactions have been 
associated with an oscillatory Ca(2+) signal, medium affinity interactions with a 
sustained Ca(2+) signal, while high affinity interactions (with full agonist) with a 
transient Ca(2+) signal (Kupzig et al., 2005). The role of ERK in the positive 
selection of T cells was initially demonstrated in a study where transgenic 
expression of a dominant negative MEK1 transgene, that is the up-stream 
activator of ERK, was shown to reduce positive selection of DP thymocytes as 
shown by a reduction in DP CD69(+) cells (Alberola-Ila et al., 1995). However, 
HY-TCR transgenic mice expressing the dominant negative transgene did not 
show a difference in the degree of negative selection, supporting initially a role 
for the MEK1/ERK1 pathway only in the positive selection of T cells (Alberola-Ila 
et al., 1995). Subsequent studies analysing the kinetics of ERK signalling 
showed that negatively-selecting peptides triggered a short but strong ERK 
signal while positively-selecting peptides resulted in a sustained long-lived ERK 
signal (Mariathasan et al., 2001; Starr and Hogquist, 2005; Werlen et al., 2000). 
It was subsequently shown by Crabtree’s lab that negatively-selecting ligands 
(high affinity ligands) activated ERK as well as the Bim-expressing apoptotic 
pathway, resulting in cell death. By contrast, positively-selecting ligands 
triggered the calcineurin-NFAT signalling pathway and turned ERK in what the 
authors described a “high competence state” preventing activation of Bim and 
allowing positive selection and further differentiation of DP thymocytes (Gallo et 
al., 2007). However, negative selection is not solely mediated by Bim and ERK 
but is also dependent on JNK and p38, which are mainly activated by the 
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kinases MAKK4/7 and MAKK3,4,6 respectively  (Enslen et al., 1998; Remy et 
al., 2010; Sabapathy et al., 2001; Tournier et al., 1997).  Indeed, DN cells from 
transgenic mice expressing a dominant-negative JNK1 transgene under the 
control of the Lck promoter were less able to undergo apoptosis following 
intravenous injection of anti-CD3 that is believed to mimic a strong signal 
through TCRαβ (Rincón et al., 1998). Moreover, JNK1 or JNK2-deficient 
thymocytes did not undergo negative selection following CD3 cross-linking thus 
implicating JNK2 as a mediator of negative selection (Sabapathy, 2001; 
Sabapathy et al., 1999). Preliminary data supporting a role for p38 in negative 
selection came from the observation that FTOC of E17 C57Bl/6 thymuses 
supplemented with the p38 inhibitor SB203580, harboured a greater proportion 
of TCRαβhigh SP thymocytes than in controls suggesting that DP cells had 
survived strong (possibly negatively-selecting) signals (Sugawara et al., 1998). 
Moreover, addition of SB203580 to E17 FTOC of HY-TCR transgenic thymuses 
rescued negative selection in male mice and did not alter positive selection in 
female. Finally, inhibiting p38 prevented the apoptosis of DP thymocytes 
following CD3-crosslinking (Sugawara et al., 1998). Altogether, these studies 
indicate a model where the strength of signal through TCRαβ recruits different 
signalling pathways responsible for inducing death versus survival of DP 
thymocytes.  
 
1.3.5 The β-selection checkpoint – An early checkpoint in T cell 
development 
Commitment to the γδ  or αβ T cell lineages occurs during a window of 
development that straddles the DN2, DN3 and DN4 stages. It is now widely 
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accepted to be dictated by the strength of signal delivered by one of the 
competing TCRs expressed at the β-selection checkpoint; TCRγδ or preTCR.  
1.3.5.1 The pre T cell receptor (PreTCR)  
a. The structure of the preTCR  
The preTCR consists of a rearranged TCRβ chain and an invariant pTα protein 
(Figure 1.16). pTα was first identified in the early 1990s following the 
observation that TCRα-deficient animals showed normal TCRβ expression and 
T cell development at the DN stage. Instead, T cell development was impaired 
at the DP stage where TCRα replaces pTα to form TCRαβ (Saint-Ruf et al., 
1994). It was subsequently discovered that TCRβ was associated, in addition to 
CD3 signalling molecules, with an unknown [3H]-leucine-labeled-33kD 
glycoprotein later named pTα (Fehling et al., 1995; Groettrup et al., 1993)  
 
The ptcra gene is located on mouse chromosome 17 (Chr 17) and on the short 
arm of human chromosome 6 (Chr 6), and is approximately 8kb long. Its 
structure is highly conserved across species, with nearly 77% homology 
between mice and humans, most of which arises from the extracellular and 
transmembrane portions (Del Porto et al., 1995; Saint-Ruf et al., 1998).  
b. There are two isoforms of pTα  
Two isoforms of pTα exist, as a result of alternative splicing (Figure 1.17). Full-
length pTα (referred to as pTαa) is composed of all four exons while the 
truncated isoform (referred to as pTαb) lacks the Ig-loop structure encoded by 
exon 2, and has been widely ignored (Barber et al., 1998). pTαb was first 
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discovered in H4β cells originally derived from splenocytes obtained from 
TCRα-deficient mice (Barber et al., 1998). 
 
Indeed, it was found that despite the lack of TCRα, these mice possessed a 
population of peripheral TCRβ(+)-only cells. Importantly, H4β cells expressed 
similar levels of TCRβ, CD69, CD3 and Zap-70 as peripheral T cells from wild-
type animals. Using PCR, it was revealed that these cells expressed a pTα 
mRNA lacking approximately 300bp, which is roughly the size of exon 2. Thus, 
it was hypothesised that pTα may be undergoing alternative splicing in the 
thymus. Thymic expression of both RNA isoforms in DN cells undergoing β-
 
Figure 1.16 The preTCR complex. The preTCR complex is composed of a TCRβ 
chain and an invariant pTα protein together with CD3 signalling molecules.  
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selection was subsequently confirmed both by PCR and northern blot (Barber et 
al., 1998).  
 
c. The role of pTα 
The role of pTα was initially demonstrated in pTα-deficient animals in which 
exon 3 and the beginning of exon 4 were disrupted by the insertion of a 
neomycin cassette. Importantly, pTα-deficient mice cannot give rise to either of 
the two pTα isoforms (Barber et al., 1998). These animals showed a profound 
block at the DN3 stage (with only 10% of the thymus represented by DP cells), 
illustrating the important role of pTα at the β-selection checkpoint. 
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Conversely, the γδ T cell compartment was increased by nearly 3-fold 
illustrating that, in normal circumstances, the preTCR competes with TCRγδ to 
divert DN progenitors to an αβ fate (this is reviewed below). The 10% of DP 
thymocytes observed in pTα-deficient mice appear to result from the use of 
TCRγδ. These DP cells can then undergo TCRα rearrangement to generate a 
TCRαβ that permits subsequent T cell development (Buer et al., 1997; Fehling 
et al., 1995). Expression of the preTCR triggers survival and proliferation of 
DN3 cells, and differentiation to the DN4 stage. Importantly, the preTCR also 
 
Figure 1.17 pTα  can undergo alternative splicing to give rise to two isoforms. 
The pTα gene is composed of 4 exons. Exon 1 encodes the leader peptide (black), 
exon 2 the Ig-loop structure (blue), exon 3 (orange) the cysteine residues necessary 
for disuphilde bonds, and exon 4 (purple) the transmembrane domain and the 
cytoplasmic tail. Following transcription, alternative splicing of the pTα primary mRNA 
transcript can give rise to two mRNA; pTαa mRNA is encoded by exons 1, 2, 3 and 4 
while pTαb lacks exon 2 and is composed of only three exons. Translation of the 
mRNA gives rise to two different proteins which, once paired with TCRβ chain, give 
rise to two different preTCRs; preTCRa and preTCRb  
  74 
 
promotes allelic exclusion at the TCRβ locus that prevents a second TCRβ 
chain from being rearranged once a successful TCRβ chain has formed the 
preTCR. Indeed, whereas most mature TCRαβ(+)CD8(+)T cells were found to 
contain only one productive TCRβ chain in BALB/c mice, two productive TCRα 
rearrangements were detected in nearly 30% of them (Casanova et al., 1991). 
This led to the hypothesis of an “ordered rearrangement process” where the first 
rearranged TCRβ chain would feedback and prevent the rearrangement of the 
second allele (Alt et al., 1984). Importantly Single cell PCR analysis of CD4(-
)CD8(-)CD25(+)thymocytes expressing intracellular TCRβ chains subsequently 
showed an increased frequency of in-frame TCRβ in WT cells (30%) compared 
to pTα-deficient cells, implicating the preTCR as a key regulator of TCRβ allelic 
exclusion (Aifantis et al., 1997). PreTCR-induced proliferation of DN3 
thymocytes was recently shown to be important for subsequent αβ 
differentiation. In this study, sorted DN3s cells that had not undergone at least 
four rounds of proliferation were unable to differentiate when cultured on OP9-
Delta-like 1 (OP9-DL1) cells, widely accepted to support T cell development 
(Kreslavsky et al., 2012). Thus, preTCR signalling may also be important for 
subsequent stages of T cell development.  
 
There have been only a few studies that have investigated the role of the 
truncated isoform of pTα (pTαb) in T cell development (Barber et al., 1998; 
Gibbons et al., 2001). Barber et al. showed that co-transfection of a 
TCRβ construct with either pTαa or pTαb in TCR-deficient H4β cells resulted in a 
lowered surface expression of TCRβ in the presence of pTαa but not pTαb 
(Barber et al., 1998). Interestingly, co-transfection of TCRβ with either one of 
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the pTα isoforms in a panel of twelve different cell lines revealed that cells co-
expressing pTαb and TCRβ were the highest IL-2 producers following CD3 
cross-linking (that is β/300.2, T6 and T10 cell lines) in comparison to cell lines 
expressing only TCRβ, only pTαa, or both TCRβ and pTαa (Barber et al., 1998). 
Thus, these preliminary results were the first to reveal a potential different 
biological role for each pTα isoform at the β-selection checkpoint. 
Subsequently, Gibbons et al., generated transgenic mice on a pTα-deficient 
background expressing either full-length pTαb or a truncated pTαb lacking the 
proline rich region of its cytoplasmic tail. These animals both showed a rescued 
DP compartment, a decreased proportion of γδ T cells and allelic exclusion of 
the TCRβ locus when compared to pTα-deficient animals (Gibbons et al., 
2001). However, both strains displayed reduced thymic cellularity compared to 
WT animals (i.e. with normal preTCR function). This suggested that although a 
preTCR consisting of pTαb was able to delivery most of the signals required to 
traverse the β-selection checkpoint, both pTα isoforms were needed to fully 
rescue T cell development. Importantly, expression of the pTα transgene in 
these animals was under the control of the proximal Lck promoter, which is 
constitutively expressed from the DN3 stage of T cell development onwards 
(Molina et al., 1992; van Oers et al., 1996). Thus, expression of the pTα 
transgene did not reproduce endogenous pTα expression. Nonetheless, these 
two studies suggest that pTαb is biologically active and capable of transmitting 
signals at the β-selection checkpoint. Thus, in conclusion the two preTCRs (that 
is preTCRa and preTCRb resulting from the association of pTαa or pTαb with 
TCRβ respectively) may have non-redundant roles at the DN to DP transition 
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that may reflect either qualitative or quantitative differences in the engagement 
of downstream signal transduction pathways.  
 
d. Regulation of the pTα gene - c-Myb, E-proteins and Notch  
Preliminary studies investigating pTα expression were hampered by its low cell-
surface expression and its high rate of endocytosis preventing the use of pTα-
specific antibodies. To circumvent this issue, reporter mice expressing human 
CD25 protein under the control of the pTα promoter (hCD25Tg) were generated 
and used to investigate pTα expression (Gounari et al., 2002). pTα mRNAs 
were detected in small gut-associated lymphoid structures called cryopatches 
and CD19(-) bone marrow cells in WT-C57Bl/6 mice using PCR (Bruno et al., 
1995). These bone marrow progenitors were subsequently further characterised  
in hCD25 mice and were c-KitlowSca-1lowIL-7Rα(+), a phenotype corresponding 
to the common lymphoid progenitors (Gounari et al., 2002; Kondo et al., 1997; 
Reizis and Leder, 2001). However, pTα expression is mainly restricted to the 
thymus (Bruno et al., 1995). Its expression is initiated at the DN2 stage of T cell 
development, reaches a peak at the DN3 stage, and subsequently ceases at 
the DP stage (Reizis and Leder, 1999). Characterisation of the upstream 
portion of the pTα gene revealed the presence of a proximal promoter (Reizis 
and Leder, 1999). In addition, a highly conserved region of both the human and 
mouse pTα gene (with up to 60% homology) located 4Kb upstream of the 5’ 
end of the pTα gene was suspected to contain an enhancer (Reizis and Leder, 
1999). Its presence was confirmed using two strains of BAC transgenic mice 
both containing an enhanced green fluorescent protein (eGFP) sequence 
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adjacent to exon 1 of the pTα gene, and either a functional or disrupted 
enhancer due to the insertion of a zeocin cassette. Flow cytometry analysis of 
DN3 thymocytes in four different transgenic founders revealed a lack of GFP 
expression in transgenic mice lacking the enhancer.  The authors concluded 
that the presence of the enhancer was required for pTα expression (Reizis and 
Leder, 2001; Tremblay et al., 2003). Moreover, analysis of the nucleotide 
sequence of the enhancer identified the presence of a consensus binding site 
for the transcription factor c-Myb. An electrophoretic mobility shift assay (EMSA) 
confirmed the interaction of c-Myb with the DNA sequence and showed that its 
mutation abolished interaction (Reizis and Leder, 2001). Finally, mutating the c-
Myb site in BAC eGFP pTα transgenic mice significantly decreased levels of 
pTα expression.  
 
 
E12, E47, E2-2 and HEB are all members of the basic helix-loop-helix (bHLH) 
family of E protein transcription factors. They bind DNA in a homodimeric or 
heterodimeric manner at enhancer box sites (E-box site) that contain the 
palindromic sequence CACGTG (Osborne, 2000).  An E-box site was identified 
in the enhancer region of the pTα gene and initial work showed that 
overexpression of the stem cell leukemia (SCL) member of the bHLH family, 
resulted in a block at the DN to DP transition that correlated with a significant 
decrease in pTα mRNA transcripts in DN3 and DN4 thymocytes. Interestingly, 
SCL and E2A or HEB transcription factors have an inverse expression through 
T cell development, which prompted the authors to investigate the role of E2A 
and HEB in regulating pTα transcription. Genetic deletion of HEB resulted in 
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decreased expression of pTα mRNA suggesting that it is also a regulator of pTα 
expression (Herblot et al., 2000; Tremblay et al., 2003).  
 
It was also demonstrated that the pTα enhancer contained a binding region 
(CCTGGGAA) recognised by the Notch 1-activated transcription factor CSL 
(CBF1, Suppressor of Hairless, Lag-1) suggesting that notch signalling had an 
important role at the β-selection checkpoint (Reizis and Leder, 2002). This was 
further confirmed with the use of reporter mice. Insertion of an eGFP reporter 
under the influence of a CSL binding site, revealed GFP expression at the DN2 
and DN3 stages, matching the pattern of pTα expression (Reizis and Leder, 
2002). Moreover, mutation of the CLS binding site resulted in a delay in pTα up-
regulation (Reizis and Leder, 2002). 
Thus, expression of the pTα gene is regulated by c-Myb, E-proteins and the 
Notch 1-induced transcription factor CSL (Reizis and Leder, 1999; Reizis and 
Leder, 2001).  
e. Interleukin-7 (IL-7) signalling at the β-selection checkpoint 
IL-7 has a central role in T cell development as demonstrated by the profound 
block observed at the DN2/DN3 stage of T cell development in IL-7Rα-deficient 
mice (Peschon et al., 1994; Sudo et al., 1993). Administration of anti-CD3 in 
vivo into RAG-deficient animals is often used to mimic progression through the 
β-selection checkpoint. It was shown that IL-7R mRNAs could be detected 
within 1.5hrs of anti-CD3 injection and was followed by the cell-surface 
expression of IL-7Rα within 6hrs suggesting that preTCR signalling was 
implicated in IL-7R expression (Trigueros et al., 2003). In agreement with this, 
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DN4 cells from pTα-/- and TCRβ-/- mice expressed significantly lowered levels of 
IL-7Rα than DN4 cells from WT, and TCRα-/- mice (Trigueros et al., 2003). 
Finally, DN4 cells from IL-7Rα-/- mice showed normal proliferation but increased 
cell death suggesting that the IL-7/IL-7Rα axis is implicated in transmitting 
survival signals at the DN4 stage. IL-7 is thought to convey survival signals 
through the activation of the pro-survival factor Bcl2. Indeed, expression of a 
Bcl2 transgene in IL-7Rα-deficient mice rescued T cell development past the 
DN stage with numbers of peripheral CD4(+) and CD8(+) T cells similar to those 
found in IL-7Rα sufficient mice (Maraskovsky et al., 1997). 
 
 
 
1.3.5.2 γδ  or αβ lineage commitment  
 
Several models have been postulated to explain why DN3 thymocytes adopt 
either a γδ or αβ T cell fate. These are; the instructional model, the stochastic or 
selective model and the signal strength model.  
 
The instructional model proposes that commitment to one lineage is solely 
dependent on the expression of a specific TCR. Thus, DN cells expressing 
TCRγδ will commit to the γδ T cell lineage whereas DN cells expressing preTCR 
will enter the αβ T cell lineage. This model led from observations made in the 
late 1980s that TCRδ transcripts could be detected two days earlier than TCRβ 
transcripts. It was therefore suggested that T cell progenitors would first attempt 
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to rearrange TCRγ and TCRδ to form a TCRγδ. If that failed the cells would then 
attempt to rearrange TCRβ to commit to the αβ T cell lineage (Pardoll et al., 
1987; Snodgrass et al., 1985). This idea then developed into a model in which 
TCRγδ and preTCR competed to instruct fate. In this version of the instructional 
model, DN cells would attempt TCRγ, TCRδ, and TCRβ rearrangements 
simultaneously, with the cell adopting a γδ cell fate if TCRγδ rearranged first, 
and an αβ T cell fate if TCRβ rearranged first. Despite its obvious merits, more 
recent work from mice deficient for TCRβ or pTα suggested that TCRγδ is also 
able to drive commitment to the αβ T cell lineage (Buer et al., 1997; Fehling et 
al., 1995). Indeed, thymuses from pTα-deficient animals, which cannot form a 
preTCR, harboured a significant number of DP thymocytes and some SP 
thymocytes (Fehling et al., 1995). In these animals, the DN to DP transition is 
partially driven by TCRγδ as pTα-/-.TCRδ-/- mice have a much smaller DP pool 
than pTα-deficient mice (Buer et al., 1997). Moreover, early expression of 
TCRαβ complexes at the DN stage in transgenic animals (e.g. in HY Tg mice) 
allows development of T cells with a γδ-like phenotype, as suggested by the 
presence of the TCRδ locus that is usually absent from conventional αβ T cells 
due to rearrangement of the TCRα locus (Bruno et al., 1996). This suggests 
that lineage commitment is not instructed by the type of TCR per se, although 
TCRγδ expression and signalling is clearly important for γδ T cell development.  
 
The stochastic or selective model, suggests that early DN thymocytes do not 
possess equal potential to adopt an αβ or γδ lineage fate and that pre-existing 
factors within the cell predispose it to one lineage or the other. In this model, 
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expression of a particular TCR is thought to only reinforce pre-commitment to a 
specific lineage. Initial observations by the Raulet group revealed that while all 
DN1 cells expressed similar levels of the IL-7 receptor α (IL-7Rα) chain, DN2 
cells had heterogenous expression. More importantly, IL-7Rα(-) DN2 thymocytes 
appeared to be skewed towards the αβ lineage, whereas IL-7Rα(+) DN2 cells 
preferentially developed as γδ T cells (Kang et al., 2001). Of note, IL-7 signalling 
is essential for TCRγ  rearrangement, which would be in agreement with the 
idea that IL7Rα(+) DN2 preferentially adopt the γδ lineage (Schlissel et al., 2000). 
However, the same group demonstrated that TCRγ rearrangement was 
independent of the IL-7Rα-mediated skewing of lineage commitment. The 
transcription factor SOX13, has also been suggested to be required for γδ but 
not αβ lineage commitment (Melichar et al., 2007). SOX13 was found to be 
expressed in only 45% of DN2 thymocytes, and correlated with expression of 
IL-7Rα (Melichar et al., 2007). While mice deficient in SOX13 showed normal 
αβ T cell development, numbers of γδ T cells were reduced by more than 50% 
(Melichar et al., 2007). Furthermore, over-expression of SOX13 compromised 
development of αβ T cells when compared with γδ T cells, suggesting that 
expression of both IL-7Rα and SOX13 within DN2 cells pre-commits 
progenitors to the γδ T cell lineage (Melichar et al., 2007). Although these two 
reports favour a pre-commitment model, further studies showed that immature 
TCRγδ-expressing DN3 thymocytes cultured on OP9-DL1 stromal cells, could 
give rise to both γδ T cells and bona fide αβ T cells (Kreslavsky et al., 2008). 
However, increasing signal strength through cross-linking of CD3 molecules 
impaired progression to the DP stage, instead favouring a γδ T cell fate 
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(Kreslavsky et al., 2008). This illustrates that DN3 cells still possess some 
plasticity to divert to the γδ or αβ lineage under instruction from TCR signalling.  
 
The most recent suggested model, the signal strength model, tries to unite the 
observations described above. This model proposes that it is signal strength, 
delivered by a particular TCR complex (TCRγδ or preTCR) that dictates lineage 
commitment. Specifically, the model states that “weak” signals drive DN 
progenitors into the αβ T cell lineage, whereas “strong” signals instruct DN cells 
to become γδ T cells. Thus, the preTCR, that undergoes high levels of 
endocytosis resulting in a low cell-surface expression, generally signals weakly 
to drive cells to the DP stage, while TCRγδ that is expressed at higher surface 
levels generally signals strongly to instruct adoption of a γδ cell fate (2005; 
Ciofani and Zuniga-Pflucker, 2010; Hayes et al., 2005). The “signal strength” 
model is best illustrated by two landmark studies. Hayes and co-workers 
showed that modulating TCR signal strength could affect lineage commitment 
of DN3 cells regardless of the type of TCR being expressed. Specifically, mice 
expressing a specific transgenic TCRγδ (Vγ6Vδ6Tg or Vγ6/Jγ1Cγ1-
Vδ6/Dδ6/Jδ2/Cδ) during early T cell development, before TCRβ is rearranged, 
could generate both γδ T cells and DP thymocytes (Hayes et al., 2005). 
However, weakening of the TCRγδ transgene signal by crossing these mice 
onto a TCRζ+/- background, in which signal transduction through the TCR is 
likely to be weakened due to a reduction of 50% in cell-surface expression of 
the TCRγδ, resulted in a significant reduction in γδ T cells and a development 
skewed towards the αβ lineage with a 1.5 fold increase in DP thymocytes (both 
in proportions and cell numbers) (Hayes et al., 2005). Conversely, increasing 
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signal strength by over expression of a TCRζ transgene in Vγ6Vδ6Tg TCRζ+/+ 
mice resulted in higher TCRγδ surface expression and increased generation of 
γδ T cells over DP thymocytes, illustrating that quantitative signalling differences 
could dictate T cell lineage commitment (Hayes et al., 2005). Finally, analysis of 
DN thymocytes ex vivo from TCRα-deficient animals, which can express only 
either a TCRγδ or the preTCR, showed that γδ T cells had higher levels of both 
phosphorylated Zap-70 and ERK1/2 when compared to αβ-lineage cells (DN3, 
DN4, ISP and DP cells) (Hayes et al., 2005). γδ T cells also had a higher cell 
surface expression of CD5, widely accepted to translate the strength of signal 
received by the cell, compared to TCRβ(+) DN3 thymocytes (Hayes et al., 2005). 
 
In the second study, Haks and co-workers manipulated the strength of signal 
delivered by a TCR on the basis of Lck availability. They used the KN6 
transgenic TCRγδ on a RAG-deficient background. The KN6 TCRγδ  recognises 
the β2m-dependent non-classical MHC class Ib molecules, T10 and T22. 
Importantly, ligand engagement of the KN6 transgenic TCRγδ with T22 was 
assumed to generate a “strong” signal. In one experiment, KN6 transgenic 
animals on a RAG-deficient background (KN6(+)RAG-/-) were crossed with a 
Lck-deficient animal to prevent transduction of a “strong” signal, while other 
KN6(+)RAG-/- transgenic animals were crossed with a β2m-deficient animal, in 
which the KN6 TCRγδ could no longer interact with T22. KN6 transgenic 
animals on a RAG-/- background have only ~1% of DP cells, but attenuation of 
signal strength, by Lck deficiency or the absence of T22, as demonstrated by 
lowered CD5 expression, led to a 126-fold and 188-fold increase in DP 
thymocytes respectively (Haks et al., 2005). Strong signalling through TCRγδ 
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has been shown to trigger increased phosphorylation of ERK, which in turn can 
activate the early growth response (Egr)-Id3 pathway that is thought to initiate 
commitment to the γδ lineage (Lauritsen et al., 2009). In agreement with this, 
the absence of Lck in the KN6 model resulted in reduced ERK phosphorylation 
as well as reduced expression of the transcription factors Egr1 and Egr3 (Haks 
et al., 2005; Hayes et al., 2005).   
 
A more recent study that presented data consistent with the signal strength 
model demonstrated co-operation between preTCR and TCRγδ to increase 
signal strength to drive cells toward the γδ T lineage (Zarin et al., 2014). Indeed, 
simultaneous expression of TCRβ and the KN6 TCRγδ in RAG2-deficient DN3 
cells led to the development of mainly mature γδ T cells. This illustrates that 
TCRγδ signals “override” the weakly-signalling preTCR, presumably on the 
basis of signal strength (Zarin et al., 2014).  
 
Collectively, these studies strongly suggest that quantitative differences in TCR 
signal strength in DN thymocytes can influence commitment towards the γδ or 
αβ lineage by modulating qualitatively different signalling pathways (e.g. ERK 
and Egr3).  
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1.4 Initiation of TCR signalling: Autonomous or ligand-driven? 
1.4.1 Autonomous signalling capacity of the preTCR  
Evidence that the preTCR may not require ligand engagement to initiate signal 
transduction first came from the observation that thymocytes could successfully 
traverse the β-selection checkpoint in MHC-I and MHC-II deficient animals 
(Koller et al., 1990). A subsequent study then demonstrated that Lck-driven 
expression of a TCRβ transgene lacking its variable domain in a RAG-1- 
deficient animal rescued development of DP cells (Irving et al., 1998). By 
contrast, expression of a fully truncated TCRβ, lacking both the variable and 
constant regions, was inefficiently expressed as demonstrated by a low CD3 
cell-surface expression and did not restore T cell development in RAG-1 
deficient mice suggesting that association with endogenous pTα chain was 
somehow unstable (Irving et al., 1998). Surprisingly, transgenic expression of a 
truncated preTCR, lacking all pTα and TCRβ Ig-loop structures (both V and C 
regions), and therefore presumably unable to engage ligand, rescued T cell 
development in RAG-1-deficient animals (with CD3 cell surface expression) 
suggesting that a fully truncated preTCR might be more stable than an 
assymetrical heterodimer (Irving et al., 1998). To assess the signalling capacity 
of the fully truncated preTCR, the latter was transfected into TCRβ-deficient 
Jurkat T cells along with a luciferase reporter plasmid regulated by NFAT 
activity. Transfection of truncated TCRβ alone, did not alter NFAT activity and 
did not restore CD3 cell surface expression (Irving et al., 1998). By contrast, 
transduction of the fully truncated preTCR or full-length TCRβ resulted in a 
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transient peak of luciferase activity within 15 hours indicative of NFAT-
dependent signalling. Thus, it was concluded that cell-surface expression of the 
preTCR was sufficient for signal initiation (Irving et al., 1998). Surface 
localization by confocal microscopy showed that the preTCR was found in 
“patchy” distribution on the cell surface reminiscent of TCRαβ cell surface 
distribution following ligand binding and raft co-localisation (Saint-Ruf et al., 
2000). Transduction into SCID thymocyte-derived cell line SCIET.27 of a vector 
containing a TCRβ (Vβ8.2Dβ1Jβ2.6Cβ2) chain and an eGFP fusion protein 
revealed clustering of the GFP signal, which was not observed when a vector 
containing GFP alone or a TCRγδ (Vγ1Jγ1Cγ4 and Vδ7.1Jδ1Cδ) gene was 
expressed, suggesting that preTCR complexes oligomerise (Saint-Ruf et al., 
2000). Lck was also shown to co-localize with more than 80% of the 
pTα chains at the cell surface (Saint-Ruf et al., 2000). Importantly, targeting of 
the preTCR complex to the cell membrane is critical for T cell development, as 
retention in the ER impairs the DN to DP transition (O'Shea et al., 1997). A 
subsequent study showed that expression of the preTCR induces rapid 
endocytosis that mimics that of TCRαβ following ligand engagement (Yamasaki 
et al., 2006; Yamasaki and Saito, 2007). Indeed, expression analysis by 
fluorescence microscopy of either a pTα-eGFP or TCRα-eGFP fusion protein 
into TCRα-deficient hybridoma cell lines (TG40β) revealed that a significant 
portion of the pTα-eGFP protein was found within intracellular vesicles 
compared to TCRα-eGFP. Incubation of the cells with PE-labelled anti-TCRβ 
antibody for 30 mins showed a greater proportion of PE signal within the cells 
transfected with pTα than TCRα (Yamasaki et al., 2006). Thus, the consensus 
opinion is that cell-surface expression of the preTCR is sufficient to drive signal 
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transduction at the β-selection checkpoint in a ligand-independent manner 
(Panigada et al., 2002; Saint-Ruf et al., 2000).  
 
Whether oligomerization of the preTCR is important for signal transduction is 
still a matter of debate. It was thought that the cysteine residues in the 
cytoplasmic tail of pTα played a role in recruiting pTα to lipid rafts that in turn 
facilitates ligand-independent signalling, but mutation of these cysteine residues 
(to alanine) did not abrogate preTCR signalling (Aifantis et al., 2002; Gibbons et 
al., 2001). Subsequently, four charged amino acids (D22 R24 R102 R117) 
contained in the Ig-loop of pTα, conserved between humans and mice, were 
implicated in the initiation of oligomerisation and subsequent preTCR triggering. 
Indeed, substitution of these residues to alanine was shown to impair preTCR 
function (Yamasaki et al., 2006). However, by contrast, evidence also exists to 
suggest that oligomerization mediated by the extracellular domains of pTα does 
not initiate signal transduction. This study used retroviral transduction of 
truncated pTα chains in foetal thymic organ cultures to show that pTαb (that 
lacks three of the four charged residues mentioned above) could induce 
preTCR signal in a very similar manner to that seen with “wild-type” pTαa 
(Ishikawa et al., 2010; Mahtani-Patching et al., 2011; Yamasaki et al., 2006). 
Crystallographic data also suggested that preTCR signalling was a 
consequence of the dimerization of two preTCR complexes through their 
extracellular Ig-loop domains resulting in a “sandwich-like” structure (Pang et 
al., 2010).  
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1.4.2 TCRγδ  signalling in DN thymocytes 
As mentioned, commitment to the γδ T cell lineage at the DN stage of 
thymocyte development is currently thought to result from a strong signal 
emanating from TCRγδ. Although a strong signal could be explained by greater 
surface expression of TCRγδ compared to the lowly-expressed preTCR, strong 
signalling is generally considered to result from ligand-engagement as 
illustrated by the activation of mature αβ T cells. However, the paucity of 
identified TCRγδ ligands has made this very difficult to study, especially in mice. 
To complicate matters further, γδ cells also acquire effector functions, in the 
shape of commitment to cytokine production, in the thymus. These 
developmental steps have also been postulated to depend on signal strength 
through TCRγδ. Thus, strong vs weak TCRγδ signals, that may (or may not) 
correlate with ligand-dependent versus ligand-independent signal initiation, may 
well not only influence αβ versus γδ lineage commitment, but also affect 
subsequent effector function of developing γδ cells. 
 
Ligand independent signalling through TCRγδ was first suggested by 
demonstration of oligomerisation of TCRδ chains in vitro mediated by the 
extracellular Ig-like variable regions of TCRδ (Jensen et al., 2008). However, 
expression in RAG-deficient cells of a truncated TCRγδ lacking either both 
variable domains or all four Ig-like extracellular domains (and thus in both cases 
lacking the CDR regions implicated in ligand binding) successfully restored γδ T 
cell development in foetal thymic organ culture suggesting that ligand-
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independent signalling was compatible with γδ T cell development (Mahtani-
Patching et al., 2011).  
 
Ligand-dependent signalling from TCRγδ has been largely studied in the context 
of T10 and T22 binding that are non-classical or unconventional MHC class-Ib 
molecules, which are known to interact with the G8 and KN6 TCRγδ. T10 and 
T22 are encoded by the TL locus and share more than 94% sequence identity. 
Both T10 and T22 associate with β2-microglobulin (β2m) but they are not 
involved in antigen presentation (Schild et al., 1994). While T10 is expressed by 
all mouse strains, T22 is absent from the BALB/c strain making them a useful 
strain in which to study γδ T cell selection and development (Ito et al., 1990). 
Thus, development of γδ T cells has been investigated in mice transgenic for 
the G8 or KN6 TCRγδs crossed onto a C57Bl/6, BALB/c or β2m-deficient 
background to modulate the presence or absence of the selecting ligands T10 
and T22 (see below) (Crowley et al., 1997; Houlden et al., 1989). These sorts of 
studies were further helped by the generation of T22-tetramers that were used 
to identify γδ T cells with T22-specific TCRs. T22-specific γδ T cells in the β2m-
deficient animals had a phenotype characteristic of naïve T cells 
(CD44lowCD122low) and with γδ T cells known to secrete IL-17-A (Jensen et al., 
2008).	By contrast, T22-specific γδ T cells from C57Bl/6 mice, where both T10 
and T22 are present, expressed a typical “ligand-engagement” phenotype 
(CD44hiCD122hi) and could produce IFN-γ (Jensen et al., 2008). Thus, it was 
concluded that ligand engagement by TCRγδ drives cells to adopt IFN-
γ-secreting potential. However, it was unclear from the study whether 
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development of T22-specific IL-17A-secreting γδ T cells was the result of ligand-
independent signalling or occurred following interactions with ligands unrelated 
to T10 and T22.    
 
Further data pertaining to the involvement of ligands in γδ T cell development 
have been obtained from the study of dendritic epidermal γδ T cells (DETC). 
DETC development was shown to be dependent on the expression of the 
surface-associated B7-like Ig superfamily member Skint-1, which is expressed 
both by keratinocytes and mTECs (Barbee et al., 2011). These findings 
stemmed from observations by Lewis and co-workers that FVB/n mice from the 
supplier Taconic farms (FVB-Tac) were devoid of DETC when compared to 
FVB/n mice from Jackson Laboratories (FVB-Jax). Development of DETC was 
restored when thymocytes from FVB-Tac animals were transferred to FVB-Jax 
thymic stroma, suggesting that the missing determinant was expressed in non-
haematopoeitic cells (Barbee et al., 2011). Genetic comparison between the 
two strains revealed a mutation in the Skint-1 gene leading to a premature 
termination of transcription. Although direct engagement of Skint-1 by γδ T cells 
remains to be shown, further work from the lab showed that in the presence of 
Skint-1, developing DETC up-regulate the transcription factors Egr3 and Tbx21 
(T-bet) in a NFAT/NFΚB dependent manner that ultimately correlates with an 
IFN-γ-producing phenotype. In agreement with ligand-dependent development, 
cross-linking of the TCR with GL3, an anti-TCRδ antibody widely used to mimic 
ligand engagement, also led to the up-regulation of Egr3. By contrast, absence 
of Skint-1 led to the up-regulation of the transcription factors Sox13 and RORγt, 
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and led to the adoption of an IL-17A-secreting phenotype (Turchinovich and 
Hayday, 2011). Thus, these studies collectively suggest that ligand-
engagement favours an IFN-γ-secreting γδ T cell fate while ligand-independent 
signalling drives development of IL-17A-producing γδ T cells.  
Finally, a recent study published again by the same group seems to contradict 
their previous findings. This work investigated the role of signal strength in the 
development of IFN-γ versus IL-17A-secreting γδ T cells using the SKG mouse 
model, which carries a mutation in Zap-70 resulting in a 90% loss in kinase 
activity (Sakaguchi et al., 2003). Flow-cytometry analysis of lymph nodes from 
these mice revealed a severely reduced complement of IL-17-producing γδ T 
cells but a largely unchanged compartment of IFN-γ-producing γδ T cells, when 
compared to WT mice (Wencker et al., 2014). This phenotype was tracked to a 
developmental defect in the thymus. From this, it was concluded that IL-17A-
producing γδ T cells require strong TCRγδ-mediated signals (through Zap-70) 
for their development, and that possibly this is likely to result from ligand 
interactions (Wencker et al., 2014).  
 
Despite significant work over the past few years, the studies reviewed in this 
section provide opposing conclusions as to the requirement of a ligand for γδ T 
cell development or the type of γδ T cell subsets generated following ligand 
engagement/strong signalling (Figure 1.18). This illustrates the general lack of 
consensus regarding the mechanism by which strong TCRγδ signals are 
generated and the role of signal strength in γδ T cell development.  These areas 
represent a main interest of our lab, and thus will also feature significantly in this 
thesis.  
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Figure 1.18 Schematic representation of the current uncertainty regarding γδ  T 
cell development. It has been proposed that TCRγδ engagement of T10 and T22 
favours the development of IFN-γ-producing γδ T cells. By contrast, ligand-independent 
signalling or recognition of currently unknown ligands may drive the development of IL-
17A producing γδ T cells. Skint-1 may also be a ligand involved in DETC development. 
Finally, using SKG mice, the Hayday lab suggested that strong signalling was required 
for development of IL-17A-secreting γδ T cells while weak signalling favoured IFN-γ-
producing cells.  
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1.5 Summary  
TCR signalling is a central pillar of T cell development. There is increasing 
evidence that TCR signal strength in DN thymocytes is fundamentally important 
for dictating T cell fate (e.g. at the β-selection or T cell selection checkpoints). 
Importantly, the TCR signalling machinery is able to translate quantitatively 
different signals (driven or not by ligands) into qualitatively different signals that 
serve to instruct cell survival versus death during T cell selection, or αβ versus 
γδ lineage commitment at the DN3 stage. Moreover, it may also determine 
subsequent γδ cell effector fate (i.e. IL-17A versus IFN-γ secretion).  
 
However, several aspects of a signal-strength-driven model of T cell 
development remain to be elucidated. For example, at the DP stage, how does 
a “strong” TCRαβ signal dictate two seemingly opposite fates; to die by 
apoptosis or to differentiate into an unconventional T cell subset. Perhaps, DP 
thymocytes constitute a heterogeneous population potentially pre-committed to 
a conventional or unconventional T cell fate. If this were the case, the factors 
responsible for establishing this heterogeneity are yet to be determined. It is 
known that DP thymocytes arise from DN3 cells following the successful 
expression of the preTCR at the β-selection checkpoint. The preTCR  exists as 
two possible isoforms; preTCRa and preTCRb, but very little work has been 
carried out to investigate their individual roles due to the perhaps mis-placed 
idea that they have redundant functions at the β-selection checkpoint. Indeed, 
both pTα isoforms (pTαa and pTαb) have been conserved across evolution and 
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are found in human, chicken, and mice, likely demonstrating that they have 
been selectively kept for an important non-redundant role in T cell development.  
Finally, in the context of γδ T cell development, the relationship between strong 
and weak signalling, and ligand-dependent and ligand-independent signalling 
are still not clear. Nor are signalling pathways that translate these differences in 
signalling intensity into distinct developmental outcomes.  
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1.6 Working hypotheses of the work presented in this thesis 
1.6.1 General hypothesis  
We hypothesise that both quantitative and qualitative differences in TCR 
signalling at the early stages of T cell development have fundamental 
consequences for subsequent T cell development and influence the type of T 
cell subsets generated by the thymus.  
1.6.2 Sub-hypothesis 1  
We hypothesise that preTCRa and preTCRb deliver qualitatively and/or 
quantitatively different signals responsible for establishing heterogeneity at the 
DP stage, that has a fundamental impact on the subsequent development of αβ 
T cells.  
1.6.3 Sub-hypothesis 2 
We hypothesise that quantitative differences in TCRγδ signalling in DN 
thymocytes recruits qualitatively different signalling pathways that drive the 
differential development of IFN-γ- versus IL-17-A- secreting γδ T cell subsets.  
 
The work presented in this thesis focuses on testing these hypotheses. The 
work on the preTCRa and preTCRb represents the largest part of this thesis 
(four chapters), whereas the γδ T cell project was undertaken in collaboration 
with other members of the lab (Dr. J. Pang and Dr. Nital Sumaria) and thus is 
represented by only a single chapter. 
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1.7 Aims 
- To characterise the expression of pTαa and pTαb isoforms of the pTα 
gene at the single cell level during T cell development.  
- To investigate the role of preTCRa and preTCRb during T cell 
development in vivo using BAC-transgenic mice.  
- To investigate the development of unconventional T cells using various 
strains of mice (C57Bl/6, FVB/n, BALB/c). 
- To investigate how quantitative differences in TCRγδ signalling are 
translated into the differential development of IFN-γ- versus IL-17A-
secreting γδ T cell. 
- To investigate the role of PI3K signalling in γδ T cell development  
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Chapter 2 
Materials and methods  
2.1 Molecular biology  
2.1.1 Gel electrophoresis 
Agarose gel electrophoresis was used to separate DNA molecules according to 
their molecular weight (size). It was used mainly to visualize PCR products,  
fragmented DNA molecules following enzymatic digestion, or in order to extract 
DNA fragments. The concentration of the agarose gel determines how tightly 
packed the polymers are between themselves. Therefore, the concentration of 
an agarose gel needs to be appropriately chosen depending on the size of the 
DNA fragment to be visualised. DNA fragments smaller than 1500bp were run 
on a 1.5% gel at 110V for 40mins. Isolation of BAC DNA fragments for 
subsequent pronuclear injection was achieved by running the DNA sample on a 
0.5% gel at 40V for 2 to 3 hours. A 1.5% gel was made by dissolving 3g of 
Agarose (Sigma-Aldrich) in 200mL of 1x TAE buffer, diluted from 50X TAE 
buffer (Table 2.1). 
 
The mixture was heated in a microwave for 1min, gently shaken and heated 
again for an extra minute to allow full dissolution of the agarose powder.  
For visualization of PCR products without subsequent sequencing or cloning, 
10µl of Ethidium Bromide (VWR) was added to the mixture once cooled down. 
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Alternatively, if the DNA sample was to be extracted for pronuclear injection or 
sequencing, 15 to 20µl of the non-mutagenesis nucleic acid gel stain, GelRed 
(Biotium), was used instead of Ethidium Bromide.  
Once thoroughly mixed, the solution was poured onto a tray and was left for  
30min at room temperature to solidify. Gels were run in 1x TAE buffer. DNA 
samples were mixed with 6X TriTrack Loading dye (Invitrogen) at a 1:6 dilution 
before loading on an agarose gel. To determine the size of DNA in the samples, 
a 1kb ladder (Fermentas) was used for PCR products with a size below 10kb. 
Alternatively, the GeneRuler high range DNA ladder (New England Bioscience, 
NEB) was used for products with a size between 10kb and 40kb.  
2.1.2 Polymerase Chain Reaction (PCR) 
Polymerase chain reaction (PCR) is a very sensitive technique allowing the 
amplification of a DNA sequence of interest. Using oligonucleotides or primers, 
the DNA region of interest is flanked and replicated by a polymerase. Each 
PCR step occurs at a specific temperature to allow denaturation of the DNA 
strands, primer binding, and elongation. The DNA is copied twice at each cycle, 
because of the presence of two strands, and therefore the quantity can be 
determined at each cycle by 2n where n represents the number of cycles. Three 
 
Table 2.1 Components of the 50X TAE buffer The table shows the reagents used for 
preparing 1L of 50X TAE buffer.  
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types of PCR reactions are presented in this section; Semi-quantitative PCR 
where the PCR products are visualized at the end of the reaction by running the 
PCR mix on an agarose gel; real-time PCR, which allows precise quantitation of 
the DNA throughout the reaction; and the single-cell PCR where semi-
quantitative PCR is carried out on a single cell.  
To avoid contamination, pipettes (Gilson), tubes (Starlab), and tube racks were 
kept separately and not used for other experiments. All equipment and 
workspaces were wiped with 1M sodium hydroxide (NaOH) solution and 70% 
Ethanol (Sigma-Aldrich) prior to setting up the PCR reaction. Gloves (SLS) were 
changed frequently throughout the experiment. 
 2.1.3 Semi-quantitative PCR  
Unless indicated in the text, a common PCR master mix was used when setting 
up a semi-quantitative PCR (Table 2.2). The primers were designed in-house 
and ordered from Eurofins MWG Operon. The dNTP mix was obtained with the 
Taq polymerase (NEB) and was diluted to a final working concentration of 
2.5mM. A common PCR programme was used for each cycle (Table 2.3). The 
elongation time is dependent on the size of the expected PCR band. 
Conventionally, 1min extension is used for every 1kb to amplify. The annealing 
temperature used for each primer was approximately 3°C below the 
manufacturer’s recommended temperature. In some cases a gradient PCR was 
set up to determine the ideal annealing temperature. The PCRs were carried 
out in a Peqstars thermocycler (Peqlab). 
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Table 2.2 List of the components constituting the PCR master mix.  The table 
shows the common PCR master mix used for semi-quantitative PCRs. Primers were 
purchased from Eurofins MWG Operon. dNTPs, Taq polymerase and the Taq Buffer 
are supplied by NEB. 
 
 
 
 
Table 2.3 Semi-quantitative PCR cycle. The first step consists of 95°C, which allows 
the two strands of DNA to come apart. The annealing temperature (Tm) is primer-
specific and was generally 3°C under the recommended temperature. 72°C represent 
the temperature at which Taq polymerase proceeds to the elongation. 
 
 2.1.4 Single-cell PCR  
Single-cell PCR was carried out in two steps using different set of primers 
(Table 2.4) (Eurofins MGW Operon). The first round PCR amplified the entire 
pTα cDNA regardless of its isoform by using a set of primers (M-pTageneF and 
M-pTageneR) recognizing a region located in exons 1 and 4 present in both 
pTα isoforms (pTαa and pTαb). 
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The second round PCR amplified pTαa (M-pTaaF and M-pTaaR) or pTαb (M-
pTabF and M-pTabR) cDNAs, respectively, by using a set of primers 
recognizing the exon boundaries present only in pTαa   or only in pTαb cDNAs.  
The first PCR cycle followed the same steps as the one described in Table 3 
with only 34 cycles. The second round PCR was carried out using 2µl from the  
1st PCR and the PCR cycle was repeated 25 times. The PCR was run in a 
Biorad thermocycler and the result was visualized on a 96-well 1% agarose gel 
(Biorad). 
 
Table 2.4 Primers used for the single-cell PCR. M-pTageneF recognises a 
sequence found in exon 1 and M-pTageneR in the un-translated region of exon 4 of 
pTα. Both were used to amplify total pTa cDNA during the first round PCR.  M-pTaaF 
binds at the exon1-2 boundaries while M-pTaaR binds at the exon 1-3 boundaries. 
Therefore, this set of primers can only recognise pTαa cDNA during the second round 
PCR. Finally, M-pTabF flanks a region at the exon1-3 boundaries and M-pTabR 
recognises a DNA sequence in exon 4, and were used to identify the pTαb isoform 
during the second round PCR. 
 
2.1.5 Real-time PCR 
In contrast to semi-quantitative PCR, real-time PCR allows quantification of a 
PCR product as the reaction progresses. A fluorescent dye is incorporated in 
the newly generated DNA making it fluorescent and allowing the thermocycler 
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to monitor the number of DNA copies present at each cycle. As a result, real-
time PCR is a very useful technique to compare differences in cDNA quantity 
across different samples. Because of its high sensitivity, it is also a useful tool to 
detect very low amounts of DNA.  
The real-time PCR was set up using the Power SYBR green PCR Master Mix 
(Applied Biosystems) according to the manufacturer’s instructions. Briefly, 1µl of 
each 10µM forward and reverse primers were mixed with 10µl of the 2X power 
SYBR Green PCR Master Mix and 2µl of cDNA was added to a final volume of 
20µl. The reaction was set up in a MicroAmp® Optical 96-Well Plate (Applied 
Biosystems) and run on a 7500 Real-Time PCR system (Applied Biosystems). 
The primers were designed in-house and ordered from Eurofins MWG Operon. 
The primers were tested for their efficiency, which was calculated using a 
standard curve generated from a 1:2 serial dilution of the cDNA template. The 
standard curve was obtained by plotting the dilution factor against the Ct value 
determined during the amplification of each dilution. The amplification efficiency 
was calculated in percentage using the equation below:  % !""#$#%&$' = (! − 1) ×100 
Where E is the amplification efficiency as defined by  
! = 10!( !!"#$%) 
And where the slope of the curve can be calculated using the following 
equation: 
!"#$% = !" − !"!" − !" 
An optimal amplification efficiency should lie between 95 and 105%.  
The Ct values were defined by setting up the Ct threshold manually above the 
background noise.  
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Table 2.5 Primers were designed in-house and ordered from Eurofins MWG 
Operon. Each primer amplified a region smaller than 120bp to allow efficient reaction. 
qpTaaF and qpTaaR were used to detect the pTαa cDNA while qpTabF and qpTabR 
detected the pTαb cDNA. GAPDH was used as the endogenous control and was 
detected using qGAPDHF and qGAPDHR.  
 
2.1.6 Genomic DNA extraction for genotyping 
Genomic DNA was isolated from ear-punch biopsies from 3 week-old pups.  
The tissues were placed in 100µl of autoclaved 0.05M NaOH (Sigma-Aldrich) in 
1.5mL eppendorf tubes (Starlab, UK) and incubated for 1hr at 95°C. Following 
incubation, 10µl of Tris-EDTA buffer (PH 8.0, Sigma-Aldrich) was added to the 
samples. To allow separation of DNA from the remaining skin fragments, the 
tubes were centrifuged in a bench-top centrifuge at 400g for 5mins at 4°C. 
Samples were either used straight away for PCR or stored at -20°C for 
subsequent use. 1µl was used during PCRs.  
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2.1.7 Bacterial artificial chromosome (BAC) 
a. Maxi prep 
The QIAGEN Large-Construct Kit was used to generate large quantities of pTαb 
BAC according to manufacturer’s instructions. The pTαb BAC was subsequently 
used for pro-nuclear injection in order to generate pTαb-expressing transgenic 
animals. Prior to starting the procedure, Buffer P3 was placed at 4°C and a 
water bath was set at 37°C. A single colony of SW102 E.coli bacteria previously 
transformed with the pTαb BAC was inoculated overnight at 32°C with vigorous 
shaking (300rpm) in 5mL of LB broth (Sigma-Aldrich) containing 
chloramphenicol (Sigma-Aldrich) at a 12.5µg.mL(-1) concentration. The following 
day, 1mL of this culture was incubated for 16hrs into 500mL of 12.5µg.mL(-1) 
chloramphenicol LB broth at 32°C with vigorous shaking (300rpm). The 
bacterial cells were harvested the next day by centrifugation at 6000g for 5mins 
at 4°C using a plus centrifuge (Sorvall RC 6+) and the supernatant was 
removed by inversion. The pellet was fully re-suspended by vortexing with 
20mL of Buffer P1 and 20mL of Buffer P2 was added for further lysis of the 
cells. Tubes were inverted 4 to 6 times and incubated at room temperature for 
no more than 5mins.  The precipitation of the proteins and the cell debris was 
achieved by mixing the solution with 20mL of pre-chilled Buffer P3. The sample 
was centrifuged at 20,000g for 30min at 4°C and supernatant was removed by 
inversion. The supernatant, containing the DNA, was filtered through a pre-
moistened folded filter-paper and DNA was precipitated by adding 0.6 volume 
of room-temperature isopropanol. Samples were mixed and centrifuged at 
15,000g for 30mins at 4°C and supernatant was removed by inversion. The 
DNA pellet was washed with 5mL of 70% ethanol and centrifuged at 15,000g 
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for 15mins. Supernatant was removed by inversion and the pellet was air-dried 
by placing the tube upside down on a clean paper towel. Once dried, the DNA 
was re-suspended in 9.5mL of Buffer EX and mixed gently to fully dissolve the 
DNA. Removal of genomic DNA and nicked BAC was achieved by adding 200µl 
of ATP-dependent exonuclease and 300µl of ATP solution to the DNA, and 
incubating in a water bath at 37°C for 60mins. After incubation, 10mL of Buffer 
QS was added to the DNA and the whole solution was applied to a QIAGEN-tip 
500 previously equilibrated with 10mL of Buffer QBT. The DNA was allowed to 
travel through the resin by gravity. The QIAGEN-tip 500 was subsequently 
washed twice with 30mL of Buffer QC and the DNA was eluted with 15mL of 
pre-warmed Buffer QF. The DNA was precipitated by adding 0.7 volumes of 
room-temperature isopropanol and centrifuged at 15,000g for 30mins at 4°C. 
Supernatant was removed by inversion and 5mL of 70% ethanol was added to 
the sample followed by centrifugation at 15,000g for 15mins. The DNA pellet 
was air dried for 5 to 10mins and re-dissolved in 500µL of TE buffer.  
 
b. Restriction digest 
The transgene used for pro-nuclear injection lacks the backbone of the BAC. 
The latter is removed through restriction digest using the restriction 
endonucleases SpeI (NEB). 10µg of pTαb BAC was digested overnight at 37°C. 
Each reaction consisted of 5µl of the restriction endonucleases SpeI (NEB) and 
5µl of the 10x CutSmart Buffer (NEB) in a final volume of 50µl. The SpeI 
enzyme recognizes the following sequences:  
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The reaction was subsequently run on a 0.5% agarose gel (Sigma-Aldrich). 
c. Gel extraction 
The pTαb BAC fragments obtained by restriction digestion were mixed with 6x 
TriTrack DNA loading dye (Thermo Scientific) at a 1:6 dilution and run on a 
0.5% agarose gel (Sigma-Aldrich) at 40V for 5hrs containing 15µl of GelRed 
(Biotium). 0.6µg of the GeneRuler high range DNA ladder (Thermo Scientific) 
was run alongside the samples to determine the band size. DNA gel extraction 
was performed using the Qiagen QIAEX II Gel Extraction Kit. In summary, the 
DNA band of interest was visualized on a UV trans-illuminator and excised from 
the gel using a clean sharp disposable scalpel (Scientific laboratory supplies, 
SLS). The gel slice was transferred to a 1.5mL eppendorf tube and weighed. 
Three volumes of buffer QX1 was added for each volume of gel. DNA was 
absorbed using 30ul of QIAEX II silica particles following 10mins of incubation 
at 50°C. The samples were centrifuged at 3000g and the supernatant was 
removed by pipetting. The pellet was washed with 500µl of Buffer QX1 followed 
by two washes with 500µl of Buffer PE. Once the supernatant was removed, the 
pellet was air-dried for up to 15mins until it became visibly white. DNA was 
eluted by adding 20µl of 10mM Tris-Cl (PH 8.5) and incubated at 50°C for 
10mins. Supernatant was removed and transferred to a fresh tube. DNA quality 
and concentration was determined by running 2µl on a 1% agarose gel.   
Alternatively, for smaller DNA products, the GeneJET gel extraction kit 
(Fermentas) was used according to the manufacturer’s instructions. The band 
of interest was visualized on a UV trans-illuminator, cut with a sharp disposable 
scalpel (SLS) and transferred into a pre-weighed 1.5mL eppendorf tube. 1 
volume of Binding Buffer was added and the sample was incubated at 50°C for 
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10mins until the gel was fully dissolved. The solution was transferred onto a 
GeneJET purification column and centrifuged for 1min at 13,000g. The column 
was washed with 100µl of the Binding Buffer if the sample was to be sent for 
sequencing and further washed with 700µl of Wash Buffer. Finally, the DNA 
was eluted into a 1.5mL eppendorf tube with 30µl of Elution Buffer.  
2.1.8 RNA extraction  
RNA extraction from thymocytes was performed to investigate the level of 
transcription of the two pTα isoforms, pTαa and pTαb. 
Thymocytes were re-suspended in 200µl of TRIZOL (Invitrogen) and 40µl of 
chloroform (SLS) in a 1.5mL eppendorf tube. The sample was shaken 
vigorously at 300rpm for 15mins at room temperature before centrifugation at 
400g for 3mins. The clear aqueous phase was carefully transferred to a fresh 
1.5mL eppendorf tube and an equal volume of 70% ethanol was added. Each 
solution was applied onto a QIAGEN RNeasy Mini-Column and centrifuged for 
30seconds at 15,000g in a bench-top centrifuge. The flow-through was 
discarded and the column was washed twice with 600µl of Buffer RW1. 
Genomic DNA was removed by incubating the column for 15mins at room 
temperature with 80µl of the DNAse1/RDD stock solution (QIAGEN) prepared 
according to the manufacturer’s instructions. The RNA was washed twice with 
500µl of Buffer RPE before being air-dried and eluted into a 1.5mL eppendorf 
tube using 25µl of RNAse-free water (Roche). The samples were stored at -
80°C for no more than 1 month. The quality of the RNA was evaluated using 
Nanodrop ND-100 spectrophotometer TM8000 (Labtech International).  
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2.1.9 DNA and RNA quantitation 
The concentration of DNA or RNA was determined by measuring the 
absorbance of 1µl of the sample using the Nanodrop ND-100 
spectrophotometer TM8000 (Labtech International) at a wavelength of 260nm. 
The quality of the sample was considered good if both the 230mn/260mn and 
260mn/280mn ratios were equal to 2.0.  
Alternatively, the concentration of the DNA sample was determined by running 
2µl of the sample on an agarose gel. The intensity of the band was compared to 
the one from the ladder where the DNA quantity for each band is known. The 
intensity between the bands was analysed using ImageJ software.  
2.1.10 cDNA synthesis  
Single-stranded cDNA was generated using the High Capacity cDNA Reverse 
Transcription Kit (Life technologies) and was used during PCR. Up to 2µg of 
RNA was retro-transcribed into a final volume of 20µl. 9µl of the eluted RNA 
was mixed with 1µl of the 20X RT enzyme mix (Life technologies) and 10µl of 
the 10x RT reaction Buffer provided. The sample was incubated at 37°C for 1hr 
and the enzyme was denatured at 95°C for 5mins. The samples were 
subsequently stored at -20°C. 
Alternatively, for single-cell PCR, both cDNA synthesis and RNA retro-
transcription took place in a 96 well-plate and RNA using specific reverse 
primers. The reaction consisted of 0.15µl of the MMLV-RT enzyme (Invitrogen) 
and 1µl of the 5X MMLV-RT Buffer mixed with 0.5µl of 2.5mM dNTPs (Ambion) 
and 0.1µl of 100µM reverse pTα primer M-pTageneR (Table 2.4) (Thermo 
Scientific or Eurofins MWG Operon). 1µl of 20% Triton-X allowed cell lysis and 
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exposure of the RNA whereas 0.25µl of RNAseOUT (Invitrogen) was required 
to prevent RNA degradation prior to cDNA synthesis. The plate was incubated 
at 37°C for 2hrs and denaturation of the enzyme was achieved by heating at 
70°C for 10mins.  
2.1.11 Sequencing  
DNA fragments or PCR products were sent for sequencing to Source 
BioScience. 5µl of DNA at a concentration of 100ng.µl(-1) (for plasmid DNA) or 1 
ng.µl(-1) /100bp (for PCR product) was transferred to a 1.5mL Eppendorf tube. 
Adequate primers were provided at a 3.2pmol/µl concentration. Analysis of the 
sequencing results was performed using the software Chromas (Technelysium) 
and Cluster W2.  
2.2 Cell Biology 
2.2.1. Isolation of lymphocytes from thymuses and from lymph nodes 
Thymuses and lymph nodes (brachial, axillary and inguinal) were dissected and 
placed in ice-cold RPMI-1640 (Invitrogen). The tissues were homogenised and 
strained through an 80µm metal mesh (Sefar Ltd., UK) into a 15mL falcon tube 
(SLS) with fluorescence-activated cell sorting (FACS) buffer to obtain a single-
cell suspension. 
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Table 2.6 Composition of FACS Buffer The table shows the composition of FACS 
buffer. The buffer was prepared under sterile conditions and was filtered before use. 
 
2.2.2. Isolation of splenocytes  
Adult mouse spleens were obtained by dissection and placed in ice-cold RPMI-
1640 (Invitrogen). Splenocytes were isolated by homogenizing the spleen and 
straining through an 80µm metal mesh (Sefar Ltd., UK) into a 15mL tube (SLS) 
to obtain a single-cell suspension. Cells were pelleted by centrifugation at 400g 
for 5mins at 4°C. Red blood cells were osmotically lysed in 500µl of ACK lysis 
buffer (Invitrogen) by incubating the sample for 10mins at room temperature. 
Splenocytes were then washed twice with FACS buffer to remove any residual 
lysis buffer.  
Alternatively, red blood cells were removed by gradient centrifugation. The cell 
suspension was under-laid with 4mL of Lymphocyte Separation Medium (LSM, 
Fischer) and tubes were centrifuged at 450g for 25mins with no brake at room 
temperature.  The interphase containing the splenocytes was aspirated using a 
Pasteur glass pipette (VWR) and transferred to a fresh tube. Splenocytes were 
subsequently washed with FACS buffer before staining for extra-cellular 
markers.  
2.2.3. Isolation of intra-epithelial lymphocytes  
Small intestines from adult mice were dissected and placed in cold RPMI-1640 
supplemented with 10% Newborn Calf Serum (NCS, Invitrogen). Fecal material 
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was flushed out from the small intestines with ice-cold PBS using an oral 
gavage needle attached to a 10mL syringe. Fatty tissues, vasculature and 
Peyer’s patches were removed, and the intestine was opened longitudinally to 
expose the lumen side. The organ was cut into small pieces of approximately 
0.5cm in length and transferred to a 50mL beaker with 40mL of 10% NCS 
RPMI-1640 and 5mM EDTA. The pieces of tissue were subsequently agitated 
for 60min at room temperature to encourage cell isolation.  
Nylon wool columns (1column/small intestine) were previously prepared by 
packing 0.7g of finely separated nylon fibers (Polysciences, USA) into a 20mL  
syringe up to the 20mL mark. The columns were covered in foil and autoclaved 
at 121°C for at least 20mins. Cell suspensions were subsequently passed 
through an autoclaved nylon wool column previously equilibrated with RPMI-
1640 with 38 mM HEPES (Life technologies). Flow-through was collected in a 
fresh tube and was washed with 10%NCS RPMI-1640. IELs were enriched on a 
discontinuous Percoll gradient (40% and 80% isotonic Percoll) (Amersham 
Biosciences). IELs were removed from the 40%-80% interphase by aspirating 
with a glass pasteur pipette and transferred to a fresh tube. The cells were 
washed with 10%NCS RPMI-1640 by centrifuging at 400g before being stained 
for FACS analysis.  
2.2.4. Foetal thymic organ culture (FTOC) 
Mouse E15 embryos were cut transversely using scissors and washed in 5mL 
of 1X PBS in a petri dish before the lungs, and the heart were removed using 
Dumont tweezers to expose the thymuses. Thymic lobes were dissected under 
a dissecting microscope and transferred to a drop of 1X PBS on a petri dish. Up 
to 5 lobes were cultured on a nucleopore membrane filter (Whatman) in 3mL of 
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filtered FTOC media (Table 2.7) in 6-well plates. In some experiments the 
following antibodies or inhibitors were added to the FTOC media: PP2 (Sigma), 
GL3 (Sigma). FTOCs were incubated at 37°C in 5%CO2 for 7-9 days (or as 
specified in the text).  
 
Table 2.7 Composition of the FTOC medium The table shows the components of 
the FTOC medium, which was prepared under sterile conditions to minimise 
contamination in FTOC.  
2.2.5. Staining protocols for Fluorescent Activated Cell sorting (FACS)  
a. Extracellular-staining  
Between 2 to 10 million lymphocytes were filtered through a 40µm strainer (BD) 
and transferred to a FACS tube (Becton, Dickinson and Company, BD). The 
tubes were centrifuged and cells were resuspended in 50µl of FACS buffer. 
Unless stated in the text, all antibodies were used at 1:100 dilution and samples 
were stained on ice, in the dark for 30 to 45 minutes. After staining, 
lymphocytes were washed twice with 1ml of FACS buffer. Prior to running the 
samples on the LSR-II flow cytometer (BD Bioscience), the cells were 
resuspended in 200µl of FACS buffer and 3µl of 4',6-Diamidino-2-Phenylindole, 
Dihydrochloride (DAPI, 2.5mg.mL(-1); Invitrogen) was added to the sample to 
allow the detection of dead cells. 
b. Intracellular staining of cytokines  
For intracellular staining of cytokines, 5 to 10 million thymocytes were 
transferred to a FACS tube and resuspended in 1mL of FTOC medium. The 
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lymphocytes were stimulated with 50ng.mL(-1) of phorbol 12-myristate 13-
acetate (PMA, Sigma-Aldrich) and 1µg.mL(-1) of Ionomycin (Sigma-Aldrich) for 
4hours at 37°C with intermittent mixing every 30mins. To prevent secretion of 
the cytokines, two protein transporter inhibitors, Monensin (eBioscience) and 
Brefeldin A (eBioscience) were added during the last 2hours at a final 
concentration of 2µM and 10µg.mL(-1), respectively. Post-stimulation, the 
samples were washed with FACS buffer by centrifugation at 400g for 5mins at 
4°C and stained for extracellular cell surface markers (refer to section 5.1.1) 
and with the Zombie Aqua™ Fixable Viability dye (1:100 dilution; Biolegend) for 
dead cell exclusion. Cells were subsequently washed with FACS buffer by 
centrifugation at 400g for 5mins at 4°C, supernatant was removed by inversion 
and the pellet was disaggregated by vortexing. The cells were fixed by drop-
wise addition of 250µl of the IC fixation buffer (eBioscience) while the sample 
was vortexed. The tube was incubated on ice, in the dark, for 15mins. The 
samples were then washed twice with 1 mL Permeabilisation buffer 
(eBioscience), previously diluted from a 10X stock in dH2O, by centrifugation at 
400g for 5mins at 4°C. Intracellular cytokines were stained by fluorochrome-
conjugated antibody diluted at 1:100 in 1X Permeabilization buffer.  The 
samples were incubated at 4°C for 45mins in the dark. Prior to analysis on the 
LSR-II flow cytometer (BD Bioscience), the cells were washed once with 1X 
Permeabilization buffer and once with FACS buffer by centrifugation at 400g for 
5mins at 4°C.  
c. Intracellular staining of transcription factors  
For intracellular detection of transcription factors, 10 million cells were 
transferred into a FACS tube and stained for extracellular markers as described 
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in section 5.1.1 and with the Zombie Aqua™ Fixable Viability dye (Biolegend) for 
dead cell exclusion. The Fixation/Permeabilization concentrate (eBioscience) 
was diluted 1:4 using the Fixation/Permeabilization diluent (eBiosicence) and 
the 10X Permeabilization buffer (eBioscience) was diluted 1:10 with dH20. 
Following extracellular staining, cells were washed in FACS buffer by 
centrifugation at 400g for 5mins at 4°C. The pellet was disaggregated by 
vortexing and the cells were resuspended in 1mL of the diluted 
Fixation/Permeabilization buffer. Cells were incubated for at least 30mins at 4°C 
in the dark and subsequently washed with 1mL of 1X Permeabilization buffer 
(eBioscience). Cells were stained for transcription factors of interest using 
antibodies diluted 1:100 in 1X Permeabilization buffer for 45mins on ice, in the 
dark. Prior to analysis on the LSR-II flow cytometer (BD Bioscience), the cells 
were washed once with 1X Permeabilization buffer and once with FACS buffer 
by centrifugation at 400g for 5mins at 4°C. 
d. Antibodies used throughout this thesis 
Protein Clone Fluorochrome Company 
TCRβ H57-597 FITC eBioscience 
TCRβ H57-597 PerCp5.5 eBioscience 
TCRβ H57-597 APCCy7 eBioscience 
TCRδ GL3 FITC eBioscience 
TCRδ GL3 PE eBioscience 
TCRδ GL3 PerCp5.5 eBioscience 
TCRδ GL3 APC eBioscience 
TCRvα2 B20.1 PE eBioscience 
CD3ε 145-2C11 V500 BD 
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CD3ε 145-2C11 PeCy5.5 eBioscience 
CD4 RM4.5 Pacific blue eBioscience 
CD4 RM4.5 FITC eBioscience 
CD4 RM4.5 PeCy7 eBioscience 
CD8α 53-6.7 Pacific blue eBioscience 
CD8α 53-6.7 FITC  eBioscience 
CD8α 53-6.7 APCCy7 eBioscience 
CD8β H35-17.2 PE eBioscience 
CD25 PC61 PeCy7 eBioscience 
CD25 PC61 APC eBioscience 
CD44 IM7 V500 eBioscience 
CD44 IM7 Pacific blue eBioscience 
CD24 M1/69 Pacific blue eBioscience 
CD45RB C363-16A APCCy7 Biolegend 
CD27 LG.7F9 PerCp5.5 eBioscience 
CD5 53-7.3 PB eBioscience 
CD5 53-7.3 FITC eBioscience 
CD69 H1.2F3 APC eBioscience 
CD117 (cKit) 2B8 APC eBioscience 
Foxp3 FJK-16s Pacific blue eBioscience 
Nur77 12.14 PE eBioscience 
Helios 22F6 APC eBioscience 
IL-17 Ebio17B7 APC eBioscience 
IFN-γ XMG1.2 PeCy7 eBioscience 
B220 RA3-6B2 FITC eBioscience 
CD11c N418 FITC eBioscience 
NK1.1 PK136 FITC eBioscience 
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Zombie Aqua NA  Biolegend 
    
Table 2.8 List of the antibodies used throughout this thesis The table shows the 
protein recognized by the antibody, the clone, the fluorochrome and the supplier. PE, 
Phycoerythrin and FITC, Fluorescein, APC Allophycocyanine 
    
e. Compensation  
 In order to set up voltages accurately and compensate for overlapping 
spectrum between two fluorochromes, single colour controls were run before 
each experiment and compensations were carried out manually on FACS Diva 
software (BD) or semi-automatically on FlowJo software (Tree Star). When 
possible, thymocytes were used to generate single colour controls. 
Alternatively, 10µl of OneComp ebeads (eBioscience) were stained with 1µl of 
antibody in 100µl of FACS buffer.  
f. Gating strategy 
Lymphocytes were identified based on their size (Forward Scatter, FSC) and 
their granularity (Side Scatter, SSC). Doublets were visualized and gated out by 
looking at scatter-height and scatter-area for both forward and side scatters 
(FSC-H versus FSC-A & SSC-H versus SSC-A). Dead cells were gated out 
using DAPI (Invitrogen) or Zombie Aqua™ Fixable Viability dye (Biolegend). 
2.2.6 FACS sorting  
a. FACS sorter  
Sorting of cells was performed on a FACSAria II cell sorter (BD Bioscience). 
Single cell sorting was performed on a MoFlo sorter (Beckman Coulter).  
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b. Depletion of thymocytes expressing CD4 and CD8 co-receptor 
molecules  
In order to save time while sorting DN subsets and therefore minimize cell-
death, CD4 and CD8 expressing thymocytes, which constitute over 80% of the 
thymus, were depleted by complement-mediated lysis. Adult mouse thymuses 
were dissected, homogenised and strained through an 80µm metal mesh into a 
15mL tube with 7mL of RPMI-1640. 250µl of each CD4 and CD8 hybridoma 
supernatant was added to the cell suspension and incubated for 10mins at 
37°C. The CD4 and CD8 hybridoma supernatants consist of anti-CD4 and anti-
CD8 IgM isotype antibodies, respectively. Complement powder (Cedarlane 
Laboratories) was resuspended in 1mL of ice-cold water. It was subsequently 
added to the cell suspension and mixed by inversion. The samples with 
complement were incubated at 37°C for an additional 30mins to allow 
components of the complement system to recognise antibody-bound cells and 
mediate cell lysis. 
In order to isolate live DN cells from the lysed CD4(+) and CD8(+) cells, the cell 
suspensions were under-laid with 4mL of  lymphocyte separation media (LSM, 
Fisher) and centrifuged at 450g for 25mins at room temperature with no brake. 
Live thymocytes were aspirated from the interphase using a glass Pasteur 
pipette (VWR) and transferred to a fresh tube. The cells were washed with 
FACS buffer by centrifugation at 400g for 5mins at 4°C before staining for 
extracellular markers as described in section 5.1.1.  
2.2.7 Flow cytometry acquisition 
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The acquisition of the flow cytometry data was done using a LSRII  flow 
cytometer (BD Bioscience) through the FACSDIVA software (BD Bioscience).  
2.2.8 Flow cytometry analysis  
Analysis of the FACS data was done using the Flow Jo software Version X 
(Tree Star). 
2.2.9 Cell count 
Dead cells were excluded from the cell counts by diluting 10µl of a cell 
suspension with 10µl of 0.4% trypan blue (Invitrogen), which is known to enter 
cells with a fractured cell membrane. 10µl of the diluted cell suspension was 
subsequently loaded onto a heamocytometer and the number of cells per mL 
was determined as follow:  
Number of cells.mL(-1) = Number of cells counted x Dilution factor x 104 
2.2.10 Mice  
C57Bl/6 and FVB mice were purchased from Charles River Laboratories.      
pTα-/-.pTαa mice on a C57Bl/6 background were generated in-house. pTα-/- and 
OT-II transgenic mice on a C57Bl/6 background were obtained from Jackson 
Laboratories. pTα-/- x TCRδ-/- were generated in-house by crossing a pTα-/- with 
a TCRδ-/- animal and backcrossing onto a C57Bl/6 background for four 
generations. Embryos were obtained by setting up timed-pregnancies. All 
animals were bred and maintained in Individually Ventilated Cages (IVC) at 
Barts and The London School of Medicine and Dentistry, ensuring a pathogen-
free environment. All experiments involving animals were performed in 
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compliance with relevant laws and institutional guidelines and were approved 
by a local ethics committee. PPL is 70/7191. 
2.2.11. Statistical Analysis  
Unless specified in the text, all statistical analysis was done using the 
GraphPad Prism software. When comparing two groups, an unpaired Student’s 
t-test with a two-tailed p value with 95% confidence intervals was performed. 
Alternatively, when comparing three or more groups, a one-way analysis of 
variance (ANOVA) with Tukey post hoc was carried out. Data are presented as 
mean ± standard deviation (SD). P>0.05 is not-significant (ns); * P<0.05; ** 
P<0.001; *** P<0.0001. 
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Chapter 3 
T cell development in pTαa-only transgenic mice 
 
3.1 Introduction  
It is still unclear why some DP progenitors undergo apoptosis following agonist 
recognition by TCRαβ during T cell selection while others differentiate into 
unconventional αβ T cells. This could suggest that DP thymocytes are a 
heterogeneous subset that do not possess an equal potential to adopt a 
conventional or an unconventional αβ T cell fate. All DP thymocytes arise from 
the DN3 stage after having efficiently traversed the β-selection checkpoint. This 
transition is governed by expression of the preTCR, made by inclusion of one of 
the alternatively-spliced pTα isoforms (pTαa or pTαb). Very little is understood 
about the role of each isoform during T cell development. We know that the two 
pTα isoform; have been conserved across evolution and are found in humans 
and mice (Smelty et al., 2010), can form functional preTCRs (Gibbons et al., 
2001), and differently affect the cell-surface expression of TCRβ, potentially 
resulting in quantitatively or qualitatively different preTCR signals (Barber et al., 
1998). In support of this, previous work in vitro performed by Juliet Mahtani-
Patching, a former PhD student in the lab, demonstrated differential expression 
for each pTα isoform across various thymocytes subsets. Furthermore, ectopic 
expression of each isoform in FTOCs in vitro promoted different T cell 
development likely due to the different qualitative, quantitative or temporal 
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signals at the β-selection checkpoint. Thus, we hypothesised that differences in 
preTCRa and preTCRb signalling at the β-selection checkpoint may be 
responsible for establishing heterogeneity at the DP stage that would be 
subsequently important for the generation of different αβ T cell subsets 
following positive selection. Here, we first investigate the pattern of expression 
of each pTα isoform at the single cell level in pre- and post-β-selected 
thymocytes and subsequently investigate the role of the pTαa isoform at the β-
selection checkpoint in vivo.  
3.2  pTαa and pTαb are differently expressed during T cell 
ontogeny – Data generated by Juliet Mahtani-Patching 
A differential pattern of expression for the two pTα isoforms throughout T cell 
ontogeny was demonstrated by Juliet Mahtani-Patching during her Ph.D. Using 
semi-quantitative PCR on Fluorescence Activated Cell (FAC) sorted DN2 
(CD25(+)CD44(-)), DN3 (CD25(+)CD44(-)), DN4 (CD25(-)CD44(-)), ISP 
(CD8(+)TCRβ(-)), DP (CD4(+)CD8(+)) and CD4(+) T cell subsets (Figure 3.1), she 
demonstrated:  
- A peak of expression for both pTαa and pTαb in the DN3 and DN4 T cell 
subsets that corresponds to cells traversing the β-selection checkpoint.  
- An unexpected expression of pTαb but not pTαa at the DP stage of T cell 
development where rearrangement of the TCRα gene is thought to 
silence pTα expression. 
- Sustained pTαb expression in mature T cells (e.g. CD4(+) T cells). 
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Thus, it was concluded that expression of pTαa and pTαb appears to be 
differentially regulated throughout T cell development, favouring the idea 
that these isoforms have a non-redundant role in T cell development. 
 
Figure 3.1 pTαa and pTαb are differentially expressed in the thymus. Semi-
quantative PCR for pTαa or pTαb was carried out on cDNA obtained from sorted DN2, 
DN3, DN4, ISP, DP and CD4(+) T cell subsets. Loading was normalised with β-actin. 
From Juliet Mahtani-Patching’s thesis. 
 
3.3 Individual C57Bl/6 DN3 and DN4 thymocytes can express 
pTαa, pTαb, or both isoforms simultaneously  
Although Juliet’s data suggested a difference in the regulation of pTαa and pTαb 
expression at the level of thymocyte subsets, we next sought to investigate 
whether each pTα isoform was expressed simultaneously or individually in 
developing thymocytes. Thus, using single-cell PCR, we investigated the 
pattern of expression of each isoform in individual DN3 and DN4 thymocytes 
from C57Bl/6 animals. C57Bl/6 thymuses were dissected and single cells were 
individually FAC-sorted into 96 well plates. Ten cells were placed in the first well 
(A1) and none in the last (H12) so they could be used as positive and negative 
controls, respectively. For the sort, lymphocytes were identified according to 
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their size and doublets were gated out using the SSC-Width (SSC-W) and SSC-
Area (SSC-A) (Figure 3.2).  
Using a cocktail of antibodies, cells were then excluded based on the 
expression of B220 (B cells), NK1.1 (NKT and NK cells), CD11c (Dendritic 
cells), TCRδ (γδ T cells) and CD4, CD8α, CD8β and TCRβ (late αβ lineage 
thymocyte). DN3 and DN4 subsets were identified by expression of CD25 and 
CD44; DN3 cells are CD25(+)CD44(-) and DN4 cells are CD25(-)CD44(-) (Figure 
3.2).  
 
 
Figure 3.2 Gating strategy for single-cell FAC-sort of DN3 and DN4 thymocytes. 
Lymphocytes are initially identified by size before doublets are removed using FSC-A 
versus SSC-W. Lineage(+) cells (B220(+), CD11c(+), NK1.1(+), CD4(+), CD8α(+), CD8β(+), 
TCRδ(+), TCRβ(+)) were gated out before DN3 and DN4 subsets were identified by 
expression of CD44 and CD25. FSC-A, Forward scatter area; SSC-A, side scatter 
area; SSC-W, Side scatter width.  
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Cells were sorted into 10µl of reverse transcription mix containing pTα-targeting 
primers. Due to the potentially low expression of pTα transcripts in a single cell, 
all pTα transcripts were first amplified using the M-pTageneF and M-pTageneR 
primers that recognise sequences within exon 1 and exon 4 of the pTα gene 
that are shared by both pTα isoforms (Figure 3.3).  
Specific amplification of pTαa or pTαb isoforms was performed using a second 
nested PCR reaction. This used primers that amplified sequences unique to 
either isoform. The pTαa forward primer (MpTaaF) was homologous to 13bp 
located at the 3’ end of Exon 1 and the first 7bp at the 5’ end of exon 2. The 
 
Figure 3.3 Overview of the methodology of single-cell PCR. Thymocytes from 
C57Bl/6 mice were FAC-sorted into 96 well-plates. Reverse transcription was 
performed using primers targeting pTα transcripts specifically. All pTα transcripts were 
then amplified using MpTageneF and M-pTageneR primers. This PCR product then 
underwent a second round of nested PCR using either M-pTaaF and M-pTaaR to 
amplify pTαa, or M-pTabF and M-pTabR2 to amplify pTαb. The PCR products were 
visualised on agarose gels and bands were extracted to be sent for sequencing to 
confirm the specificity of the PCR reaction. 
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pTαa reverse primer (M-pTaaR) was homologous to the last 13bp of exon 3 and 
the first 7bp of exon 4. Because exon 2 is absent from pTαb transcripts, these 
primers amplified pTαa only. Recognition of pTαb transcripts followed a similar 
strategy where the pTαb forward primer (M-pTabF) traversed the exon 1:3 
boundary absent from pTαa transcripts; M-pTabF recognises 13bp located at 
the 3’ end of exon 1 and the first 10bp of exon 3. The pTαb reverse primer was 
homologous to 19bp of exon 4. The data was visualised by running the 
products on agarose gels. The results suggested that DN3 and DN4 
thymocytes could express pTαa-only, pTαb-only or both pTα transcripts 
simultaneously (Figure 3.4).  
 
 
Out of 47 wells containing DN3 cells, two wells were detected to express pTαa-
only, against nine expressing pTαb-only. Three cells expressed both 
pTα isoforms. Similarly, out of 47 wells that contained DN4 cells, four expressed 
pTαa-only, or pTαb-only, while both pTα transcripts were amplified in three 
 
Figure 3.4 C57Bl/6 DN3 and DN4 thymocytes can express pTαa, pTαb or both  
pTα  isoforms simultaneously. (A) An example of a PCR result obtained from single-
cell PCR for  pTαa and pTαb. The expected band for pTαa is 341bp and for pTαb it is 
87bp (B) Data summarising the numbers of cells detected to express one or the other 
isoform.  
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wells. This cannot be considered as a quantitative result.  Instead, it simply 
illustrates that cells could contain either pTαa, pTαb, or both isoforms. The 
relatively low efficiency of the experiment (only 25 out of 94 wells (~26.6%) 
gave us a result) could be due to sorting issues or to some degree of 
competition between each set of primers. It could also indicate that some cells 
do not express the preTCR.   
To confirm the specificity of the PCR, bands corresponding to pTαa (341bp) and 
pTαb (87bp) were extracted and sent for sequencing. Band extraction and 
sequencing of the 341bp product corresponding to the pTαa isoform was 
efficient and successful (Figure 3.5). The sequence matched 100% the pTαa 
cDNA sequence obtained on the PubMed website 
(http://www.ncbi.nlm.nih.gov/pubmed).  
By contrast, despite the successful extraction of pTαb bands, sequencing 
efficiency was poor and did not allow us to align it successfully to the pTαb 
cDNA sequence. The reason for this was unclear. Nonetheless, the size of the 
band (87bp) gave us some confidence that the PCR product was specific for 
pTαb. 
In conclusion, this suggested that individual DN3 or DN4 thymocytes could 
express pTαa, pTαb or both pTα mRNA simultaneously at the β-selection 
checkpoint.  
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3.4 Overview of the generation of pTαa transgenic mice (work 
initiated by Juliet Mahtani-Patching) 
Data obtained from FTOCs in vitro from the PhD of Juliet Mahtani-Patching had 
suggested that pTαa and pTαb could have non-redundant differential roles in T 
cell development at the β-selection checkpoint (Mahtani-Patching, 2010). 
However, expression of the pTα isoforms in these studies was under the 
 
Figure 3.5 The pTαa isoform was successfully amplified during single-cell PCR 
reaction as shown by sequencing. (A) Chromatogram obtained from the 
sequencing of pTαa. (B) The alignment of the sequencing result with pTαa confirmed 
the specificity of the PCR.  
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control of a retroviral promoter, rather than the physiologically relevant 
pTα promoter, which could result in non-physiological pTα expression. To 
overcome this issue, a bacterial artificial chromosome (BAC) pTαa-only 
transgenic mouse line was generated in-house to investigate the role of 
pTαa (only) at the β-selection checkpoint. A BAC consists of a large DNA 
vector containing a targeted piece of genomic DNA that includes a gene of 
interest (here pTα), and the regulatory elements required for its 
physiological expression. Thus, BAC transgenic animals are likely to 
express the transgene at the right place and at the right time during T cell 
development (Heintz, 2001; Sharan et al., 2009). pTα transgenic mice have 
been generated previously but under the control of the proximal Lck 
promoter which is unlikely to reproduce normal pTα expression (Gibbons et 
al., 2001). Additionally, the role of each isoform in the generation of different 
T cell subsets was not investigated (Gibbons et al., 2001).  The BAC used in 
the generation of BAC pTαa transgenic mice (BMQ452P20) consists of 41Kb of 
C57Bl/6 chromosome 17, that includes 8.5kb of the pTα gene. Using a 
recombination-mediated genetic engineering technique (recombineering) exons 
1 and 2 were fused to prevent splicing out of exon 2 thus forcing the expression 
of only pTαa (Figure 3.6).  
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Figure 3.6 Schematic representation of the pTαa BAC transgene.  (A) A BAC 
containing the pTα gene (top panel) was purchased from the Ensembl organisation 
and underwent several steps of recombineering where exon 1 and 2 were fused to 
prevent alternative splicing resulting in a pTα gene that can generate only pTαa (bottom 
panel). (B) A GALK cassette was amplified by PCR using primers sharing some 
homology with the GALK sequence and intron 1.  Insertion of the GALK cassette within 
intron 1 was catalysed by the bacteriophage λ Red system. Successful transformants 
were identified by growing bacteria onto a galactose-containing plate. Removal of 
GALK and fusion of exon 1 and 2 happened simultaneously in a subsequent stage. 
Oligos homologous to exon 1 and 2 were annealed to one another and used to remove 
intron 1 through homologous recombination resulting in a pTα gene unable to undergo 
alternative splicing following transcription. Thus, pTαa only will be generated. 
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BAC-pTαa-transgenic founders were bred onto a pTα-deficient background and 
pups were weaned at 3 weeks of age as required by home office regulations. 
The pTαa.pTα-/- colony was established and sustained for subsequent 
experiments by breeding a pTαa.pTα-/-  transgenic animal with a   pTα-/- animal 
resulting in ~50% of pTαa.pTα-/- pups. Genotyping was performed by PCR using 
ears snips. To control for the quality of the genomic DNA a PCR was run using 
primers recognising a 466bp DNA sequence located 9.5Kb upstream of the 
pTα gene (Figure 3.7). A second PCR amplified a 450bp sequence across exon 
1 and 2 of the pTα gene, which was specific for the pTαa-only transgene.  
 
Figure 3.7 pTαa.pTα -/- transgenic litters were genotyped by PCR. (A) PCR 
amplifying a 466bp sequence upstream of the pTα gene was used to assess the 
quality of the DNA. The positive control was obtained from previously genotyped mice. 
(B) A second PCR was carried out on the same samples using primers amplifying 
specifically the pTαa transgene. Here, out of six pups genotyped, three are positive for 
the transgene.  L, 1Kb Ladder; NTC, no template control 
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3.5 The pTαa transgene successfully drives transition of DN 
thymocytes across the β-selection checkpoint  
PreTCR signalling at the DN3 stage is known to drive developing thymocytes 
towards an αβ T cell fate. Indeed, absence of the preTCR in pTα-deficient mice 
results in a severe depletion of αβ T cells and the accumulation of γδ T cells  
(Fehling et al., 1995; Neilson, 2004). In light of this, we first investigated 
whether the pTαa transgene was able to promote the DN3àDN4àDP transition 
(in a pTα-/- background) and to divert DN3 thymocytes away from a γδ fate. All 
flow cytometry analyses throughout this thesis share a common initial gating 
strategy (Figure 3.8); lymphocytes are first identified by size using forward 
scatter area (FSC-A) and by granularity using side scatter area (SSC-A); 
doublets are removed by sequentially gating on FSC-A and FSC-H and SSC-A 
and SSC-Height (SSC-H). Finally, live thymocytes are then identified by 
exclusion of the DNA-bound dye 4',6-diamidino-2-phenylindole (DAPI) (Figure 
3.8). 
 
Figure 3.8 The initial steps of the gating strategy shared across all flow 
cytometry analysis. Lymphocytes are initially identify according to their size on the 
SSC-A and FSC-A profile before doublets are removed by visualising the cells on a 
FSC-H versus FSC-A plot and subsequently using SSC-H versus SSC-A. Dead cells 
are removed using the auto-fluorescent DAPI dye. FSC, forward scatter; SSC, side 
scatter; A, area, H, height; DAPI, 4',6-diamidino-2-phenylindole.  
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Flow cytometry analysis of the thymus from pTαa.pTα-/- mice revealed that the 
pTαa transgene was expressed as it largely rescued the profound block in αβ T 
cell development observed in pTα-deficient mice. Not only did the CD4 vs CD8 
plots from pTαa.pTα-/- mice resemble wild-type (WT) controls (rather than pTα-/- 
mice) but there was also significant reduction of γδ T cells (to ~2.5%) compared 
to pTα-/-mice (~18%) although not quite as low as WT animals (~0.5%) (Figure 
3.9). Upon analysis of cell numbers, we noted that although thymus cellularity 
was significantly greater in pTαa.pTα-/- thymuses (~50x106 cells) compared to 
pTα-/- animals (~5x106 cells), it was nevertheless 3-fold lower than C57Bl/6 
mice (~170 x106 cells) (Figure 3.10). This partial rescue could be due to the 
absence of the second pTα isoform (pTαb) or possibly to a subtle timing issue of 
transgene expression. 
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Figure 3.9  The pTαa transgene significantly rescues αβ  T cell development in a 
pTα -/- background. (A) Representative flow cytometry plots (from n>10) from 
thymuses of C57Bl/6, pTα-/-  and  pTαa.pTα-/- mice showing  showing CD4 versus CD8 
profiles (B) Representative flow cytometry plots (from n>10) from C57Bl/6, pTα-/-  and  
pTαa.pTα-/- transgenic mice shown TCRδ versus TCRβ profiles  (C) Summary bar 
charts of the percentages of γδ T cells as a percentage of all living cells from thymus 
of C57Bl/6, pTα-/-  and  pTαa.pTα-/- transgenic mice. ****p<0.0001; ** p<0.01; *** 
p<0.001 error bar is SD.  
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3.6 The development of mature TCRβ (+)CD4(+) and TCRβ (+)CD8(+) 
T cells is rescued in lymph nodes from pTαa.pTα -/- mice 
compared to pTα-deficient animals.  
The data presented above suggested that the pTαa transgene largely rescued 
qualitatively αβ T cell development in a pTα-/- background. This prompted us to 
assess whether the number of mature αβ T cells was also restored in the 
periphery of pTαa.pTα-/- animals. As shown in figure 3.11, flow cytometry 
analysis of lymph nodes demonstrated that expression of pTαa largely rescues 
the proportion and cell number of peripheral CD4(+) and CD8(+) T cells.  
 
 
Figure 3.10 Total number of thymocytes in C57Bl/6, pTα -/- and pTαa.pTα -/- mice 
Summary bar charts (from n>10) showing the total number of thymocytes from the 
thymuses of C57Bl/6, pTα-/- and pTαa.pTα-/- transgenic mice. ****p<0.0001; error bar is 
SD. 
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Indeed, while pTα-deficient animals harbour about ~5.0x105 CD4(+) T cells, 
pTαa.pTα-/- mice had on average about 5-6 times more cells (~2.8x106 cells). 
Similarly, pTα-deficient animals have a largely lymphopenic CD8(+) 
compartment with only ~2.0x105 cells against ~3.0x106 cells in pTαa.pTα-/- 
animals (compared with ~3.9x106 cells in C57Bl/6 mice) (Figure 3.11).  
 
Figure 3.11 The pTαa transgene successfully rescues the development of mature 
CD4(+) and CD8(+) T cells in a pTα -/- background. (A) Representative flow cytometry 
plots (from n>10) showing CD4 versus CD8 profiles from lymph nodes from C57Bl/6, 
pTα-/-  and  pTαa.pTα-/- mice. (B) Summary bar charts of total numbers of CD4(+) and 
CD8(+) lymphocytes in all three strains.****p<0.0001; *** p<0.001; ** p<0.01; ns is non 
significant; error bar is SD. 
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Thus, the pTαa transgene was able to largely rescue conventional CD4(+) and 
CD8(+) T cell development in a pTα-/- background  (Figure 3.11). 
3.7 The pTαa transgene does not rescue the development of 
unconventional TCRαβ (+)CD8αα (+) IELs 
As documented in the introduction, we had previously hypothesised that 
signalling events at the β-selection checkpoint might be responsible for 
establishing heterogeneity amongst DP thymocytes that could then impact on 
subsequent T cell selection. Because conventional CD4(+) and CD8(+) T cells 
appeared largely rescued in thymus and LN from pTαa.pTα-/- transgenic mice 
we sought to investigate whether this was also the case for agonist-selected T 
cells. The lab has had an ongoing interest in understanding the development of 
agonist-selected unconventional TCRαβ(+)CD8αα(+) intra-epithelial 
lymphocytes (IELs), which prompted us to investigate their development in 
pTαa.pTα-/- mice. pTα-deficient animals, which cannot express a preTCR, also 
lack TCRαβ(+)CD8αα(+) IELs, implicating β-selection as an important checkpoint 
in their development (Fehling et al., 1995). Small intestines from C57Bl/6, pTα-/- 
and pTαa.pTα-/- mice were dissected, epithelial lymphocytes were isolated and 
cells were analysed by flow cytometry. Because we were mainly interested in 
CD8(+) IELs, CD4(+) cells were gated out and populations of γδ and αβ IELs were 
identified using anti-TCRδ and anti-TCRβ antibodies. CD8α and CD8β were 
then used to look at three populations of interest; conventional 
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TCRαβ(+)CD8αβ(+) IELs; unconventional TCRαβ(+)CD8αα(+) IELs; and 
unconventional TCRγδ(+)CD8αα(+) IELs. 
 
Although great care is taken to obtain a pure population of epithelial 
lymphocytes, we observed significant variability (up to five-fold) regarding the 
number of cells that were isolated per small intestine. This has somewhat 
restricted our analysis of total cell number, and effectively forced us to mainly 
concentrate on cell proportions (Figure 3.12).  
 
 
Figure 3.12 The total number of intra-epithelial lymphocytes (IEL) varies 
significantly across different experiments. Summary dot plot showing the 
total number of cells obtained from the small intestine of C57Bl/6, pTα-/- , and  
pTαa.pTα-/- mice. Cell numbers varied significantly between experiments. 
 
On analysis of the small intestine of the three groups of mice, it was evident that 
pTαa.pTα-/- mice had a significant reduced proportion of TCRαβ(+) IELs when 
compared to WT animals. This proportion was more similar to that seen in pTα-/- 
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mice, suggesting that expression of the transgenic pTαa had not efficiently 
rescued development of this subset. Importantly, this depletion of TCRαβ(+) IELs 
was restricted to the unconventional TCRαβ(+)CD8αα(+) IEL subset as 
proportions of conventional TCRαβ(+)CD8αβ(+) IELs or TCRγδ(+) IELs were 
largely rescued by the pTαa transgene. Indeed, TCRαβ(+)CD8αβ(+) IELs and 
TCRγδ(+)CD8αα(+) IELs constitute on average 15% and 25% of the CD4(-) 
subset in both C57Bl/6 and pTαa.pTα-/- transgenic mice. Thus, the TCRαβ(+) IEL 
ratio of conventional TCRαβ(+)CD8αβ(+) IELs to unconventional 
TCRαβ(+)CD8αα(+) IELs that is ~1.5 in WT animals, and is almost 20 in   
pTα-/- mice, is still significantly raised in pTαa.pTα-/- mice with a ratio of ~8 
(Figure 3.13).  
 
Thus, although the development of conventional T cells seems to be largely 
rescued by the pTαa transgene in both the lymph node and to a slightly lesser 
extent the gut, the availability of only the pTαa isoform at the β-selection 
checkpoint appears to disproportionately affect the development of agonist-
selected TCRαβ(+)CD8αα(+) IELs.   
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Figure 3.13 The TCRαβ (+)CD8αα (+) IELs are not rescued by the pTα a transgene.  
(A) Representative flow cytometry plots (n>8) looking at IEL populations in the small 
intestine of C57Bl/6, pTα-/-  and  pTαa.pTα-/- mice. Percentages of cells are indicated 
near each gate. (B) Summary bar graphs (n>8) of the proportion of TCRαβ(+)CD8αα(+), 
TCRαβ(+)CD8αβ(+) and TCRγδ(+)CD8αα(+)IELs out of CD4(-) IELs (C) Summary bar 
graph (n>8) of the ratio of conventional  TCRαβ(+)CD8αβ(+) IELs to unconventional 
TCRαβ(+)CD8αα(+) IELs. **** p< 0.0001 *** p < 0.001, **p < 0.01, * p < 0.05, ns is for 
not significant. Error bars are SD.  
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3.8 The pTαa transgene does not fully rescue the development 
of thymic TCRαβ (+)CD8αα (+) IEL progenitors. 
The reduced proportion of TCRαβ(+)CD8αα(+) IELs in the small intestine of 
pTαa.pTα-/- transgenic animals led us to then assess the development of their 
progenitors in the thymus that have been defined by Hilde Cheroutre’s lab as 
TCRδ(-) DN (CD4(-)CD8(-)) CD5(+)TCRβ(+) (Lambolez et al., 2007). In WT 
C57Bl/6 mice the percentage of these progenitors (as a proportion of all DN 
cells) was ~11%. In pTα-/- mice, these cells were largely absent, representing 
only 0.2% of DN cells. However, in pTαa.pTα-/- mice this subset was ~4% of DN 
cells suggesting that the transgene is capable of rescuing their development to 
some extent (Figure 3.14). Of note, the large disparity in the size of the DN 
population between the three groups (for example, 1.5%, 60.0%, 8.5% in 
C57Bl/6, pTα-/-, and pTαa.pTα-/- mice, respectively (Figure 3.9) is likely to affect 
the calculation of IEL progenitors. 
 
To try to clarify whether thymic IEL progenitors were reduced in pTα-/-.pTαa 
mice, we looked at TCRαβ(+)CD8αα(+) IEL progenitors based on the recently 
described phenotype of CD4lowCD8low (DPdull), CD5(+), CD69(+), PD1(+) and 
CD122(+) (McDonald et al., 2014). Preliminary analysis led to a similar 
conclusion as that above; that there is a reduction of TCRαβ(+)CD8αα(+) IEL 
progenitors in pTαa.pTα-/- mice (~8% of DPdull) compared to C57Bl/6 mice 
(~16% of DPdull) (Figure 3.15). 
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Figure 3.14 pTαa.pTα -/- mice harbour a reduced compartment of thymic 
TCRαβ (+)CD8αα (+)IEL progenitors. (A) Representative flow cytometry plots (n>10) 
looking at CD4(-)CD8(-),TCRαβ(+),CD5(+) IEL progenitors in the thymus of C57Bl/6, pTα-/-  
and  pTαa.pTα-/- mice. Percentages of cells are indicated near each gate. (B) Summary 
bar graph (n>10) of the proportion of CD4(-)CD8(-)TCRαβ(+)CD5(+) IEL progenitors in 
C57Bl/6, pTα-/-  and  pTαa.pTα-/- mice (C)  Summary bar graph (n>10) of the total cell 
number of CD4(-)CD8(-)TCRαβ(+)CD5(+) IEL progenitors in C57Bl/6, pTα-/-  and  
pTαa.pTα-/- mice. DN is Double negative (CD4(-)CD8(-)) **** p<0.0001 *** p < 0.001. 
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Figure 3.15 pTαa.pTα -/- transgenic mice harbour a reduced compartment of 
recently described TCRαβ (+)CD8αα (+)IEL progenitors. (A) Representative flow 
cytometry plots (n=2) looking at DPdull, CD5(+), CD69(+), PD1(+) and CD122(+) IEL 
progenitors in the thymus of C57Bl/6, pTα-/-  and  pTαa.pTα-/- transgenic mice. 
Percentages of cells are indicated near each gate. (B) Summary graph (n=2) of the 
proportion of DPdull, CD5(+), CD69(+), PD1(+) and CD122(+) IEL progenitors in C57Bl/6, 
pTα-/-  and  pTαa.pTα-/- mice. DP dull is (CD4lowCD8low); 
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3.9 Characterisation of TCRαβ (+) and TCRγδ (+) IEL populations 
in the small intestine of C57Bl/6, FVB/n, and BALB/c mice.  
It had previously been noted in the lab that different strains of WT mice 
(C57Bl/6, FVB/n, BALB/c) had different ratios of conventional 
TCRαβ(+)CD8αβ(+) to unconventional TCRαβ(+)CD8αα(+) IELs, that was 
somewhat reminiscent of that observed in pTαa.pTα-/- mice when compared to 
C57Bl/6 mice. Importantly, these are WT strains and have been extensively 
used as “controls” in numerous studies (Kunisawa et al., 2007; Mysorekar et al., 
2002; Panwala et al., 1998).  Comparing T cell subsets in different strains of WT 
mice has, on some occasions, allowed scientists to gain a particular insight into 
T cell development or function (Barbee et al., 2011; Turchinovich and Hayday, 
2011). This is well demonstrated by identification of Skint-1 required for 
dendritic epidermal γδ T cells (DETC) development and maintenance in the 
murine skin. The importance of Skint-1 came to light following the comparison 
of two different strains of FVB/n mice (Barbee et al., 2011). Indeed, it was noted 
that FVB/n mice from the supplier Taconic farms (FVB/n-Tac) lacked DETC 
compared to FVB/n mice from the Jackson laboratories (FVB/n-Jax). Transfer of 
FVB/n-Tac thymocytes to FVB/n-Jax thymic stroma restored DETC 
development suggesting that a developmental determinant was present in non-
haematopoietic cells (Barbee et al., 2011). Genetic comparison of the two 
strains revealed a mutation in the Skint-1 gene resulting in premature 
termination of translation and thus a mutated protein (Barbee et al., 2011). 
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To investigate the IEL compartments of the three WT strains, lymphocytes were 
isolated from the small intestine and analysed by flow cytometry. (Figure 3.16). 
The first notable difference in IEL populations between the three strains was a 
significant reduction in TCRαβ(+) IELs in BALB/c mice compared to the other 
two strains (~5% of CD4(-) IELs compared to ~30% in C57Bl/6 and ~40% in 
FVB/n mice). By contrast, the TCRγδ(+)IEL compartment was not significantly 
different (~40% of CD4(-) cells for all three strains).  
 
 
Figure 3.16 BALB/c mice harbour a reduced proportion of TCRαβ (+) IELs but not 
TCRγδ (+) IELs compared to C57Bl/6 and FVB/n mice. (A) Representative flow 
cytometry plots (from n>6) looking at the IEL populations in the small intestine of 
C57Bl/6, FVB/n and BALB/c mice. (B) Summary bar graphs (n>6) of the proportions of 
TCRαβ(+) and TCRγδ(+) IELs out of CD4(-)IELs in the small intestines of C57Bl/6, FVB/n 
and BALB/c mice. **** p< 0.0001, * p < 0.05, ns is for not significant.  
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Analysis of the proportions of each TCRαβ(+) IEL population (that is the 
TCRαβ(+)CD8αβ(+), TCRαβ(+)CD8αα(+), and TCRγδ(+)CD8αα(+) subsets) revealed 
that TCRαβ(+)CD8αα(+) IELs were found in lower proportions in FVB/n mice 
(~7%  of CD4(-) cells) and BALB/c mice (~3%) compared to C57Bl/6 mice 
(~13%) (Figure 3.17). TCRαβ(+) IELs were then analysed further by calculating 
the ratio of conventional TCRαβ(+)CD8αβ(+) IELs to unconventional 
TCRαβ(+)CD8αα(+) IELs. For C57Bl/6 mice this ratio was ~1.0, with roughly 
equal proportions of the two types of TCRαβ(+)IELs. However, for BALB/c mice 
this ratio was nearer 0.5, while FVB/n mice had a ratio of conventional to 
unconventional IELs that approached 6.0 (Figure 3.17). Thus, in three strains of 
WT mice, housed in the same facility, and purchased from the same supplier, 
the proportion of conventional and unconventional IELs varied significantly. Of 
particular interest were FVB/n mice as these mice appear to have a significantly 
reduced unconventional TCRαβ(+)CD8αα(+) IEL pool. We hypothesised at this 
point that this reduction in unconventional gut IELs in FVB/n mice may be due 
to compromised thymic development of unconventional IEL progenitors.  
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Figure 3.17 C57Bl/6, FVB/n and BALB/c mice harbour different proportions of 
TCRαβ (+)CD8αα (+) IELs. (A) Representative flow cytometry plots (from n>6) looking at 
the IEL populations (TCRαβ(+)CD8αα(+), TCRαβ(+)CD8αβ(+) and TCRγδ(+)CD8αα(+)IELs) 
in the small intestine of C57Bl/6, FVB/n and BALB/c mice. Percentages of cells are 
indicated near each gate. (B) Summary bar graphs (n>6) of the percentages (of total 
CD4(-) IELs) of TCRαβ(+)CD8αα(+), TCRαβ(+)CD8αβ(+) and TCRγδ(+)CD8αα(+)IELs (C) 
Summary bar graph (n>6) of the ratio of TCRαβ(+)CD8αβ(+) to TCRαβ(+)CD8αα(+) IELs. 
**** p< 0.0001 *** p < 0.001, **p < 0.01, ns is for not significant.  
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3.10 Characterisation of IEL progenitors in the thymus of adult 
C57Bl/6, FVB/n and BALB/c mice. 
The relative decrease or increase in TCRαβ(+)CD8αα(+) IELs in the small 
intestines of FVB/n and BALB/c mice respectively, led us to investigate whether 
this was mirrored by the pool of thymic IEL progenitors from 6-week old adult 
mice. On average, C57Bl/6 mice had ~4.0x105 CD4(-)CD8(-)TCRβ(+)CD5(+) (so- 
called) unconventional IEL progenitors that represented ~12% of the thymic DN 
pool. By comparison, FVB/n mice had only ~2.0x105 cells (~9% of the DN 
subset), while BALB/c mice had significantly more (5.0x105 cells) that were 
almost 20% of the DN compartment (Figure 3.18). Thus, the numbers and 
proportions of thymic unconventional IELs progenitors mirrored the relative 
proportions of unconventional IELs in the three strains of WT mice, suggesting 
that a possible reason for the reduced or increased proportions of 
unconventional IELs in FVB/n or BALB/c mice may be related to T cell 
development in the thymus.  
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3.11 Characterisation of recently-described IEL progenitors in 
the thymus of adult C57Bl/6, FVB/n and BALB/c mice 
To provide support for the findings above, the thymuses of C57Bl/6, BALB/c, 
and FVB/n mice were also analysed for the recently described subset of thymic 
IEL progenitors that are DPdull TCRαβ(+)CD5(+)PD1(+)CD69(+)CD122(+). 
 
Figure 3.18 TCRαβ (+) CD5(+) IELs progenitors are reduced in FVB/n mice 
compared to C57Bl/6 and BALB/c mice. (A) Representative flow cytometry plots 
(n>5) of CD4(-)CD8(-)TCRαβ(+)CD5(+) IEL progenitors in the thymus of C57Bl/6, FVB/n 
and BALB/c mice. Percentages of cells are indicated near each gate. (B) Summary bar 
graph (n>5) of the percentage (from CD4(-)CD8(-)cells) of CD4(-)CD8(-)TCRαβ(+)CD5(+) 
IEL progenitors in C57Bl/6, FVB/n and BALB/c mice (C) Summary bar graph (n>5) of 
total cell number for  CD4(-)CD8(-)TCRαβ(+)CD5(+) IEL progenitors in C57Bl/6, FVB/n 
and BALB/c mice *** p< 0.001, **p< 0.01, * p< 0.05, ns is not significant. DN is double 
negative for CD4 and CD8α.  
  149 
 
Consistent with the previous analysis, FVB/n mice contained a decreased 
compartment of these cells (~16% of the DPdull subset, and 2.0x105 cells) when 
compared to C57Bl/6 mice (~19% of DPdull cells, 3.5x105 cells) (Figure 3.19). 
Although this failed to reach statistical significance, somewhat surprisingly 
BALB/c mice also showed a reduced proportion (9.3%  of DPdull cells) and 
number of these IEL progenitors (2.0x105 cells) when compared to C57Bl/6 
mice. Thus, taken together, the data appear to support a hypothesis in which 
FVB/n mice have reduced unconventional gut IELs with a concomitant 
decrease in thymic IEL progenitors, when compared to C57Bl/6 mice.  
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Figure 3.19 Preliminary analysis of recently-described DPdull TCRαβ (+)CD5(+) 
PD1(+)CD69(+)CD122(+)IEL progenitors. (A) Representative flow cytometry plots 
(n>2) looking at recently-described DPdull,TCRαβ(+),CD5(+), PD1(+),CD69(+), CD122(+) 
IEL progenitors in the thymus of C57Bl/6, FVB/n and BALB/c mice. Percentages of 
cells are indicated near each gate. (B) Summary dot plot of total number of 
DPdull,TCRαβ(+),CD5(+), PD1(+),CD69(+), CD122(+) IEL progenitors in C57Bl/6, FVB/n 
and BALB/c mice. DP is double positive for CD4 and CD8α.   
  151 
 
3.12 Characterisation of thymic IEL progenitors in seven day 
FTOCs of C57Bl/6 and FVB/n thymuses 
Foetal thymic organ culture (FTOC) is a useful technique to follow the kinetics 
of T cell development over a certain period of time (Jenkinson and Owen, 
1990). E15 foetal thymuses, from timed pregnant C57Bl/6 or FVB/n females, 
were dissected and cultured for 7 days in FTOC media. It was actually 
challenging to get embryos from all three strains (C57Bl/6, FVB/n and BALB/c 
strains) simultaneously, so we subsequently focused our analysis on C57Bl/6 
and FVB/n mice.  Flow cytometry analysis of these cultures showed a 
decreased proportion and cell number of CD4(-)CD8(-)CD5(+)TCRβ(+) thymic IEL 
progenitors in FVB/n mice (~0.4% of DN cells, 250 cells in total) compared with 
C57Bl/6 mice (~0.6% as of DN cells, 1.0x103 cells in total) (Figure 3.20).  
Thus, the data presented in the last few sections suggest that in comparison to 
C57Bl/6 mice, FVB/n mice have significantly fewer unconventional 
TCRαβ(+)CD8αα(+) IELs. Moreover, rather than being a consequence of the gut 
environment, these data suggest that in FVB/n mice thymic IEL progenitors do 
not develop to the same extent as for C57Bl/6 animals. 
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3.13 Investigating the early stages of T cell development in 
C57Bl/6 and FVB/n mice  
Data presented from both the thymus and the gut of C57Bl/6 and FVB/n mice 
suggest that in comparison to C57Bl/6 mice, FVB/n animals have fewer IEL 
 
Figure 3.20 Investigating the development of TCRαβ (+)CD5(+) IEL progenitors in foetal 
thymic organ cultures (FTOC). (A) show represensative flow cytometry plots (from n>5) of 
E15 C57Bl/6 and FVB/n lobes cultured for 7 days. (B) shows a summary bar chart of the 
proportion of CD4(-)CD8(-)TCRαβ(+)CD5(+) IEL progenitors in FTOC run in (A) for 7days. (C) 
shows the total number of TCRαβ(+)CD5(+) thymic IEL progenitors in a 7-day FTOC. 
****p<0.0001 **p < 0.01, error bars are SD.  
  153 
 
progenitors and fewer unconventional TCRαβ(+)CD8αα(+) cells that is similar to 
the phenotype of pTαa.pTα-/- mice when compared to wild-type controls. 
Because the key feature of pTαa.pTα-/-  mice is the expression of pTαa only and 
thus preTCRa only, this prompted us to investigate the early stages of T cell 
development in FVB/n mice with a particular focus on the DN3 to DN4 transition 
where the preTCR is expressed. Analysis of the DN compartment first requires 
the removal of CD4(+) and CD8(+) thymocytes (using antibodies against CD4 
and CD8α), as well as other mature T cells such as NKT cells and γδ T cells 
(using both anti-TCRβ and anti-TCRδ antibodies). The DN3 and DN4 subsets 
are subsequently identified through the differential expression of CD25 and 
CD44, being CD25(+)CD44(-) for DN3 cells and CD25(-)CD44(-) for DN4 cells. 
Using this approach we compared the DN3 to DN4 transition in C57Bl/6 and 
FVB/n mice. C57Bl/6 mice had a ratio of DN3 cells to DN4 cells of ~1.8, which 
represents an expected distribution of DN3 to DN4 cells judging by previous 
studies(Yui, 2010). By contrast, analysis revealed what appeared to be a partial 
block in the DN3 to DN4 transition in FVB/n mice with an increased proportion 
of DN3 thymocytes (~60%) and a 3-fold increase in the DN3 to DN4 ratio (~4.5) 
(Figure 3.21).  
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Figure 3.21 FVB/n mice have an impaired DN3 to DN4 transition compared to 
C57Bl/6 animals. (A) Representative flow cytometry plots looking at the thymic DN3 
and DN4 subsets in C57Bl/6 and FVB/n mice. The transition from the DN3 to the DN4 
stage is represented by a red arrow. Percentages of cells are indicated near each gate. 
The ratio of DN3 to DN4 thymocytes obtained from at least 5 experiments is 
summarised in a summary bar graph in (B). (C) Summary bar graph (n>5) showing 
CD25 mean fluorescent intensity (MFI) on DN3 cells from C57Bl/6 mice and FVB/n 
mice **** p < 0.0001, ***p < 0.001. 
 
 
A block at the DN3 to DN4 transition of thymocyte development is also 
indicated by increased CD25 expression on DN3 cells, as observed in pTα-
deficient mice where the absence of the preTCR leads to a large accumulation 
of DN3 cells with significantly greater CD25 expression (Fehling et al., 1995). 
On analysis of CD25 levels on DN3 cells from C57Bl/6 and FVB/n mice, a 2-fold 
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increase of CD25 expression was observed on FVB/n DN3 thymocytes (~3200 
MFI units) compared to C57Bl/6 DN3 cells (~1500 MFI units) (Figure 3.21). 
Thus, these data suggest that in comparison to C57Bl/6 mice, FVB/n mice have 
an inefficient DN3 to DN4 transition.  
3.14 FVB/n DN3 thymocytes over-express pTαa compared to 
C57Bl/6 DN3 cells 
The data presented above suggest an inefficient DN3 to DN4 transition in 
FVB/n mice. This partial impairment could be the result of inappropriate 
expression of one of the pTα isoforms (and thus the preTCR) at the β-selection 
checkpoint. To test this idea, we examined the level of expression of each pTα 
isoform in the DN3 and DN4 subsets of C57Bl/6 and FVB/n mice using real-time 
PCR (qPCR). The methodology used is summarised in figure 3.22. As pTαb is 
generally omitted from studies, it was not possible to set up a TaqMan qPCR as 
the TaqMan probe available from ABI does not discriminate between the two 
pTα isoforms. As an alternative, we set up SYBR green qPCR, in which the 
SYBR dye binds to newly-generated double-stranded DNA resulting in the 
emission of a fluorescent signal detectable by the PCR thermocycler (Becker et 
al., 1996).  
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Figure 3.22 Overview of the steps taken for investigating the level of pTαa and 
pTαb transcripts in DN3 and DN4 thymocytes from C57Bl/6 and FVB/n mice. 
 
We used three individual sets of in-house designed primers recognising pTαa, 
pTαb, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH; as a 
reference gene). The amplicon size for qPCR is usually kept below 200bp to 
ensure high efficiency during the amplification process. pTαa transcripts were 
amplified using a forward primer (qpTaaF) traversing the exon1:2 boundary, 
being homologous to 14bp at the 3’ end of exon-1 and 6bp at the 5’ end of 
exon-2. The reverse primer bound to a 20bp sequence found in exon-2 
resulting in an amplicon of 106bp. The forward primer for pTαb (qpTabF) was 
homologous to 13bp found at the 3’ end of exon-1 and 10bp located at the 5’ 
end of exon-3. The pTαb reverse primer (pTabR2) was homologous to 20bp in 
exon-4 resulting in an amplicon of 87bp. GAPDH was amplified with a forward 
primer recognising 20bp in exon-4, while the reverse primer was homologous to 
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20bp in exon-5 resulting in an amplicon of 64bp. Because our experiment 
focused on the expression levels of pTα at steady state in DN3 and DN4 cells, it 
was considered that expression of GAPDH would be similar across the two 
subsets and could therefore be used as a reference gene. GAPDH has also 
been extensively used as a reference gene in other studies (Douglas et al., 
2001; Goff and Huntington, 2009).  
Before running our qPCR, several steps of optimisation were required. The 
qPCR reaction should yield a “linear curve” across serially-diluted samples with 
a coefficient of determination (R2) above 0.98. Amplification efficiency was also 
assessed by generating a standard curve from a 1:2 serial dilution of template 
and their corresponding cycle threshold (CT) values.  The CT threshold was 
manually determined. The data was visualised in a linear manner and the 
threshold was set up so that it would be above the baseline but within the 
exponential phase of the reaction (Figure 3.23).   
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Figure 3.23 The cycle threshold (CT) was determined manually The amplification 
plot can be divided into several phases (1) Corresponds to background fluorescence. It 
is conventionally called the baseline. (2) During the exponential phase the differences 
in cDNA concentration between each sample can be easily visualised.  PCR products 
are increasing following a 2n pattern, where n is the number of cycle. (3) During the 
linear phase the PCR product is still being amplified but the gap between each sample 
is not maintained like during the exponential phase. The PCR reaction subsequently 
reaches a plateau phase where the concentration of PCR products no longer increases 
as depicted by (4). Rn corresponds to the ratio between the fluorescence emission 
intensity of the reporter dye and the fluorescence emission intensity of the passive 
reference dye. ΔRN is Rn-Rn of the baseline. CT, cycle threshold 
 
For this experiment, cDNA from DN3 cells from C57Bl/6 cDNA mice were 
serially-diluted four times at 1:2. A qPCR was run using primers detecting pTαa-
only, pTαb-only or GAPDH in individual wells. Each dilution contains half the 
amount of cDNA than in the previous well, which means that the threshold cycle 
(CT) value between each dilution should be separated by one CT value if the 
reaction is 100% efficient. Indeed, the quantity of product is visualised as log2(n) 
where n is the dilution factor. Thus, in our experiment, where samples were 
diluted 1 in 2, this results in log2(2), which equals to 1 CT value. The Power 
SYBR Green kit that we used allowed us to manipulate the final concentration 
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of our set of primers. We first tested 500nM as a final concentration. Each 
sample was run in duplicates and the melting curves were scrutinized to identify 
potential primer dimerisation or unspecific amplification. For each reaction, the 
software generates a peak indicating the melting temperature at which the 
primers target the cDNA sequence allowing its amplification. A very efficient 
PCR reaction should have a precise alignment between each peak 
demonstrating that each amplification took place at the same temperature. The 
peaks obtained for the GAPDH-targeted qPCR showed a precise overlap 
between the different peaks averaging around a temperature of 80°C, 
suggesting that the reaction was specific (Figure 3.24).  
 
 
 
 
Figure 3.24 Melting curves obtained for each PCR reaction Melting curves are 
generated during qPCR reactions and can be indicative of primer dimerization (5) or 
unspecific product amplification (1),(2),(3),(4).  
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By contrast, the PCRs amplifying the pTαa and the pTαb isoforms gave different 
peaks with various melting temperature (1), (2), (3) and (4). The extra peak at a 
lower Tm (5) for pTαb reflected the presence of unspecific product or primer 
dimerization (Figure 3.24). 
 
Altogether, these observations indicated that the PCR reaction for pTαa and 
pTαb was not optimal as initially designed. To work out the percentage 
efficiency, each dilution factor was plotted on the x-axis (Log2 Scale) while the 
CT values were plotted on the y-axis. Adjacent data points were joined to obtain 
a straight line. The reaction efficiency was calculated as;  % !""#$#%&$' = (! − 1) ×100 
Where E is defined by;  
! = 10!( !!"#$%) 
And where slope can be defined as;  !"#$% = !! − !!!! − !! 
Where a and b represent two points located on the line, !! and !! are their 
corresponding values on the y-axis and !!, !! the values on the x-axis. 
 
While pTαa and GAPDH PCRs had an efficiency of 102% and 103% 
respectively, pTαb efficiency was 128%, considered to be above the acceptable 
range of 100%(+/-5%). Moreover, each R2 value was below 0.98 consistent with 
a relatively poorly optimised reaction (Figure 3.25).  
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The unspecific amplification suggested by the non-overlapping melting curves 
for the pTαa and pTαb qPCR reactions could be due to the presence of too 
much primer that favours unspecific recognition. Thus, the experiment was 
repeated using half the primer concentration (to obtain a final concentration of 
250nM). The pipetting error was very minor with less than a 0.2 difference 
between each CT values resulting in a neat overlap of the amplification curves 
between each duplicate as well as a clean no template control (NTC) (Figure 
3.26). Lowering the primer concentration produced a much higher specificity for 
the pTαa and pTαb qPCR reactions as seen by the alignment of all the melting 
curves at around 83°C for both pTαa and pTαb, and ~80°C for GAPDH (Figure 
3.27). 
 
Figure 3.25 The amplification efficiency is not optimal for GAPDH, pTαa and pTαb 
qPCR reactions. A straight line is obtained by plotting the dilution factor of each 
sample on the x-axis and the corresponding CT values on the y-axis. The slope is 
calculated the amplification efficiency is calculated with the formula described in the 
text. R2, coefficient of determination; CT, cycle threshold;  
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New standard curves were generated that revealed an improved efficiency of 
reaction in all three cases with 102% efficiency for the pTαa qPCR, 101% for 
GAPDH, and 96% for pTαb (Figure 3.27). Moreover, each standard curve had a 
R2 value of 0.99 indicating a high degree of reproducibility for these PCR 
reactions. Finally, to visualise the amplified PCR product, the samples were run 
on agarose gels to confirm the specificity of the amplification (Figure 3.27).  
 
Figure 3.26 The pipetting error is minor between each duplicate in the GAPDH, 
pTαa and pTαb qPCR reactions. Amplification curves showing of the GAPH, pTαa or 
pTαb qPCRs showing the variation between each duplicate within the same diluted 
sample. The pipetting errors were minor as CT<0.5 between duplicates. The CT was 
manually set up within the exponential phase. CT, cycle threshold 
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Figure 3.27 Using the lower final concentration of primers improved the qPCR 
reactions for GAPDH, pTαa and pTαb. (A) Melting curves obtained from the GAPDH, 
pTαa and pTαb qPCR run on serially diluted samples. (B) Standard curves were drawn 
and the amplification efficiency was calculated. The three PCR reactions showed an 
amplification efficiency within the acceptable range (+/-5%) (C) qPCR products were 
run onto an agarose gel to confirm the size of the amplicons.  
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For all reactions, bands of the expected size were observed; pTαa = 106bp, 
pTαb = 87bp, GAPDH = 64bp. Taken together, these data suggest that the 
qPCR reactions were reliable and could be used to analyse pTαa and pTαb 
expression. 
 
The expression of pTαa and pTαb in DN3 and DN4 cells from C57Bl/6 and 
FVB/n mice was assessed using the optimised qPCR methodology described 
above. The data obtained were normalised against the reference gene GAPDH 
by following the formula below;  
ΔCT = CT(pTα) – CT (GAPDH) 
This corresponds to the difference in expression between GAPDH and pTαa or 
pTαb. Thus, the higher the expression of pTαa and pTαb, the smaller the CT 
value and therefore the smaller the ΔCT. (This is because GAPDH transcripts 
are found at higher concentrations that pTα transcripts resulting in a GAPDH CT 
value lower than pTα CT) Thus, in order to visualise this in a more desirable 
manner, we plotted 
!!!! value to allow an increase in gene expression to appear 
as a higher value in our results.  
 
On running these reactions, pTαa expression in DN3 cells was found to be 
significantly greater in FVB/n mice than in DN3 cells from C57Bl/6 animals. By 
contrast, pTαb was expressed at a similar level in both DN3 and DN4 subsets in 
C57Bl/6 and FVB/n mice (Figure 3.28).  
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Figure 3.28 DN3 thymocytes from FVB/n mice express greater amounts of pTαa 
but not pTαb, in comparison with C57Bl/6 thymocytes. (A) The relative level of  
pTαa and  pTαb transcripts expressed by the DN3 thymocytes or DN4 thymocytes (n>2) 
(B) from C57Bl/6 and FVB/n mice. ΔCT corresponds to the normalised CT value of the 
reaction according to the reference gene GAPDH. *p<0.05, ns is for not significant  
 
Thus, unlike pTα-/- mice, which have a block at the DN3 to DN4 transition due to 
the inability to express any of the preTCRs, DN subsets in FVB/n mice appear 
to be able to express both pTα isoforms. However, the pTαa isoform was found 
to be over-expressed (1/ΔCT=0.55) in FVB/n DN3 cells when compared to 
C57Bl/6 mice (1/ΔCT=0.3).  
3.15 The pTαa transgene only partially rescues the DN3 to DN4 
transition in pTαa.pTα -/- transgenic animals.  
The data generated by Juliet Mahtani-Patching in vitro and discussed earlier in 
this chapter, suggested a dominant role for pTαa over pTαb in T cell 
development. Thus, over-expressing the pTαa isoform might have a similar 
affect as having only pTαa at the β-selection checkpoint. This idea linked the 
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two areas of investigation described so far in this chapter; namely thymic 
development in both pTαa.pTα-/- mice, and in FVB/n vs C57Bl/6 mice.  Indeed, 
the reduced IEL compartment and reduced IEL progenitors in FVB/n mice were 
reminiscent of the phenotype described for pTαa.pTα-/- animals. This prompted 
us to investigate the DN3 to DN4 transition in pTαa.pTα-/- animals more closely, 
as FVB/n mice had displayed distinct features at the β-selection checkpoint (see 
Figure 3.21).  
 
Flow cytometry analysis of adult C57Bl/6, pTα-/- and pTαa.pTα-/- revealed that 
pTαa.pTα-/- animals have a partial block at the DN3 to DN4 transition 
reminiscent of the FVB/n mice. This was illustrated by an increased DN3:DN4 
ratio (~5) and elevated CD25 levels on pTαa.pTα-/- DN3 thymocytes (~3500 MFI 
units) compared to a ratio of ~1.5 in C57Bl/6 mice and a CD25 fluorescence 
intensity of ~2500 MFI units (Figure 3.29). Thus, the expression of only pTαa in 
the BAC transgenic pTαa.pTα-/- mice at the DN stage of T cell development was 
not sufficient to fully restore the transition through the β-selection checkpoint to 
that seen in wild type animals. 
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Figure 3.29 pTαa.pTα -/- transgenic mice have a partially impaired DN3 to DN4 
transition. (A) Representative flow cytometry (n>10) profiles of DN3 and DN4 subsets 
from the thymus of C57Bl/6, pTα-/-  and  pTαa.pTα-/- transgenic mice (B) Bar chart 
summarising the DN3 to DN4 ratio (n>10) observed in C57Bl/6, pTα-/-  and  pTαa.pTα-/- 
transgenic mice (C) Summary bar of the mean fluorescence intensity (MFI) or CD25 on 
DN3 thymocytes from each strain of mice. .****p<0.0001; *** p<0.001; ** p<0.01; error 
bar is SD. 
3.16 pTαa signals weakly at the β-selection checkpoint 
There is very little work exploring whether pTαa and pTαb convey different 
signals at the β-selection checkpoint during T cell development. Nonetheless, it 
has been shown that expression of pTαa in vitro led to a marked reduction in 
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surface expression of TCRβ which was not  the case for pTαb (Barber et al., 
1998). This was also demonstrated by Juliet Mahtani-Patching during her Ph.D, 
where retroviral transduction of pTα-deficient thymocytes with pTαb-encoding 
viruses led to higher TCRβ expression than with transduction with pTαa-
encoding  
viruses (Figure 3.30).  
 
The level of TCRβ expression should correlate with the strength of signal 
delivered to the cell, which would suggest that preTCRa signals more weakly 
than preTCRb. Interestingly, differences in signal strength are widely accepted 
to result in qualitatively different signals that drive commitment of developing 
thymocytes to either the αβ or γδ lineages (Hayes et al., 2005). Moreover, these 
differential signals could potentially establish heterogeneity amongst DP 
 
Figure 3.30 preTCRa is expressed at lower surface levels than preTCRb. Summary 
bar graph (n>3) of the mean fluorescence intensity of TCRβ on pTα-/- thymocytes 
transduced with vector only, pTαa or pTαb. *** p<0.001; * p<0.05; error bar is SD. Juliet 
Mahtani-Patching’s work 
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thymocytes. Thus, we sought to investigate the strength of signal received by β-
selected thymocytes in our various strains of wild type and transgenic mice.  
The strength of signal received by DP progenitors during positive selection is 
conventionally visualised by the level of cell-surface expression of CD5 on 
naïve TCRαβ(+)CD4(+) and TCRαβ(+)CD8(+) SP thymocytes (Azzam et al., 1998).  
Signalling through the preTCR also results in the cell-surface expression of 
CD5. Indeed, Paul Love and his lab demonstrated that DN4 thymocytes, which 
have undergone  β-selection, showed a modest up-regulation of CD5 
expression consistent with the weak signalling capacity of the preTCR. 
compared to TCRγδ (Azzam et al., 1998). Thus, using CD5, we first investigated 
the strength of signal received by β-selected DN3 thymocytes, specifically 
focusing on FVB/n and pTαa.pTα-/- mice. The lack of a robust commercially 
available directly-conjugated pTα antibody rendered the task of accurately 
identifying preTCR-expressing DN3 thymocytes difficult and prompted us to find 
an alternative strategy. β-selected DN3 have been reported to undergo a c-Myc-
dependent burst of proliferation as they traverse the β-selection checkpoint 
(Laurent et al., 2004). It was later reported by others that the transferrin 
receptor, CD71, is up-regulated during proliferation in a c-Myc-dependent 
manner with its level of expression being proportional to the degree of 
proliferation (Janas et al., 2010). In addition, preTCR-expressing DN3 cells will 
be expressing TCRβ chains, which should be readily detectable intracellularly 
(i.c.) despite the low surface expression of the preTCR. Thus, we combined 
CD71 with i.c.TCRβ in order to distinguish β-selected DN3 cells (Brekelmans et 
al., 1994; Larrick and Cresswell, 1979). Surface TCRβhigh and TCRδ(+) 
thymocytes were first gated out as they represent mature αβ and γδ T cells 
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respectively, before looking at the DN3 subset defined as CD25(+)CD44(-). 
Unexpectedly, gating on β-selected DN3 cells from C57Bl/6, pTα-/- and 
pTαa.pTα-/- mice using CD71 and i.c.TCRβ did not reveal evidence of the 
impaired DN3-DN4 transition described previously for pTαa.pTα-/- mice when 
compared to wild type controls, as CD71(+)i.c.TCRβ(+) cells were found in similar 
proportions  in pTαa.pTα-/- transgenic and C57Bl/6 mice (~12%) (Figure 3.31).  
We next evaluated CD5 levels on β-selected CD71(+)i.c.TCRb(+) DN3 
thymocytes from C57Bl/6, pTα-/- and pTαa.pTα-/- mice. CD5 on β-selected DN3 
thymocytes from pTαa.pTα-/- mice was nearly half (~700 units) to that of the 
similar subset of C57Bl/6 thymocytes (~1400 units) suggesting that these cells 
had received a weaker signal through preTCRa than when both pTα isoforms 
are available at the β-selection checkpoint. We then applied this analysis to 
FVB/n DN3 thymocytes to investigate whether the apparent over-expression of 
pTαa would correlate with lower CD5 expression compared to C57Bl/6 DN3 
thymocytes. We gated on the DN3 subset in a similar manner as described 
before and compared CD5 expression on DN3 CD71(+)i.c.TCRβ(+) thymocytes 
between C57Bl/6 and FVB/n mice. We found that (albeit not reaching statistical 
significance) FVB/n DN3 CD71(+) i.c.TCRβ(+) thymocytes displayed a lower CD5 
expression than similarly gated C57Bl/6 DN3 thymocytes across two 
independent experiments (Figure 3.32). Thus, CD5 levels on β-selected DN3 
thymocytes from FVB/n mice (when compared to those levels in C57Bl/6 mice) 
are consistent with a weaker signal from the preTCR during β-selection. 
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Figure 3.31 Analysis of the β-selection checkpoint with CD71 and i.c.TCRβ .  (A) 
Representative flow cytometry profiles (n=4) of DN3 cells and representative flow 
cytometry histograms of CD5 on CD71(+)i.c.TCRβ(+) (in blue) or  CD71(-)i.c.TCRβ(-) (in 
grey) in the thymus of C57Bl/6, pTα-/-  and  pTαa.pTα-/- transgenic mice. (B) is a 
summary bar chart of the percentage of DN3 cells that are CD71(+)i.c.TCRβ(+). (C) 
shows summary bar charts of the mean fluorescence intensity of CD5 on DN3 
CD71(+)TCRβ(+) cells (n>4). ****p<0.0001; ** p<0.01; * p<0.05 ns, non-significant error 
bar is SD; MFI, Mean fluorescence intensity; i.c., intracellular; e.c. extracellular. 
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Figure 3.32 DN3 β-selected cells express lower levels of CD5 in FVB/n 
compared to C57Bl/6 mice. (A) Representative histograms of CD5 cell surface 
expression in thymic DN3 CD71(+)i.c.TCRβ(+) cells (blue) and CD71(-) cells (grey) in 
C57Bl/6 and FVB/n animals (B) Bar graph summarising (from n>2) CD5 MFI on DN3 
CD71(+)i.c.TCRβ(+) thymocytes. MFI, mean fluorescence intensity; i.c., intracellular; 
e.c. extracellular; ns, non-significant 
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3.17 Investigating IEL development in TCRαβ  transgenic OT-II 
mice 
The set of data presented above highlight a correlation between a weak TCR 
signal at the DN stage of T cell development and a reduced compartment of 
unconventional TCRαβ(+)CD8αα(+) IELs. This prompted us to explore whether 
strong signalling at the β-selection checkpoint would correlate with an increased 
TCRαβ(+)CD8αα(+) IEL compartment. To do this we utilised TCRαβ transgenic 
mice that have been shown to express their transgene TCRα chain prematurely 
in DN thymocytes due to the promoter they use to express the transgene. 
Because TCRα displays a greater affinity for TCRβ than pTα , it preferentially 
binds TCRβ when both are co-expressed at the DN stage, resulting in the 
expression of a TCRαβ complex instead of preTCR (Trop et al., 2000). 
Although early TCRαβ signalling has been associated with an inefficient DN to 
DP transition, a substantial pool of DP progenitors are generated and mature 
CD4(+) and CD8(+) T cells are found in the periphery suggesting that early 
TCRαβ expression is not completely incompatible with T cell development 
(Bruno et al., 1996; Huang and Kanagawa, 2004; Lacorazza et al., 2001). 
Finally, TCRαβ is thought to deliver a stronger signal than the preTCR primarily 
due to its much higher surface expression and its ability to bind self-
peptide/MHC ligands. Indeed, transgenic TCRαβ expressed in DN cells can 
drive γδ T cell development (Bruno et al., 1996).  
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We therefore decided to use TCRαβ transgenic animals to assess whether 
strong signalling from the transgenic TCR at the DN stage would preferentially 
favour TCRαβ(+)CD8αα(+) IEL development. Previous experiments undertaken 
in MHC I or MHC II-restricted TCRαβ transgenic animals (e.g. AND, H-Y and 
OT-I) had demonstrated an increased proportion of TCRαβ(+)CD8αα(+) IELs,  
and it was suggested that TCRαβ(+)CD8αα(+) IELs develop following agonist 
selection (Leishman et al., 2002). However, delaying the expression of the 
transgenic TCRα to the DP stage in H-Y mice through a CD4-cre-lox 
recombineering system, resulted in an unchanged proportion of 
TCRαβ(+)CD8αα(+) IELs in male H-Y mice (with ligand present), implicating the 
timing of TCRα expression as critical (Baldwin et al., 2005).  
 
In this study, OT-II mice were used, which express a single type of MHC-II-
restricted TCRαβ complex comprising a Vβ5(+)TCRβ chain and a Vα2(+) TCRα 
chain. This TCRαβ complex specifically recognises the ovalbumin 323-339 
(OVA323-339) peptide presented by MHC-II and are often used to study positive 
selection in the thymus.  
 
We first explored the DN3 to DN4 transition in OT-II mice. CD4(+),CD8(+) and 
TCRδ(+) T cells were gated out before visualising the DN3 and DN4 subsets 
based on expression of CD25 and CD44 (DN3: CD25(+)CD44(-); DN4 CD25(-
)CD44(-)). Although various studies have reported an impaired DN to DP 
transition in TCRαβ transgenic mice, both OT-II and C57Bl/6 mice showed a 
DN3 to DN4 ratio of ~1.5 suggesting an efficient DN3 to DN4 transition (Figure 
3.33).  
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Figure 3.33 The DN3 to DN4 transition appears efficient in OT-II mice. (A) 
Representative flow cytometry profiles (n=4) of thymic DN3 and DN4 subsets from 
C57Bl/6 and OT-II mice. The DN3 to DN4 transition is shown by the red arrow (B) 
Summary bar chart of the ratio of DN3 to DN4 thymocytes in thymuses from C57Bl/6 
and OT-II mice. ns; non-significant 
 
To check that signalling through the TCRαβ transgene was strong in DN 
thymocytes, CD5 levels were analysed on DN3 cells that expressed the 
transgenic TCRαβ (compared with DN3 cells that did not express the transgenic 
TCRαβ and γδ T cells). This analysis revealed that about 30% of T cells 
expressed the transgenic TCRαβ identified through the use of the Vα2-specific 
antibody marker (Figure 3.34). Interestingly, we observed that Vα2(-) cells were 
mainly restricted to the DN3 subset (CD25(+)CD44(-)) while Vα2(+) cells were 
found within the DN4 subset suggesting a rapid progression through the β-
selection checkpoint once the transgene TCRαβ was expressed.  Upon CD5 
analysis, the transgenic TCRαβ appeared to signal at a similar level to TCRγδ 
with a CD5 MFI of ~1600 and ~1900 MFI units, respectively. This seemed to 
indicate that expression of a TCRαβ transgenic complex in DN cells did indeed 
transduce a strong TCR signal.  
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Figure 3.34 OT-II thymocytes expressing the transgenic TCRαβ  signal strongly at 
the DN stage of T cell development. Representative flow cytometry profiles (from 
n=4) of OT-II thymocytes showing DN3 (CD25(+)CD44(-)) and DN4 (CD25(-)CD44(-))  
thymocyte subsets from Vα2(+) and Vα2(-) populations. Cell surface expression of CD5 
is then showed on a histogram to investigate signal strength. This shows that 
transgenic TCRαβ signals strongly compared to cells negative for the transgene. MFI; 
mean fluorescence intensity 
 
3.18 OT-II mice have an increased proportion of TCRαβ (+) 
CD8αα (+) IELs 
The data presented above suggest that DN cells from OT-II mice that express 
the transgenic TCRαβ receive a strong signal presumably due to the early 
expression of the TCRα chain. We therefore sought to investigate the 
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proportions of TCRαβ(+)CD8αα(+) IELs in the small intestine of OT-II compared 
to C57Bl/6 mice. OT-II mice showed a 2.5-fold increase in TCRαβ(+)CD8αα(+) 
IELs (~30% of CD4(-) IELs) compared to C57Bl/6 mice (~12%). This was very 
obviously evident when the ratio of conventional TCRαβ(+)CD8αβ(+) to 
unconventional TCRαβ(+)CD8αα(+) was assessed. For OT-II mice, this was ~0.4 
whereas it was ~1.5 for control animals (Figure 3.35). 
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Figure 3.35 OT-II mice have an increased proportion of TCRαβ (+)CD8αα (+) 
IELs. (A) Representative flow cytometry plots (n=4) looking at IEL populations in 
the small intestine of C57Bl/6 and OT-II mice. Percentages of cells are indicated 
near each gate. (B) Summary bar graph (n=4) of TCRαβ(+)CD8αα(+) and 
TCRαβ(+)CD8αβ(+) IELs in C57Bl/6 (black) and OT-II mice (grey). (C) Summary 
bar graph (n=4) of the ratio of conventional TCRαβ(+)CD8αβ(+) to unconventional 
TCRαβ(+)CD8αα(+) IELs. Error bars are SD. *** p < 0.001, **p < 0.01. 
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3.19 Early TCRα  expression in pTα -/-.TCRδ -/-mice 
Although we used OT-II mice to investigate the role of increased TCR signal 
strength at the DN stage of T cell development on TCRαβ(+)CD8αα(+) IEL 
development, the TCRαβ transgene is obviously restricted to a single Vβ5/Vα2 
combination. Thus, we sought to expand this analysis to a system where  
different TCRα chains could be expressed early at the DN stage during T cell 
development. The lab has had a colony of pTα-deficient by TCRδ-deficient 
(pTα-/-.TCRδ-/-) animals that were first generated to be used as a background 
strains for the pTαa transgenic mice described previously. However, upon 
analysis of the thymus of these mice, we could unexpectedly detect 
(considering these mice cannot generate either preTCR or TCRγδ) a 
considerable proportion of DP thymocytes (~14% of total cells), compared to 
pTα-deficient (~12%) and C57Bl/6 mice (~83%) (Figure 3.36). 
 
As pTα-/-.TCRδ-/- mice cannot express the preTCR or the TCRγδ the only 
possible TCR chain that could pair with TCRβ at the β-selection checkpoint 
would be a TCRα chain, presumably expressed prematurely at the DN stage. 
Because TCRα and TCRδ share the same locus, this prompted us to examine 
how the TCRδ-deficient animals were generated by Tonegawa’s lab in 1993 
(Itohara et al., 1993). In order to “knockout” the TCRδ chain, the constant region 
of TCRδ was disrupted through homologous recombination with a pPMKO 
vector containing a phosphoglycerate kinase I promoter (PGK) and a Neomycin 
cassette (Neo). The latter is required during the positive selection of embryonic 
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stem cells (ES) that have successfully integrated the vector and therefore 
disrupted the TCRδ constant region. 
 
It was subsequently reported that the presence of a PGK-Neo cassette can 
alter the regulation of adjacent genes through mechanisms that are presumably 
related to the PGK promoter binding numerous transcription factors (it is 
generally considered to be a strong promoter) (Pham et al., 1996). Thus, TCRα 
expression may be dis-regulated in TCRδ-/- animals, due to the presence of the 
PGK promoter, resulting in early TCRα expression (Figure 3.37).  
 
Figure 3.36 FACS profile of C57Bl/6, pTα -/- and  pTα -/-.TCRδ -/- thymuses. 
Representative flow cytometry plots (n=4) of DN, DP, and SP cells from C57Bl/6,    
pTα-/-  and  pTα-/-.TCRδ-/- mice. Despite the absence of both the preTCR and the TCRγδ 
to drive progression through the DN to DP stages, pTα-/-.TCRδ-/- mice have a significant 
proportion of DP thymocytes. Percentages of cells are indicated near each gate. DN, 
CD4(-)CD8(-); DP, CD4(+)CD8(+); SP, CD4(+) or CD8(+) 
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Figure 3.37 Schematic overview of the mutated TCRδ  locus The TCRδ locus is 
embedded within the TCRα locus. The constant region of the TCRδ locus was targeted 
with a pPMKO vector sharing some homology to the regions on each side of the 
constant region and containing a PGK-Neo cassette. As recombination took place, the 
TCRδ constant region was replaced by the PGK-Neo cassette. The latter has been 
reported to influence expression of neighbouring genes and might be the reason why 
pTα-/-.TCRδ-/- mice generate DP thymocytes, despite the lack of both TCRγδ and pre 
TCR complexes.  
 
To test this idea, the presence of TCRαβ complexes in post-selected DN4 
thymocytes in pTα-/-.TCRδ-/- mice was assessed. Unfortunately, a pan-anti-
TCRα antibody is not commercially available. Thus, we limited our analysis to 
three anti-Vα antibodies targeting the Vα2, Vα8 and Vα11. Flow cytometry 
analysis of surface TCRβ and TCRVα2/8/11 on thymic DN4 cells (CD25(-
)CD44(-)) from C57Bl/6, pTα-/- and pTα-/-.TCRδ-/- mice showed that in C57Bl/6 
mice (~1.1%) and pTα-/- mice (0.3%) only very few cells expressed the TCRα 
chains in question. However, 10.7% DN4 cells from pTα-/-.TCRδ-/- mice 
expressed the  Vα2/8/11chains. Futhermore, a clear TCRβ(+) population can be 
seen in the DN4 subset of pTα-/-.TCRδ-/- mice probably corresponding to 
TCRαβ complexes that are using Vα segments not detected by our analysis 
(Figure 3.38) 
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Figure 3.38 TCRα  is expressed early in pTα -/-.TCRδ -/-mice Representative flow 
cytometry plots (n=4) of DN3 and DN4 subsets from C57Bl/6, pTα-/-  and  pTα-/-
.TCRδ-/- mice. pTα-/-.TCRδ-/-mice have an increased proportion of TCRβ(+)Vα2/8/11(+) 
cells at the DN4 stage of T cell development. DN, CD4(-)CD8(-). Ns is for not 
significant; * p<0.05 
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3.20 pTα -/-.TCRδ -/-  mice have an increased proportion of 
TCRαβ (+)CD8αα (+) IELs 
As pTα-/-.TCRδ-/- mice have expression of a heterogeneous set of 
TCRαβ complexes at the DN stage of T cell development, this strain was used 
as an alternative to OT-II mice to assess the effect of strong TCR signalling at 
the DN to DP transition, specifically with regard to the development of 
TCRαβ(+)CD8αα(+) IELs. Interestingly and supporting our view that strong 
signalling at the β-selection checkpoint favours the subsequent development of 
unconventional IELs, pTα-/-.TCRδ-/- mice (like OT-II mice), had almost a 3-fold 
increase in the proportion of TCRαβ(+)CD8αα(+) IELs when compared to 
C57Bl/6 mice (~30% versus ~10% respectively of all CD4(-) IELs) (Figure 3.39). 
Moreover, the ratio of conventional IELs to unconventional IELs also differed, 
being ~1.2 in C57Bl/6 mice but lowering to ~0.4 in pTα-/-.TCRδ-/- mice. Thus, 
unconventional IEL development again appears favoured by strong TCR 
signalling at the β-selection checkpoint. 
3.21 Conclusion 
Here, we showed that pTαa-only transgenic mice and WT-FVB/n mice have a 
compromised unconventional TCRαβ(+)CD8αα(+) IEL compartment compared 
to C57Bl/6 mice. This is associated with a reduced pool of thymic IEL 
progenitors and a partially inefficient thymic DN3 to DN4 transition.  
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Figure 3.39 pTα -/-.TCRδ -/-mice have a greater proportion of TCRαβ (+)CD8αα (+) IELs 
than C57Bl/6 mice. (A) Representative flow cytometry plots (n=4) looking at the IEL 
population in the small intestine of C57Bl/6 and pTα-/-.TCRδ-/-mice. Percentage of cells 
are indicated near each gate. (B) Summary bar graph (n=4) of TCRαβ(+)CD8αα(+) and 
TCRαβ(+)CD8αβ(+)IELs as a proportion of CD4(-)IELs(C) Ratio of  TCRαβ(+)CD8αβ(+) to 
TCRαβ(+)CD8αα(+)  IELs in C57Bl/6 and pTα-/-.TCRδ-/-mice. Error bar is SD. *** p < 
0.001, * p < 0.05 
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Whereas pTαa-only transgenic mice lack pTαb, we show that FVB/n DN3 
thymocytes over-express pTαa compared to pTαb. Importantly, evidence 
suggests that pTαa signals weakly at the DN stage through the analysis of CD5 
levels. Finally, strong signalling (as depicted by CD5 levels) at the DN stage of 
T cell development (through prematurely expressed TCRαβ complexes) 
appears to favour unconventional TCRαβ(+)CD8αα(+) IELs development. 
Taken together, these data argue that the strength of signal received 
through TCR complexes at the β-selection checkpoint correlate strongly with 
the subsequent development of unconventional IELs. 
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Chapter 4 
T cell development in pTαb-only transgenic mice  
4.1 Introduction 
FVB/n and pTαa-only transgenic mice, in which pTαa signalling is dominant or 
exclusive respectively, show a reduced proportion of TCRαβ(+)CD8αα(+) IELs. 
This was associated with an inefficient thymic DN3 to DN4 transition and lower 
CD5 cell-surface expression. This is in line with previously published data 
suggesting that pTαa signals weakly compared to the other truncated pTα 
isoform (pTαb). Indeed, expression in vitro of pTαb results in higher TCRβ 
expression than pTαa, which appears to result in stronger preTCR signalling 
(Barber et al., 1998). Importantly, despite its truncated form, pTαb was shown 
capable of directing DN progenitors through the β-selection checkpoint in vivo 
confirming its ability to signal (Barber et al., 1998; Gibbons et al., 2001; Irving et 
al., 1998; Mahtani-Patching et al., 2011). Thus, we decided to investigate 
whether preTCRb signalling at the DN stage would rescue, and even favour the 
development of TCRαβ(+)CD8αα(+) IELs. To test this idea, we generated BAC 
pTαb-only transgenic animals that were crossed onto a pTα-/- background such 
that they express only pTαb at the β-selection checkpoint, and assessed 
TCRαβ(+)CD8αα(+) IEL development.  
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4.2 Overview of the generation of pTαb–only transgenic mice 
A similar procedure as described in the previous chapter was undertaken by 
Dr.J.Mahtani-Patching to generate the construct that was used to produce BAC 
pTαb–only transgenic mice. The BAC (purchased from Ensembl Organisation) 
was manipulated so that exon 1 and exon 3 were fused, and exon 2 removed to 
prevent alternative splicing, and to enforce expression of only the pTαb isoform 
only (Figure 4.1). The recombineering steps were similar to those described 
previously; a GALK sequence was incorporated by homologous recombination 
between exons 1 and 2 allowing positive selection of the successful 
recombinants by selection on galactose. The second cloning steps differed 
slightly from before as it involved simultaneous replacement of both the GALK 
cassette and intron 2, resulting in the fusion of exons 1 and 3 (Figure 4.1).  
Two primers of 100bp sharing a homology to 85bp of the 3’ end of exon 1 and 
of the 5’ end of exon 3 were designed and annealed to create a double 
stranded DNA. The latter was electroporated into GALK(+)BAC(+)SW102 
bacteria resulting in the fusion of exons 1 and 3 following homologous 
recombination. GALK(-) pTαb-only BAC transformants were identified by growing 
bacteria on a deoxy-galactose containing plate.  
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Figure 4.1 Schematic overview of the pTαb-only BAC. A BAC containing the pTα 
gene (top panel) was purchased from the Ensembl organisation. Several 
recombineering steps were performed to fuse exons 1 and 3 to prevent alternative 
splicing. Thus, the pTα gene can only generate the pTαb isoform.  
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4.3 Successful juxtaposition of exon 1 and 3 was validated by 
PCR and sequencing.  
Before passing the pTαb-only transgene to the transgenic facility for pro-nuclear 
injection, the GALK(-) pTαb-only BAC was tested for successful fusion of exons 1 
and 3. This was first verified by PCR. We used the forward primer pTa15s 
 
Figure 4.2 Schematic overview of the recombineering steps undertaken to fuse 
exons 1 and 3 to generate the pTαb-only BAC transgene. A GALK cassette was 
amplified by PCR using primers sharing some homology with the GALK sequence and 
some with intron 1. Insertion of the GALK cassette within intron 1 was catalysed by the 
bacteriophage λ Red system. Successful transformants were identified by growing 
bacteria on a galactose-containing plate. Removal of GALK and fusion of exon 1 and 3 
happened simultaneously in a subsequent stage. Oligos homologous to exon 1 and 3 
were annealed to one another and used to cut out intron1, exon 2 and intron 2 through 
homologous recombination. Thus the remaining pTα gene is unable to undergo 
alternative splicing following transcription and can only generate the pTαb isoform.  
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homologous to 24bp found 194bp upstream of exon 1 and the reverse primer 
pTa20s homologous to 24bp located 394bp downstream of exon 3. PCR 
products were run on an agarose gel. We obtained a 810bp band suggesting 
that exon 1 and 3 had been correctly fused (Figure 4.3A).  
 
This band was extracted from the gel, purified and then sent for sequencing 
using the same primers (pTa15s and pTa20s) (Figure 4.3B). The sequencing 
was successful and the result was aligned to a pTαb sequence in which exons 1 
and 3 are fused (Figure 4.4). Upon analysis, we found a point mutation where a 
thymine nucleotide had been replaced by a cytosine residue. However, once 
 
Figure 4.3 Exons 1 and 3 were successfully fused in the pTαb only BAC. (A) 
The PCR amplified a 810bp sequence spanning the exon 1 and 3 boundary. The 
PCR result was visualised on a 1.5% agarose gel (B) The 810bp band was 
extracted (red box) so that the DNA sequence could be validated by sequencing. 
NTC, no template control 
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the sequence was translated into amino acids, the resulting protein matched 
100% with the pTαb protein sequence from PubMed.  This is due to a redundant 
genetic code where the GCC or GCT codons both encode the amino acid 
alanine (A). To continue the analysis of the pTαb-only BAC, it was subsequently 
digested by the restriction endonuclease SpeI, which cuts DNA following 
recognition of a ACTAGT sequence. This was to make sure there had been no 
major changes in the structure of the BAC and to prepare the fragment 
containing pTαb for injection. Digestion of the BAC was expected to result in six 
products with a 26.8kb band corresponding to the fragment containing pTαb-
only transgene (Figure 4.5A&B). Figure 4.5B and 4.5C demonstrate that the 
expected bands were observed at roughly the correct intensitites (for their size). 
The fragment containing pTαb (The 26.8Kb band) was then carefully extracted 
and purified. A small sample was then run on a 0.5% gel to confirm the integrity 
of the DNA molecule, before passing it onto the transgenic facility of Liverpool 
University for pro-nuclear injection  (Figure 4.5C). 
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Figure 4.4 Although the pTαb-only BAC carries a point mutation, this does not 
affect the sequence of the pTαb protein. (A) The sequencing result (bottom line) was 
aligned to the pTαb cDNA sequence (top line) obtained from PubMed. The point 
mutation where a thymine residue has been mutated to a cytosine base is shown by 
the red circle. The start codon (ATG) is indicated in green (B) The protein encoding 
exon 1 and 3 was aligned to the reference sequence from PubMed. The mutation 
previously identified is indicated by the red circle. Due to the redundancy in the genetic 
code both GCC or GCT codons encode for an alanine residue. 
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Figure 4.5 Preparation of the pTαb-only transgene for pro-nuclear injection (A) 
Schematic representation of the pTαb-only BAC and the six cutting sites of the SpeI 
enzyme (B) The digested pTαb-only BAC was run on a 0.5% gel to allow the separation 
of the six bands and identification of the 26.8Kb band containing the pTαb-only gene 
(C) Following extraction of the band, 2µl of the sample was run onto a 0.5% gel to 
assess the quality of the DNA before being passed onto the transgenic facility at 
Liverpool University for pro-nuclear injection. L; Ladder 
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4.4 pTαb-only transgenic founders were identified by PCR  
  At weaning age, 16 pups born after pro-nuclear injection of C57Bl/6 fertilized 
oocytes were transferred to the Barts and the London School of Medicine 
animal facility and were ear-snipped for genotyping. DNA was extracted and 
two independent PCRs were carried out. The first PCR tested the integrity of 
the DNA following extraction and consisted of the pTa1s and pTa2 primers 
amplifying a 466bp sequence located 9.5Kb upstream of the pTα gene (Figure 
4.6A). The second PCR amplified a 492bp sequence specific to the pTαb-only 
construct. For this, the forward primer (F1-3) was homologous to 24bp spanning 
the exon 1 and 3 boundary while the reverse primer, pTa20s, recognised 394bp 
downstream of exon 3 (Figure 4.6B).  
 
Figure 4.6 PCR to identify possible founders for the pTαb-only transgene.          
(A) PCR amplifying a 466bp sequence located upstream of the pTα gene to assess 
the quality of the DNA. (B) A second PCR on the same samples using primers 
amplifying a 492bp sequence specific to the pTαb transgene. Eight pups were 
identified as carrying the pTαb transgene. L, Ladder; NTC, no template control 
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We found that out of 16 pups, eight were positive for the transgene. Two of 
these animals were subsequently bred onto a pTα-/- background to prevent 
expression of the endogenous pTα isoforms.  
4.5 Preliminary investigation of the small intestine of the first 
generation of pTαb-only transgenic mice  
Founders positive for the BAC pTαb-only transgene also carry two copies of the 
intact wild-type endogenous pTα-gene (WT-pTα). Thus, in order to generate a 
colony of mice expressing pTαb-only at the β-selection checkpoint, founders 
were bred with pTα-deficient mice. Animals obtained from the first generation 
were all carrying one endogenous pTα-deficient allele, one WT-pTα allele and 
about 50% of them also carried the pTαb-only transgene resulting in two 
possible genotypes: pTα-/+ or pTα-/+.pTαbTg. Importantly, at this stage, 
transgenic animals carry the pTαb-only transgene in addition to the WT-
pTα allele, which can generate both pTαa and pTαb following alternative 
splicing. Thus, we considered these animals to be essentially over-expressing 
pTαb, as they express one more copy of pTαb rather than pTαa when compared 
to non-transgenic littermates.  
 
We showed in chapter 3 that FVB/n mice, which appear to over-express the 
weakly signalling pTαa isoform at the DN stage of T cell development, have a 
reduced TCRαβ(+)CD8αα(+) IEL compartment. Indeed, the ratio of conventional 
TCRαβ(+)CD8αβ(+) to unconventional TCRαβ(+)CD8αα(+) IELs is ~5 in these 
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mice as opposed to ~1.3 in C57Bl/6 mice. This led us to hypothesise that 
perhaps over-expression of the pTαb isoform in pTα-/+.pTαbTg mice might 
favour generation of unconventional TCRαβ(+)CD8αα(+) IELs. Unfortunately, 
there was limited time to analyse these mice before the end of my PhD. 
Nonetheless, preliminary flow cytometry analysis of the IEL compartment 
revealed no significant differences between the over-expressing pTαb-only mice    
(pTαb.pTα-/+) and the littermate controls (pTα-/+) negative for the pTαb-
transgene (Figure 4.7). Despite the lack of statistical significance, both 
conventional and unconventional TCRαβ(+) IELs appeared slightly reduced on 
average in pTαb.pTα-/+ mice (~10% and ~13% respectively as of all CD4(-) IELs) 
compared to littermate controls (~12.5% and ~15.5% as of all CD4(-) IELs 
respectively). However this resulted in a similar ratio (~1.3) of 
TCRαβ(+)CD8αβ(+) to TCRαβ(+)CD8αα(+) IELs between pTαb.pTα-/+ and pTα-/+ 
mice, which is also similar to that observed in WT C57Bl/6 controls.  
 
Thus, this preliminary experiment did not reveal any definitive phenotype 
related to whether over-expression of pTαb at the β-selection checkpoint 
influences TCRαβ(+)CD8αα(+) IELs development.  
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Figure 4.7 Preliminary analysis of the small intestine of pTαb.pTα -/+ mice. (A) 
Representative flow cytometry plots (n=3) looking at the IEL population in the small 
intestine of  pTαb.pTα-/+ and pTα-/+ mice. Percentages of cells are indicated near each 
gate. (B) Representative bar graphs (n=3) of TCRαβ(+)CD8αα(+) and TCRαβ(+)CD8αβ(+) 
IELs (C) Representative bar graph (n=3) of the ratio of TCRαβ(+)CD8αβ(+) to 
TCRαβ(+)CD8αα(+) IELs. ns is not significant.  
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4.6 Preliminary investigation of thymic T cell development in 
pTαb.pTα -/+ mice 
Despite the lack of a clear phenotype in the small intestines of pTαb.pTα-/+ mice, 
we subsequently assessed whether over-expression of pTαb influences thymic 
T cell development in pTαb.pTα-/+ animals compared to pTα-/+ littermate 
controls. Analysis of the total number of thymocytes averaged around 2x108 
cells in both pTαb.pTα-/+ and pTα-/+ mice (Figure 4.8A). Thus, over-expression of 
pTαb does not appear to influence thymus size. PreTCR signalling competes at 
the DN stage with TCRγδ. We therefore sought to investigate whether γδ T cell 
development was affected. However, flow cytometry analysis of TCRδ(+) cells 
showed no significant differences between pTαb.pTα-/+ mice(~0.25% of all 
lymphocytes) and pTα-/+ mice (~0.25% of all lymphocytes) (Figure 4.8B&C). 
 
One of our main hypotheses is that signalling at the DN stage of T cell 
development through pTαa or pTαb may be responsible for establishing DP 
heterogeneity that subsequently allows different T cell subsets to develop. We 
therefore assessed whether T cell development in pTαb-transgenic mice 
favoured the generation of certain αβ T cells subsets. Analysis of DP 
(CD4(+)CD8(+)) or DN(CD4(-)CD8(-)) cells in pTαb.pTα-/+ and littermate pTα-/+ 
mice did not reveal any differences between the two strains with ~80% of DP 
cells and ~2% of DN thymocytes as a proportion of total lymphocytes (Figure 
4.8).  
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Figure 4.8 Preliminary analysis of the thymus of pTαb.pTα -/+ mice  
(A) Representative bar graph (n=3) of the total number of thymocytes from pTαb.pTα-/+ 
and pTα-/+ mice. (B) Representative FACS profile (n=3) of total γδ thymocytes from 
pTαb.pTα-/+ and pTα-/+ mice and the corresponding summary bar chart in (C). (D) 
shows representative flow cytometry profiles of CD4(+) and CD8(+) T cells in  pTαb.pTα-/+ 
and pTα-/+ mice. (E) Summary bar charts of the proportions of DP, DN and CD4(+)SP 
and CD8(+)SP thymocytes in  pTαb.pTα-/+ and pTα-/+ mice.   ns, non-significant; error 
bar is SD; DN, double negative for CD4 and CD8α; DP, Double positive for CD4 and 
CD8α proteins. 
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4.7 Conclusion 
Together, these preliminary analyses of pTαb-transgenic mice on a pTα-/+ 
background did not reveal any significant differences in thymus size, thymic T 
cell subset representation, or unconventional TCRαβ(+)CD8αα(+) IEL 
development. Importantly, the presence of the one endogenous WT-allele is 
likely responsible for the “normal” phenotype of these mice, especially 
considering evidence from our lab (and others) that pTαa is dominant to pTαb. 
Nonetheless, the ideal scenario would be to analyse these animals on a pTα-
deficient background. Unfortunately, time ran out on my PhD before these 
breedings were possible.  
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Chapter 5  
Investigating the DP-to-SP transition in FVB/n and pTαa transgenic 
animals 
 
5.1 Introduction 
A central hypothesis of this thesis has been that different signalling events 
occurring at the DN stage of T cell development could be responsible for 
promoting subsequent differential development of T cell subsets (eg. 
conventional versus unconventional TCRαβ(+) T cell subsets). Consistent with 
this, we identified in chapter 3 a correlation between the strength of signal 
delivered at the DN stage of T cell development and the ratio of conventional 
TCRαβ(+)CD8αβ(+) IELs to unconventional  TCRαβ(+)CD8αα(+) IELs found in the 
small intestine of mice. Whereas “weaker” signalling at the β-selection 
checkpoint seems to oppose unconventional TCRαβ(+)CD8αα(+) IEL 
development in FVB/n and pTαa.pTα-/- mice, “stronger” signalling through an 
early-expressed TCRαβ or TCRγδ complex seemed to favour their development 
as suggested in OT-II and pTα-/-.TCRδ-/- mice. To extend this idea, the DP-to-
SP transition in FVB/n and pTαa.pTα-/- mice, where positive and negative 
selection of T cells occurs, was explored further, as this represents a branching 
point at which different subsets of conventional and unconventional T cell 
subsets develop. 
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5.2 Investigating the proportion of positively selected DP 
thymocytes in FVB/n and pTαa.pTα -/- mice  
Positive selection of DP thymocytes triggers cell-surface expression of the 
activation marker CD69 and post-selected DP cells represent between 3 to 5% 
of all DP thymocytes (Yamashita et al., 1993). To investigate positive selection, 
we first defined the proportion of newly positively selected DP thymocytes that 
we identified as CD4(+)CD8(+)CD69(+) in C57Bl/6, FVB/n and pTαa.pTα-/- mice. 
 
Figure 5.1 Analysis of positively selected DP thymocytes in FVB/n and   
pTαa.pTα -/- mice. (A) Representative histograms (from n>4) of CD69 expression on 
DP thymocytes from C57Bl/6, FVB/n and pTαa.pTα-/- mice (B) Summary bar chart (from 
n>4) of the percentage of CD69(+) DP cells from C57Bl/6, FVB/n and pTαa.pTα-/- mice 
(C) Summary bar chart (from n>4) of the ratio of pre-selected (CD69(-)) to post-selected 
CD69(+)DP thymocytes. DP is Double positive (CD4(+)CD8(+)); Error bars are SD; **** 
p<0.0001, ***  p<0.001; *p<0.05; ns is for not significant. 
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Flow cytometry analysis revealed a significantly increased proportion of 
positively selected DP thymocytes (~4.0% of DP cells) in both FVB/n and 
pTαa.pTα-/- mice compared to that of C57Bl/6 mice (~2.5% of DP cells) (Figure 
5.1).  
 
Indeed, the ratio pre-selected DP cells (CD69(-)) to positively selected DP 
thymocytes (CD69(+)) was of ~20 for FVB/n and pTαa.pTα-/- mice, but nearly 
double that in C57Bl/6 mice with a ratio of ~40 (Figure 5.1). Thus, these data 
appear to suggest that positive selection of DP thymocytes is favoured or 
“accelerated” in FVB and pTαa.pTα-/- mice, compared to controls. 
5.3 Conventional thymic TCRαβ (+)CD4(+) and TCRαβ (+)CD8(+) T 
cells are found in greater proportions in FVB/n and pTαa.pTα -/- 
transgenic mice 
As a greater proportion of DP thymocytes appeared to be showing evidence of 
positive selection in FVB/n and pTαa.pTα-/- mice compared to C57Bl/6 controls, 
we sought to analyse the relative proportions of mature thymic CD4(+) and 
CD8(+) T cells. FVB/n and pTαa.pTα-/- mice had on average a significantly 
increased proportion of TCRαβ(+)CD4(+) T cells (~9% of all thymocytes) 
compared to C57Bl/6 mice (~5%). TCRαβ(+)CD8(+) T cells were increased by 2-
fold in pTαa.pTα-/- (~3% of total thymocytes), but not in FVB/n mice (~1.5%), 
compared to C57Bl/6 animal (~1.5%) (Figure 5.2).  These changes in SP 
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thymocyte percentages were also partialy reflected in the proportion of total DP 
cells in these animals, for example in pTαa.pTα-/- mice, in which the DP pool 
accounted for only 65% of total thymocytes compared to 80% for C57Bl/6 mice. 
Indeed, the DP-to-SP ratio in FVB/n and pTαa.pTα-/- mice was significantly 
different to that seen in C57Bl/6 mice, being 6 for pTαa.pTα-/- animals, 7 for 
FVB/n mice, but nearly 11 in C57Bl/6 controls (Figure 5.3).  
Taken together, these data suggest that for a given pool of DP cells, FVB/n and 
pTαa.pTα-/- mice appear to generate a greater number of mature SP thymocytes 
than in C57Bl/6 animals.  
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Figure 5.2 FVB/n and pTαa.pTα -/- mice harbor a greater proportion of SP 
thymocytes. (A) Representative flow cytometry profiles (from n>5) of TCRαβ(+)CD4(+) 
(pink)  and TCRαβ(+)CD8(+) thymocytes (blue) from FVB/n, C57Bl/6 and pTαa.pTα-/- mice 
(B) Summary bar chart of the percentages  of TCRαβ(+)CD4(+) and TCRαβ(+)CD8(+)  
thymocytes from  FVB/n, C57Bl/6 and pTαa.pTα-/- mice. (C) Summary bar chart of the 
percentages of DP thymocytes from FVB/n, C57Bl/6 and pTαa.pTα-/- mice. DP is double 
positive (CD4(+)CD8(+)); **** p<0.0001; ns is for not significant 
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Figure 5.3 Analysis of the DP-to-SP ratio in C57Bl/6, FVB/n and  pTαa.pTα -/- mice. 
Summary dot plot (n>13) showing the DP-to-SP ratio in C57Bl/6, FVB/n and  
pTαa.pTα-/- mice. DP, Double Positive CD4(+)CD8(+); SP Single positive TCRαβ(+)CD4(+) 
or  TCRαβ(+)CD8(+) thymocyte;**** p<0.0001 
 
5.4 The DP-to-SP ratio does not correlate with thymus size in 
C57Bl/6, FVB/n, or  pTαa.pTα -/- mice  
Upon analysis of the thymus in chapter 3, we noticed that in pTαa.pTα-/- mice, 
the pTαa transgene only partially rescued the total number of thymocytes on a 
pTα-/- background. Indeed, pTαa.pTα-/- mice had on average only approximately 
5x106 thymocytes, whereas C57Bl/6 and FVB/n thymuses contained about 
1.6x108 cells (Figure 3.10). Published data has suggested that the efficiency of 
positive selection is affected by the availability of peptide-MHC complexes in 
stromal niches (Prockop et al., 2002). We therefore investigated whether the 
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“enhanced” DP-to-SP transition that we described for pTαa.pTα-/- mice could be 
due, at least in part, to a greater availability of selecting stromal niches, that 
would be present in a thymus with reduced cellularity. Thus, we looked for 
correlation between the ratio of DP-to-SP thymocytes and thymus size (as a 
surrogate for the number of stromal niches). Although when all mice in the 
study were analysed, the larger thymuses from C57Bl/6 mice had a higher DP-
to-SP ratios, and the smaller pTαa.pTα-/- thymus has the lowest DP-to-SP 
ratios, no correlations were observed when only mice of a certain type were 
assessed; with R2 values of 0.02 for C57Bl/6, 0.08 for FVB/n mice and 0.05 for 
pTαa.pTα-/- mice (Figure 5.4). Thus, differences in DP-to-SP ratios in the 
different strains of mice cannot be explained by a difference in the size of the 
thymus. 
 
Figure 5.4 The thymic DP-to-SP ratio is not correlated to thymus size. The DP-to-
SP ratio is plotted on the y-axis while total thymic cell number is found on the x-axis 
(Log scale).  
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5.5 Investigating the role of CD5 in conventional versus 
unconventional T cell development. 
We have suggested that “weaker” signalling at the DN stage of T cell 
development results in low CD5 expression that was associated with reduced 
development of unconventional TCRαβ(+)CD8αα(+) IELs in the gut of FVB/n and 
pTαa.pTα-/- mice compared to C57Bl/6 mice. By contrast, “stronger” signalling at 
the DN stage, for instance through early-expressed transgenic TCRαβ 
complexes, triggers a higher surface expression of CD5 and correlated with a 
greater proportion of unconventional TCRαβ(+)CD8αα(+) IELs in the small 
intestine of OT-II and pTα-/-.TCRδ-/- mice compared to C57Bl/6 mice. Thus, this 
led us to investigate whether the level of CD5 expression was directly 
responsible for altered DP cell sensitivity to positive selection, which would 
explain the accelerated DP-to-SP transition and the differences in the ratio of 
unconventional versus conventional IELs in the small intestines of FVB/n and 
pTαa.pTα-/- mice. Indeed, CD5 has previously been shown to influence T cell 
fate during development and was demonstrated to regulate cell sensitivity to 
TCR stimulation (Azzam et al., 2001; Tarakhovsky et al., 1995). To investigate 
this idea, thymuses and small intestines from four CD5-deficient (CD5-/-), four 
CD5 over-expressing (CD5Tg) mice and one littermate WT control were kindly 
shipped to us on ice within 48hrs by Professor Paul Love from NIH in Bethesda 
(US). Unfortunately upon reception, the small intestines from all mice had 
undergone a damaging degree of self-digestion, a commonly observed 
phenomenon when these organs are not processed within 12 hours of 
dissection. This forced us to focus our analysis on the thymus, which appeared 
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largely unaffected by cell death based on DAPI staining that we routinely do. 
Due to the presence of only one C57Bl/6 littermate control, we also included 
data obtained from C57Bl/6 mice bred at Queen Mary University (QMUL) 
(named here after C57Bl/6 QMUL) in order for us to draw meaningful 
conclusions. CD5-/- mice had on average a greater proportion of total single 
positive CD4(+) (~14%) and CD8(+) (~2%) T cells than the C57Bl/6 USA control 
mouse (Figure 5.6). However, they harboured a similar absolute number of cells 
with ~6x106 CD4(+) and ~0.8x106 CD8(+) T cells. By contrast, CD5 over-
expressing mice (CD5Tg) harboured similar proportions of CD4(+) and CD8(+) T 
cells compared to the C57Bl/6 USA control mouse. However, analysis of cells 
numbers revealed a largely reduced number of CD4(+) and CD8(+) T cells in 
CD5Tg mice compared to C57Bl/6 USA mice (Figure 5.5).  
 
Finally, the ratio of DP-to-SP thymocytes was assessed in the various groups of 
mice. This revealed a reduced DP-to-SP ratio in CD5-deficient animals (~5) that 
was similar to the ratio observed in FVB/n and pTαa.pTα-/- mice, and 
approximately 2-fold less than that seen in C57Bl/6 mice (~11).  This supports a 
tentative hypothesis that reduced CD5 expression at the DP stage (caused by 
weaker signalling at the DN stage) could permit DP cells to be more sensitive to 
positive selecting TCRαβ signals that would reduce the DP-to-SP ratio. 
However, CD5Tg mice also had a reduced DP-to-SP ratio averaging around 6, 
which at face value argues against such a conclusion.  
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Figure 5.5 Preliminary analysis of CD5-deficient and CD5 overexpressing mice 
(A) Representative flow cytometry profiles of CD4 versus CD8 expression for 
thymocytes from one C57Bl/6 CD5Tg littermate control received from the US, CD5-
deficient (CD5-/-) and CD5 overexpressing (CD5Tg) transgenic mice  (B) Summary bar 
chart of the percentages of  TCRαβ(+)CD4(+) and TCRαβ(+)CD8(+) thymocytes from  one 
C57Bl/6 littermate control, C57Bl/6 mice from QMUL, CD5-/- and CD5Tg mice (C) 
Summary bar graphs of cell number for TCRαβ(+)CD4(+) and TCRαβ(+)CD8(+) 
thymocytes in C57Bl/6, CD5-/- and CD5Tg mice.  
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Nonetheless, expression of the CD5 transgene was under the regulation of the 
CD2 promoter that results in the early expression of CD5 during the DN phase 
of T cell development and hence to a reduced cell sensitivity to TCR signalling 
at the β-selection checkpoint. Thus, CD5Tg mice might not represent an ideal 
model to test this hypothesis.  
5.6 Conclusion 
Here we show that FVB/n and pTαa.pTα-/- mice have a lower DP-to-SP ratio 
compared to C57Bl/6 mice suggesting an enhanced transition from the DP 
stage to the SP stage; a transition driven by positive selection. Importantly, this 
does not appear to result from differences in thymus size, which prompted us to 
 
Figure 5.6 DP-to-SP ratios in C57Bl/6, CD5-/- and CD5Tg mice Summary dot plot 
showing the DP-to-SP ratio in one C57Bl/6 CD5Tg littermate control received from the 
US, C57Bl/6 mice from QMUL, CD5-deficient (CD5-/-) mice and CD5-overexpressing 
(CD5Tg) transgenic mice. DP, Double Positive CD4(+)CD8(+); SP Single positive   
TCRαβ(+)CD4(+) or  TCRαβ(+)CD8(+) thymocytes 
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postulate that differences in CD5 expression resulting from quantitatively 
different signals at the DN stage might be responsible for influencing 
subsequent positive selection events. Consistent with this, we show that 
preliminary analysis of the thymuses of CD5-deficient animals reveals that they 
too have a lower DP-to-SP ratio. Analysis of the small intestines of these mice 
has yet to be carried out to investigate whether this also correlates with a 
greater ratio of conventional TCRαβ(+)CD8αβ(+) to unconventional 
TCRαβ(+)CD8αα(+) IELs. Thus, this chapter presents preliminary evidence to 
suggest that signalling events at the DN stage could be responsible for 
subsequent T cell selection. If supported by further studies, this would reveal a 
previously unpredicted role for pTα and the preTCR at the β-selection 
checkpoint.  
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Chapter 6  
 
Investigating the role of TCRγδ signalling in γδ T cell development 
 
6.1 Introduction 
There are substantial data supporting a model, now widely accepted, that γδ T 
cell lineage commitment is dictated by strong signalling delivered by 
TCRγδ (Hayes et al., 2005). Strong signals are commonly associated with 
ligand engagement by the TCR, in contrast to the weak signal delivered by the 
preTCR in a ligand-independent manner. However, it remains unclear which 
factors (e.g. ligands, cytokine, etc) are responsible for driving the development 
of different γδ T cell subsets, especially the thymic generation of IFN-γ versus 
IL-17A-producing γδ T cells. TCR signal strength has a central role throughout 
αβ T cell development in driving T cell differentiation (e.g. CD4(+) versus CD8(+) 
T cells). As a result and by analogy, a similar idea has been applied to the role 
of TCRγδ in γδ T cell development. However, the lack of known ligands for a 
majority of murine γδ T cells (~99%) has rendered the task complicated 
(Crowley et al., 1997). In contrast to αβ T cell development, which can be 
characterised using previously well-defined cell-surface markers, a consensus 
nomenclature is yet to be defined for developing thymic γδ T cell subsets. Thus, 
we have first sought to characterise different γδ T cell subsets and their cytokine 
potential using a combination of previously published cell-surface markers 
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(Coffey et al., 2014; Jensen et al., 2008; Michel et al., 2012; Prinz et al., 2006; 
Ribot et al., 2009). We then investigated the role TCRγδ in γδ T cell 
development using foetal thymic organ culture (FTOC) supplemented with the 
selective inhibitors or antibodies (Figure 6.1). Importantly, this project was 
carried out in collaboration with other members of the lab and thus the data 
presented here represent only a small fraction of the whole work. 
 
 
 
 
Figure 6.1 Experimental approach. The role of TCRγδ signalling in γδ T cell 
development will be investigated by (A) using the TCRδ-crosslinking antibody (GL3) 
widely recognised to strengthen TCR signalling or by (B) using a src-kinase inhibitor 
PP2 which inhibits Lck and therefore prevents phosphorylation of the ITAMs thus 
resulting in a weakened TCR signal. Indeed, TCR signalling involves the 
phosphorylation of ITAMs (yellow circle) by Lck.  
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6.2 Characterisation of six γδ  T cell subsets from lymph nodes 
of C57Bl/6 mice 
Various cell surface markers have been used across numerous studies to 
characterise γδ T cell subsets, but a precise nomenclature that robustly 
distinguishes IL-17A versus IFN-γ-producing γδ T cells had yet to be defined. 
For example, although expression of the TNF-receptor family member CD27 is 
commonly used to identify IFN-γ secreting γδ T cells, some CD27(-) γδ T cells 
have also been shown to produce a small amount of IFN-γ following stimulation 
(Ribot et al., 2009). Thus, we first sought to characterize γδ T cells from lymph 
nodes (LN) of C57Bl/6 mice based on the combined expression of CD24, 
CD44, the protein phosphatase CD45RB, NK1.1 and the interleukin 7 receptor 
α (IL-7α) chain CD127. We first sub-divided γδ T cells into immature (CD24(+), 
or subset 1) and mature (CD24(-), or subset 2)  subsets and subsequently 
identified six subsets based on CD44 and CD45RB expression (that we have 
named 1a, 1b, and 2a to 2d) (Figure 6.2).  
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Figure 6.2 Six distinct γδ  T cell subsets can be identified from lymph nodes of 
C57Bl/6 mice. (A) Representative flow cytometry profiles (n=3) of γδ T cells obtained 
from lymph nodes of adult (>6 weeks) C57Bl/6 mice, where different γδ T cell subsets 
can be identified using CD24, CD27, CD44, and CD45RB The immature population 
(γδCD24+, green) can be further divided into two subsets 1a (CD44(-)CD45RB(-)) and 1b 
(CD44(-)CD45RB(+)) while four subsets can be identified in the mature population 
(γδCD24-, purple):  2a (CD44(-)CD45RB(-)),  2b (CD44(-)CD45RB(+)),  2c 
(CD44lowCD45RB(+)),  and 2d (CD44(+)CD45RB(-)) 
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We next assessed these subsets for expression of CD27, IL-7Rα and NK1.1 as 
well as their cytokine potential following 4hr stimulation at 37°C using phorbol 
myristate acetate (PMA) and ionomycin to activate the cells unspecifically 
(Chatila et al., 1989). Subset 1a (CD44(-)CD45RB(-)) represents approximately 
two third of the immature subset (65%) and mainly expressed CD27 while 
subset 1b (CD45RB(+)) consists of approximately 35% of all immature cells and 
displays a heterogenous surface expression of CD27. Both the 1a and 1b 
subsets do not express NK1.1 or IL-7Rα. While subset 1a has very little 
cytokine-secreting capacity, subset 1b displays some IFN-γ-secreting potential.  
Four subsets can be identified within the mature subset (2); subset 2a     
(CD44(-)CD45RB(-)) mainly expresses CD27 but no NK1.1 nor IL-7Rα and 
appears to display limited cytokine secretion capacity (Figure 6.3). Subset 2b 
(CD44(-)CD45RB(+)) and 2c (CD44(+)CD45RB(+)) express CD27 but no IL-
7Rα and both secrete IFN-γ with ~22% and ~62% of IFN-γ producing cells 
respectively. The 2c subset appears to be the only subset with a heterogenous 
expression of NK1.1. Finally, subset 2d (CD44(+)CD45RB(-)) does not express 
CD27, nor NK1.1 but does express the IL-7Rα and up to ~50% of the cells 
display a IL-17A secreting potential making it the greater source of IL-17A 
cytokine (Figure 6.3).   
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Figure 6.3 Six distinct γδ  T cell subsets with different cytokine-secreting 
potential can be identified in the lymph nodes of C57Bl/6 mice. (A) Representative 
histograms of CD27, NK1.1, and IL-7Rα on 1a, 1b, 2a, 2b, 2c, and 2d subsets (B) 
Representative flow cytometry plots (n>3) of intracellular IL-17A and IFN-γ cytokines. 
Percentages of IL-17A(+) and IFN-γ(+) cells are indicated near each gate. (C) 
Representative bar charts (n=3) of the cytokine contribution from the γδCD24- subset 1a 
and 1b as well as γδCD24+ subset 2a, 2b, 2c and 2d in lymph nodes of C57Bl/6 mice.  
Error bars are SD; **** p<0.0001, ***  p<0.001; *p<0.05; ns is for not significant. 
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6.3 The six γδ  T cells subsets identified from the lymph nodes 
can be found in the thymus of C57Bl/6 mice. 
Having identified six peripheral γδ T cell subsets based on CD24, CD27, CD44 
and CD45RB surface expression, we subsequently sought to investigate 
whether these populations could also be found in the adult thymus. Using the 
same gating strategy as above, a large proportion of γδ T cells were found with 
an immature phenotype with up to 90% of the cells expressing CD24 (Figure 
6.4).   
 
Figure 6.4 The six γδ  T cell subsets identified previously from the lymph nodes 
can be found in the adult thymus  (A) Representative flow cytometry profiles (n=3) of 
γδ T cells obtained from thymus of adult (>6 weeks) C57Bl/6 mice, where different γδ T 
cell subsets can be identified using CD24, CD44, CD27 and CD45RB. The γδCD24+ 
subset can be further divided into two subsets 1a (CD44(-)CD45RB(-)) and 1b      
(CD44(-)CD45RB(+)) while four subsets can be identified in the γδCD24-population:  2a 
(CD44(-)CD45RB(-)),  2b (CD44(-)CD45RB(+)),  2c (CD44(+)CD45RB(+)),  2d 
(CD44(+)CD45RB(-)) (B) Representative histograms of CD27, NK1.1, and IL-7Rα on 1a, 
1b, 2a, 2b, 2c, and 2d subsets.  
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In contrast to αβ T cells, γδ T cells commit to effector function before egressing 
the thymus (Prinz et al., 2013). Thus, we investigated the cytokine secreting 
potential of each thymic γδ T cell subset following stimulation with PMA and 
Ionomycin. Whereas subset 1a displayed in the lymph node a small IFN-γ-
secreting potential, it appears in the thymus to be skewed towards an IL-17A-
secreting fate with 8% of cells displaying an IL-17A-secreting potential. On the 
other hand, the 1b subset mainly harbored IFN-γ-secreting cells constituting 
about 10% of the subset. Amongst the γδCD24(+) subset, the pattern of 
expression of CD27 and IL-7Rα recapitulated what had been seen in the LN. 
While only the 2c subset in the LN showed a small NK1.1(+) population, the 
thymic 2b and 2c subsets largely expressed NK1.1. Similar to the LN, the 2c 
and 2d subsets harboured a large proportion of IFN-γ (25%) and IL-17A-
secreting cells (65%) respectively (Figure 6.5). While 15% of the 2a cells 
displayed an IFN-γ-secreting potential in the LN, they were mainly skewed 
towards an IL-17A secreting potential in the adult thymus.  
 
Thus, the data collected here suggest that the γδ T cell subsets identified from 
LN of C57Bl/6 mice can also be found in the thymus and display a largely 
similar phenotype. 
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Figure 6.5 The six γδ  T cell subsets identified previously from the lymph nodes 
can be found in the thymus. (A) Representative flow cytometry plots (n>3) of 
intracellular IL-17A and IFN-γ cytokines following stimulation with PMA and ionomycin 
for 4hrs at 37°C. Percentages of IL-17A(+) and IFN-γ(+) cells are indicated near each 
gates. (B) Representative bar graph (n=3) of the cytokine contribution from the 
immature γδCD24- subset 1a and 1b as well as the mature γδCD24+ subset 2a, 2b, 2c and 
2d in the thymus of C57Bl/6 mice.  Error bars are SD. 
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6.4 Investigating the consequences of augmenting TCRγδ  
signal strength in γδ  T cell development 
γδ T cell subsets develop in waves. Indeed, unlike αβ T cells, certain γδ T cell 
subsets develop within certain windows of time from embryonic life onwards. 
Vγ5-expressing γδ T cells (or DETC) constitute the first γδ T cell subset to arise 
at day 13.5 of embryonic life (E13.5) and continue their development until about 
E16, which partially overlaps with the Vγ6(+) γδ subset that develop from about 
E15 (Figure 6.6). Finally, Vγ4(+) and Vγ1(+) γδ T cells develop from the neonatal 
period onwards (Carding and Egan, 2002; Prinz et al., 2013) (Figure 6.6).  
 
Figure 6.6 Thymic-derived γδ  T cells develop in waves Vγ5(+)cells are the first γδ 
cells arising from day 12-15 of embryonic life (E12-E15). Vγ6(+)γδ T cells arise 
subsequently around E16 and are followed by Vγ4(+) and Vγ1(+)γδ  T cells, which 
develop during the neonatal period.  Vγ7(+)γδ T cells are not represented here as there 
is some debate as to whether they develop extrathymically. 
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Because of these early waves, FTOC represents an ideal tool to investigate 
γδ T cell development. Moreover, FTOC has been shown to faithfully 
recapitulate T cell development in vitro (Jenkinson et al., 1992).  
Strong TCR signal is often associated with ligand engagement and full 
phosphorylation of the ITAMs found on CD3 and TCRζ molecules. Despite the 
lack of known ligands for murine γδ T cells, strong signalling can be mimicked 
by cross-linking the TCRγδ using anti-TCRδ antibodies, such as the clone 
known as GL3. Thus, to investigate the effect of increasing TCRγδ signal 
strength on γδ T cell development, we cultured E15 thymic lobes with 1µg.mL(-1) 
of GL3 for 7 days with one day of rest to allow potentially down-regulated TCRγδ 
to be re-expressed on the cell-membrane. At the end of these cultures, flow 
cytometry analysis revealed a significant reduction in both the proportions and 
cell number of the CD44(+)CD45RB(-) “2d” population in the presence of GL3 
compared to control cultures (Figure 6.7B & C). Upon stimulation with 
PMA/ionomycin and analysis of cytokine-secreting potential, we found that the 
CD44(+)            CD45RB(-)cells that did develop in the presence of GL3, had a 
significant decrease in IL-17A-secreting capacity on a per cell basis as judged 
by decreased IL-17A MFI levels (Figure 6.7E & G). By contrast, numbers of 
IFN-γ-secreting cells were largely unchanged in GL3-supplemented FTOC 
(Figure 6.7F). This set of data suggests that increasing signal strength during γδ 
T cell development by cross-linking TCRδ appears incompatible with the 
development of IL-17A-secreting γδ T cells while it allows CD45RB(+) γδ subsets 
to develop similarly to the control. Thus, development into an IL-17A-secreting 
γδ T cell fate does not appear to be driven by strong signalling through TCRγδ 
suggesting that instead, a weak TCRγδ signal might be required.  
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Figure 6.7 Increasing TCRγδ  signal strength impairs IL-17A-producing γδ  T cell 
development. (A) Representative flow cytometry profiles (n>3) of γδ T cells obtained 
from E15 FTOC following 7days supplemented with GL3. Summary bar chart (n>3) 
of the proportion (B) and cell numbers (C) of each mature subset 2a, 2b, 2c, and 2d 
subsets. (D) Representative flow cytometry plots (n>3) of intracellular IL-17A and 
IFN-γ cytokines. Percentages of IL-17A(+) and IFN-γ(+) cells are indicated near each 
gates. (E) Summary bar graph (n>3) of the numbers of IL-17A-secreting γδ T cells 
amongst the 2a and 2d subset in control and GL3-supplemented FTOCs. (F) 
Summary bar graph (n>3) of the numbers of IFN-γ-secreting γδ T cells amongst the 
2b and 2c subset in control and GL3 cultures. (G) Summary bar graph (n>3) of the 
mean fluorescence intensity (MFI) of IL-17A cytokine in the 2a and 2d subset.  Error 
bars are SD; ** p<0.01; *p<0.05; ns is for not significant. 
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6.5 Investigating the effect of weakening TCRγδ  signalling in γδ  
T cell development.  
The data presented above suggest that strong signalling through TCRγδ impairs 
IL-17A-secreting γδ T cell development. This prompted us to investigate 
whether weakening of the TCRγδ signal would, by contrast, favour the 
development of this subset. TCR signalling is initiated through the 
phosphorylation of tyrosine residues in the ITAM domains of the CD3 proteins 
and TCRζ by the src-family tyrosine kinase Lck. This creates a docking site for 
Zap-70 (Straus and Weiss, 1993; Wang et al., 2010; Wange et al., 1993). 
Importanty, for our studies, Lck activity can be inhibited by the src-kinase 
inhibitor PP2 (1-tert-Butyl-3-(4-chlorophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-
amine) (Alice et al., 2012). Thus, we supplemented FTOCs with increasing 
concentrations of PP2 and followed the development of γδ T cells for 7 days. 
Somewhat surprisingly on analysis we observed that the proportion and cell 
number of the 2a and 2d γδ subsets decreased as the concentration of PP2 
increased suggesting that weakening TCRγδ signal strength compromises their 
development (Figure 6.8). By contrats, at the highest concentration of PP2, the 
only subset that developed was the CD45(+)CD44(+) “2c” subset. This suggests 
that normally, cells destined to develop to this fate signal strongly, so that in the 
presence of PP2 they can still develop. The 2c subset was shown by other 
members of the lab to harbor a large proportion of Vγ5(+) cells, which are 
thought to require strong ligand-dependent TCRγδ signals to develop (Barbee et 
al., 2011).  Alternatively, Vγ5(+) cells γδ cells commence their development at 
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day 14 of embryonic development, and as our FTOC system uses E15 lobes, 
some Vγ5(+) cells may have developed prior to the addition of PP2.    
Next, cytokine-secreting potential was assessed upon stimulation of the cells 
with PMA and ionomycin. This revealed a reduction in IL-17A-secreting cells 
that mirrored the reduction of the 2d subset, yet the MFI of those cells 
committed to IL-17A secretion remained similar to controls. IFN-γ cells were 
largely un-affected up to a concentration of 1.0µM. At 1.5µM, while numbers of 
IFN-γ-producing cells decreased in the 2b subset, the 2c subset remained 
largely unaffected (Figure 6.9).  
 
Collectively, these data suggest that while strong TCRγδ signalling triggered by 
anti-TCRδ antibody cross-linking was incompatible with the development of IL-
17A-secreting γδ T cells, weakening of TCRγδ signalling by inhibiting Lck activity 
did not appear to favour their development either. This is somewhat 
paradoxical. However, taken at face value, one could argue that IL-17A-
secreting γδ cells require a specific window of Lck activity for their development. 
Thus, increasing (with GL3) or decreasing (with PP2) this activity outside of this 
Lck window are both incompatible with the development of IL-17A-secreting γδ 
T cells.  
 
  227 
 
 
Figure 6.8 Reduced TCRγδ  signalling impairs the development of IL-17A-
secreting γδ  T cells. (A) Representative flow cytometry profiles (2≤n<4)of γδ T cell 
subsets following 7-day culture of E15 C57Bl/6 thymic lobes supplemented with the 
Src-kinase inhibitor PP2 at various concentrations indicated underneath each column. 
Percentages are indicated next to the respective gate. (B) Summary bar chart of the 
proportion of mature γδ T cell or total cell number (C) following 7-day FTOC 
supplemented with PP2. Error bars are SD; *** p<0.001, **p<0.01; *p<0.05; ns is for 
not significant. 
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Figure 6.9 Inhibition of Lck impairs the development of IL-17A(+) γδ  T cells. (A) 
Representative flow cytometry profiles (2≤n<4) of intracellular IL-17A and IFN-γ from 
the subsets 2a, 2b, 2c and 2d following 7-day FTOC supplemented with increasing 
concentrations of PP2 (B) Bar chart showing number of 2a and 2d IL-17A(+) γδ T cells 
following 7-day FTOC supplemented with PP2 (C) Bar chart showing number of IFN-
γ(+) γδ T cells within the 2b and 2c subsets following 7-day FTOC supplemented with 
PP2.  Error bars are SD; **p<0.01; *p<0.05; ns is for not significant. 
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6.6 Investigating the role of PI3K signalling in γδ  T cell 
development 
The data presented above suggest that a certain windoaw of Lck activity is 
permissive for the developmet of IL-17A-secreting γδ T cells. Thus, we 
hypothesized that this restricted Lck activity could activate a specific pathway 
that drives development of IL-17A-secreting γδ T cells. This prompted 
investigation of alternative TCR signalling pathways that could be responsible 
for driving the development of IL-17A versus IFN-γ-secreting γδ T cells. 
Phosphoinositide 3-kinase (PI3K) signalling represents a major signalling 
pathway in immune cells. Class IA PI3Ks are PI3Kα, PI3Kβ, and PI3Kδ, while  
PI3Kγ is a class IB PI3K (Okkenhaug and Vanhaesebroeck, 2003). PI3K 
signalling has been implicated in development of certain B cell subsets 
demonstrating its importance in lymphocyte development (Ramadani et al., 
2010). Moreover, knocked-out PI3Kδ and PI3Kγ animals, where signallling 
through PI3Kδ and PI3Kγ was absent, were largely protected from imiquidod-
induced psioriasis-like dermatitis, which was associated with reduced IL-17A in 
the lesion and a reduction in IL-17A-secreting γδ T cells in the draining lymph 
node, suggesting that PI3K signalling is required for IL-17A cytokine secretion 
by γδ T cells (Roller et al., 2012). Thus, this prompted us to investigate whether 
PI3K signalling could play a central role in the development of IL-17A-secreting 
γδ T cells. To test this idea, we cultured E15 C57Bl/6 thymic lobes for 7-days 
supplemented with the pan-PI3K inihibitor ZSTK474. Inhibition of PI3K 
signalling largely supported our hypothesis, as the treatment  
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resulted in a significant reduction in the development of the IL-17A-committed 
« 2d » subset (Figure 6.10). Moreover, these cultures appeared to favour 
expansion of CD45RB(+)CD44(-) « 2b » cells, and interestingly allowed both the 
2b and 2c subsets to commit to IFN-γ secretion at far greater levels than control 
(Figure 6.10D).  
 
Finally, to investigate the additive effects of TCRγδ signalling (that reduces IL-
17A-commited γδ cell development) and PI3K inhibiton (that also reduces the 
generation of IL-17-specific γδ T cells), we co-cultured E15 lobes with the pan-
PI3K inhibitor and the TCRδ crosslinking antibody GL3. This resulted in an 
increased proportion of both 2b and 2c cells while the development of the 2a 
and 2d subsets was significantly compromised. Upon stimulation of the cells 
with PMA/ionomycin, we saw a clear reduction in IL-17A-producing γδ cells, 
while the development of IFN-γ-producing γδ T cells was largely favoured. This 
suggested that while PI3K signalling is required for IL-17A(+) γδ T cell 
development, it also appears to inhibit commitment to IFN-γ-secretion in 
CD45RB(+) γδ cells suggesting that a different signalling pathway is implicated in 
their development. Importantly, addition of GL3 and the PI3K inhibitor were 
additive, severely impairing IL-17A(+) γδ T cell development. 
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Figure 6.10 PI3K signalling is required for IL-17A(+)γδ  T cell development. (A) 
Representative flow cytometry profiles (n>3) of γδ T cells obtained from E15 FTOC 
following 7-day culture with pan-PI3K inhibitor alone or in addition to GL3. Summary 
bar graph (n>3) of the proportion (B) and total cell number (C) of each subset 2a, 2b, 
2c, and 2d. (D) Representative flow cytometry plots (n>3) of intracellular IL-17A and 
IFN-γ. Percentages of IL-17(+) and IFN-γ(+) cells are indicated near each gates. (E) 
Summary bar graph (n>3) of the numbers of IL-17A-secreting γδ T cells amongst the 
2a and 2d subset in control, Pan-PI3K inhibitor alone and in addition to GL3. (F) 
Summary bar graph (n>3) of the numbers of IFN-γ-secreting γδ T cells amongst the 2b 
and 2c subset in Pan-PI3K inhibitor and Pan-PI3K inhibitor plus GL3.  Error bars are 
SD; ****p<0.0001, **p<0.01; *p<0.05; ns is for not significant. 
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6.7 Conclusion 
Using previously published cell surface markers, we have identified six 
peripheral γδ T cell subsets that were also found in the thymus of C57Bl/6 mice. 
We have investigated the role of TCRγδ signal strength in the development of 
these different subsets and more specifically in the development of IL-17A(+) 
versus IFN-γ(+) γδ T cells. We showed that strong TCRγδ signalling was 
incompatible with the development of IL-17(+) γδ T cells but that un-predictably, 
reducing TCRγδ signal strength did not favour their development either. Instead, 
we have identified a previously unknown role for PI3K signalling in driving IL-
17A(+) γδ T cell development that at the same time restricts commitment of 
CD45RB(+)γδ T cells to IFN-γ secretion.  
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Chapter 7  
Discussion and future work  
Part I – αβ  T cell development  
7.1 Introduction 
TCR signalling is fundamentally important throughout T cell development as it 
participates in the generation of heterogeneous T cell subsets critical for 
immune responses against a wide range of infections. TCR signalling is widely 
accepted to instruct cell fate (αβ or γδ fate) at the DN3 stage of T cell 
development, as well as T cell survival (or death) at the DP stage during 
conventional αβ T cell selection (Haks et al., 2005; Hayes et al., 2005). 
Although these developmental choices are often explained by a signal-strength-
model, it remains unclear how seemingly equivalent “strong” signals through the 
TCR can instruct different cell fates. For example, strong agonist TCRαβ 
signals at the DP stage of T cell development, can instruct either death by 
apoptosis or development into unconventional T cell subsets (Ashton-Rickardt 
et al., 1994; Jordan et al., 2001; Oh-Hora et al., 2013; Yamagata et al., 2004). 
Because all DP cells arise from DN3 cells that have successfully undergone β-
selection, this led us to hypothesise that different signalling events at the DN 
stage of T cell development may contribute to the establishment of a 
heterogeneous DP pool, imprinting DP cells with different potentials to adopt 
alternative T cell fates. Traversing the β-selection checkpoint requires cell 
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surface expression of the preTCR complex composed of a rearranged TCRβ 
chain and an invariant pTα chain (Fehling et al., 1995). Importantly, pTα can 
generate two isoforms following alternative splicing; pTαa or pTαb (Barber et al., 
1998). Although αβ T cell development is undoubtedly severely impaired in the 
absence of pTα, very little is known about the differential roles of the pTα 
isoforms during T cell development (Gibbons et al., 2001). Despite having both 
been shown to efficiently form a preTCR complex, they differently affect cell-
surface expression of TCRβ, and  appear to be differentially expressed during T 
cell development possibly resulting in qualitatively, quantitatively or temporally 
different preTCR signals (Barber et al., 1998; Campese et al., 2009; Ramiro et 
al., 2001). This led us to hypothesise that differential use of the two pTα 
isoforms could have important consequences for the subsequent development 
of different T cell subsets by contributing to the generation of a heterogeneous 
DP subset.   
 
Thus, this thesis has principally focused on understanding whether signalling 
events occurring at the DN stage of thymocyte development could be 
responsible for establishing a heterogenous DP subset; more precisely by 
generating DP cells that do not possess equal potential to adopt a conventional 
versus unconventional T cell fate. To directly test this hypothesis, we first 
assessed pTα isoform expression at the single cell level at the β-selection 
checkpoint. Then, with a focus on pTαa, we subsequently investigated 
conventional T cell versus unconventional T cell development in BAC 
transgenic animals expressing pTαa-only or FVB/n mice that we show over-
express pTαa compared to pTαb. Finally, we have attempted to understand the 
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impact of “strong” signalling at the DN stage for conventional versus 
unconventional T cell development.    
7.2 Alternative splicing of pTαa and pTαb is differently 
regulated during T cell development 
Using PCR on single-sorted DN3 and DN4 thymocytes, we demonstrated that 
they can express pTαa only, pTαb only, or both isoforms simultaneously. This 
suggests that splicing to produce the two isoforms of pTα can be differentially 
regulated in single thymocytes despite them being at the same developmental 
stage. This could suggest that some degree of heterogeneity already exists 
among preTCR-expressing cells. As pTαb transgenic mice have generally been 
shown to support early T cell development at the DN3 to DN4 transition 
(Gibbons et al., 2001), our results support our initial hypothesis that pTαa and 
pTαb may have different roles at the β-selection checkpoint. This is further 
supported by data generated by Juliet Mahtani-Patching (a former PhD student 
in the lab) who showed during her PhD that murine thymocyte subsets express 
variable amounts of pTαa or pTαb throughout T cell development (Mahtani-
Patching, 2010). Whereas pTαa expression is terminated at the DP stage of T 
cell development, Juliet showed that pTαb expression is maintained up to the 
CD4(+) SP stage (Mahtani-Patching, 2010). In addition, Campese et al. 
(Campese et al., 2009) have shown that thymic CD4(+)CD25(+) T cells (which 
consist mainly of Foxp3(+) cells and thus are T regulatory cells) have a 2.7-fold 
increase in pTαb expression compared to conventional CD4(+) T cells, and that 
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pTαb was preferentially expressed over pTαa in these cells. Moreover, data 
obtained by real-time PCR on human intra-thymic T cell subsets revealed a 
differential pattern of pTα isoform expression throughout human T cell 
development (Ramiro et al., 2001). The data presented in these studies were 
obtained by PCR carried out at the level of thymocyte subsets and could be 
investigated at the single-cell level with the optimized assay that we have 
developed. Thus, future work should focus on investigating pTαa and pTαb 
expression in murine ISP, DP, CD4SP and CD8SP subsets, as well as in IEL 
progenitors (DPdull CD5(+)TCRβ(+)PD-1(+)CD69(+)), and T regulatory cells. This 
could shed some insight onto the importance of each isoform for the 
development of certain subsets of T cells.  
 
Interestingly, we show that FVB/n DN3 cells over-express pTαa compared to 
C57Bl/6 cells. This difference is however not maintained at the DN4 stage of T 
cell development. These data add further weight to our idea that pTα isoforms 
are differently regulated throughout T cell development. This appears to be 
strain-dependent and should be considered when FVB/n mice are used as 
controls to study T cell development as it might have implications for some T 
cell development (e.g.FVB/n vs C57Bl/6).  
 
Alternative mRNA splicing is a critical biological process, which allows the 
coding diversity of the genome to be significantly increased while being finely 
regulated. However, the regulators of alternative splicing during T cell 
development remain largely unstudied. It was recently described that an 
increase in expression of the RNA binding protein CELF2 (CUGBP, Elav-Like 
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Family Member 2) results in changes in mRNA splicing during T cell 
development (Mallory et al., 2015). Unfortunately, although CELF2 expression 
appeared to increase from the β-selection checkpoint up to the DP stage, 
alternative splicing of pTα isoforms was not investigated (Mallory et al., 2015).  
Conditional ablation in mice of the splicing regulator SC35 using a Lck-driven 
Cre/Loxp strategy showed a partial block in the DN to DP transition. Moreover, 
analysis of the DN compartment showed a slight increase in DN3 cells 
compared to WT controls reminiscent of the partial DN3 to DN4 block observed 
in our pTαa.pTα-/- mice. The authors attributed this phenotype to a clear 
reduction in expression of the alternative spliced CD45 isoform CD45RB, and 
preTCR isoforms were unfortunately not investigated (Wang et al., 2001).  
 
Altogether these data support our initial hypothesis that pTαa and pTαb may 
have different roles at the β-selection checkpoint, but their physiological 
relevance during T cell development remains to be ascertained. Moreover, 
identifying alternative splicing regulators implicated in pTα regulation using a 
microarray approach should provide novel insight into the early stages of T cell 
development.  
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7.3 The timing of expression of the pTαa transgene in  
pTαa.pTα -/- mice 
pTαa.pTα-/- transgenic mice had been previously generated by the Hayday 
laboratory (Gibbons et al., 2001). However, pTαa transgene expression was 
under the regulation of the Lck promoter, which despite being turned on as 
early as the DN3 stage of T cell development remains active during subsequent 
DP and SP stages of T cell development, during which pTα expression should 
normally be terminated (Mingueneau et al., 2013; Shimizu et al., 2001). We felt 
it was of critical importance to recapitulate physiological pTα expression for our 
transgenic mice. Indeed, the sustained expression of pTα has been associated 
with leukemogenesis and pTα transcripts were detected in human T-acute 
lymphoblastic leukaemias (T-ALL) (Bellavia et al., 2002). To circumvent such 
issues, we chose to investigate the role of pTαa in T cell development using 
BAC transgenic mice that were generated in-house by a previous PhD student. 
Because the pTαa BAC consists of a large piece of genomic DNA carrying both 
the pTα gene and its regulatory elements, choosing this approach should have 
faithfully recapitulated pTα expression during T cell development (Heintz, 
2001). Constitutive pTαa expression in FTOC was shown to be associated with 
ISP accumulation, a feature that was not observed in pTαa.pTα-/- mice, 
supporting the idea that the expression of the pTαa transgene is regulated to 
some extent throughout T cell development (Mahtani-Patching, 2010). We also 
show that the severely impaired DN to DP transition observed in pTα-deficient 
animals appear to be largely rescued by the pTαa transgene. The proportion of 
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γδ T cells is also largely restored, suggesting that the pTαa transgene efficiently 
signals (with TCRβ) to divert thymocytes away from a γδ T cell fate. By contrast, 
total thymic cellularity remains significantly lower in pTαa.pTα-/- mice compared 
to C57Bl/6 mice and more in-depth analysis of the DN subsets revealed a 
subtle block at the DN3 to DN4 transition. Although the lack of pTαb in 
pTαa.pTα-/- mice could be a possible explanation for the phenotype described 
here, these data could also be due to non-physiological pTαa expression. Thus, 
this raises the possibility of a timing of expression issue with our pTαa 
transgene in pTαa.pTα-/- mice. Although this possibility was considered during 
my PhD, I have been unable to fully investigate it due to optimization problems 
with the real time PCR assay described earlier, when assessing pTαa 
expression in FVB/n DN3 and DN4 subsets. This may be due to the presence 
of truncated WT pTα transcripts in pTαa.pTα-/- mice (where exon 3 and 4 have 
been replaced by a neomycin gene), creating some form of competition, and 
impeding good target amplification. Future work should focus on assessing 
transgene expression during T cell development in both the WT and transgenic 
mice. If the pTαa transgene is shown to be expressed either earlier or later than 
it would normally be expressed, it would suggest that some of the phenotypes 
observed in these mice may be due to this issue.  
7.4 PreTCRa signals more weakly than preTCRb 
FVB/n mice, which over-express pTαa transcripts in DN3 cells compared to 
C57Bl/6 cells, have a partially impaired DN3 to DN4 transition and a lower CD5 
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expression on post-β-selected DN cells. Similar data were obtained with 
pTαa.pTα-/- mice, which only express pTαa at the DN stage of T cell 
development. Levels of CD5 are modulated throughout T cell development and 
are considered to positively represent the strength of TCR signal received by a 
particular cell (Azzam et al., 1998). Post-β-selected DN3 cells from FVB/n and 
pTαa.pTα-/- mice both express lower cell surface levels of CD5 compared to WT 
C57Bl/6 cells. Thus, we suggest that post-β-selected DN3 cells from FVB/n and 
pTαa.pTα-/- mice have received a weaker signal than in “normal” WT C57Bl/6 
mice. Although this idea could and should be validated by other approaches 
such as the phosphorylation state of TCRζ, it is consistent with the study of 
Barber et al. who demonstrated that transfection of pTαa into TCRβ-expressing 
cells resulted in a reduction of TCRβ expression compared to pTαb, highlighting 
that the different isoform of pTα regulate TCRβ expression to different extents. 
Furthermore, FTOC data generated in the lab have shown that cell surface 
expression of preTCRb is greater than preTCRa (Mahtani-Patching, 2010). 
Indeed, differences in TCR cell surface expression is often thought to translate 
into quantitatively different and thus perhaps also qualitatively different 
intracellular signals (Hayes et al., 2005). Thus, one could hypothesise that 
preTCRa and preTCRb deliver qualitatively different signals at the β-selection 
checkpoint, which might account for differences in subsequent T cell 
development (further discussed below).  
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7.5 Signal strength at the DN stage and acquired CD5 levels 
may influence subsequent T cell selection 
 
Paul Love and colleagues have shown using transgenic TCRαβ mice that the 
levels of CD5 expression on developing thymocytes could affect DP cell 
sensitivity during positive/negative selection (Azzam et al., 2001). Indeed, using 
both MHC-I- and MHC-II-restricted transgenic TCRαβ mice (P14, H-Y, D010.10 
TCR, AND transgenic TCRs recognizing lymphocytic choriomeningitis virus, a 
male antigen, ovalbumin peptide and pigeon cytochrome c respectively) they 
showed that over-expression of CD5 resulted in a decrease of SP cells whereas 
ablation of CD5 “accelerated” SP development (Azzam et al., 2001; Azzam et 
al., 1998; Kaye et al., 1989; Murphy et al., 1990; Pircher et al., 1989). Indeed, 
increasing cell sensitivity to MHC/self-peptide interactions by reducing CD5 
levels allowed positive selection of previously un-selected TCRs resulting in a 
greater proportion of SP thymocytes. This can be explained by the fact that 
TCR affinity for MHC/self-peptide is believed to adopt a pyramid-like shape (as 
suggested by work carried out on T regulatory cells) (Hogquist et al., 2005; 
Jordan et al., 2001). Thus, a larger number of DP cells express TCRs with very 
weak affinity to MHC/self-peptide while very few display TCRs with high affinity 
to MHC/self-peptide. Altogether, this study supports a model where CD5 levels 
on DP thymocytes affect positive selection and in turn development of SP 
thymocytes.  
 
In this thesis, CD5 levels are used to suggest that pTαa signals weakly at the β-
selection checkpoint, as shown in FVB/n and pTαa.pTα-/- mice compared to 
  242 
 
C57Bl/6 mice (discussed above). This is associated in the gut with a reduced 
proportion of unconventional TCRαβ(+)CD8αα(+)IELs, whereas conventional T 
cells appear largely rescued, in comparison with pTα-/- and C57Bl/6 mice. 
Importantly, unconventional TCRαβ(+)CD8αα(+)IELs are thought to express 
TCRs with high(er) affinity to MHC/self-peptide and undergo “agonist” selection 
in the thymus (Yamagata et al., 2004). Conversely, “stronger” signalling at the 
DN stage of T cell development through the premature expression of TCRαβ 
complexes in OT-II and pTα-/-.TCRδ-/- mice was associated with increased CD5 
expression at the DN stage and an increased relative proportion of 
unconventional TCRαβ(+)CD8αα(+)IELs. This led us to hypothesise that the 
strength of signal “recorded” by developing thymocytes at the β-selection 
checkpoint would dictate subsequent CD5 expression levels, which in turn 
would influence DP sensitivity to TCR signals during positive/negative selection. 
Thus, weak signalling at the DN stage would translate to low CD5 and a greater 
cell sensitivity to TCR signals. This would potentially select a larger proportion 
of SP thymocytes as seen in FVB/n and pTαa.pTα-/- mice. Consistent with this, 
we show that FVB/n and pTαa.pTα-/- mice have a reduced CD69(-)DP to 
CD69(+)DP ratio suggesting that a greater proportion of DP thymocytes have 
been positively selected compared to C57Bl/6 mice. This also correlated with a 
decrease DP-to-SP ratio in FVB/n and pTαa.pTα-/- mice compared to C57Bl/6 
mice. By contrast, stronger signalling at the DN stage, through either preTCRb 
(possibly-yet to be confirmed experimentally) or through prematurely-expressed 
TCRαβ complexes like in OT-II and pTα-/-.TCRδ-/- mice, triggers greater CD5 
upregulation that decreases DP cell sensitivity to TCR signals. This would 
partially impede positive selection of conventional T cells, but would perhaps 
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favour unconventional T cell development. This hypothesis could explain why a 
seemingly equivalent “strong” signal at the DP stage can in one case trigger 
positive selection of unconventional T cells, while also promoting apoptosis and 
death of conventional T cells. This hypothesis is supported by our data from 
CD5-/- mice which have a reduced DP-to-SP ratio compared to C57Bl/6 mice. 
However, the reduced DP-to-SP ratio in CD5-overexpressing mice would not be 
consistent with this hypothesis. Importantly, expression of the CD5 transgene in 
CD5Tg mice is under the regulation of the CD2 promoter and is thus expressed 
early in T cell development (Azzam et al., 2001). This might have affected 
signal strength in DN3 cells and thus might not have been the ideal model to 
investigate our hypothesis.  
 
To assess and compare the sensitivity of DP thymocytes in C57Bl/6, FVB/n and 
pTαa.pTα-/- strains we thought to measure the amplitude of Ca(2+) signalling 
following TCR cross-linking as this is known to correlate with TCR signal 
strength (Mariathasan et al., 1998). Thus, we hypothesised that DP cells from 
FVB/n and pTαa.pTα-/- mice would be more sensitive to TCR cross-linking than 
C57Bl/6 cells and would in turn flux greater amounts of Ca(2+). Unfortunately, 
due to technical issues, we were unable to carry out this experiment. Indeed, 
we were unable to visualise calcium influx following anti-CD3 crosslinking by 
flow cytometry in control C57Bl/6 cells.  
 
A similar approach could be undertaken by crossing FVB/n and pTαa.pTα-/- 
mice with Nur77-GFP mice, which express GFP under the control of the Nur77 
promoter and has been shown to be a good indicator of the TCR signal 
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received by cells(Moran et al., 2011). Thus, this could be a useful read out of 
the DP sensitivity. One would expect Nur77 expression to be greater in 
CD69(+)DP cells from FVB/n and pTαa.pTα-/- mice compared to C57Bl/6 mice.  
 
The sensitivity of the cell could also be investigated in terms of negative 
selection, which can be assessed by superantigen-mediated deletion of cells 
that expressed certain TCR-Vβ chains. Superantigens derive from the “remains” 
of endogeneous retroviruses belonging to the mouse mammary tumour virus 
family (MMTV) that have long ago integrated into the mouse genome. 
Recognition of thymus-associated superantigens through TCRβ/MHC 
interactions triggers a very strong TCR signal resulting in the negative selection 
of developing DP cells expressing specific TCR-Vβ chains. Thus for instance, 
recognition of Mtv9 results in the deletion of TCRVβ8-expressing T cells (Acha-
Orbea et al., 1991).  
 
Superantigens represent a useful tool to analyse negative selection. However, 
C57Bl/6 mice, and thus pTαa.pTα-/- mice (on a C57Bl/6 background), lack the 
MHC-II I-Eα chain involved in superantigen presentation and thus superantigen-
specific T cells do not undergo negative selection in these animals. To 
overcome this issue, β-selected DN3 thymocytes from pTαa.pTα-/- mice, 
expressing low CD5 levels, could be sorted and used to repopulate thymic 
lobes obtained from mice sufficient for I-Eα, such as BALB/c mice. I-Eα-
expressing stromal cells should then present superantigens and induce 
negative selection in pTαa.pTα-/--derived DP cells. The Vβ usage of SP 
thymocytes could then be assessed, which could be used as a read out of 
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effective negative selection was and to ascertain whether their sensitivity to 
TCR signalling is altered.  
 
We show in this thesis that the “accelerated” DP-to-SP transition in FVB/n and 
pTαa.pTα-/-mice does not correlate with the size of the thymus. However, this 
could be due to environmental cues from the thymic stroma. To confirm that this 
feature is cell-intrinsic, future work could generate mixed bone marrow chimeras 
where C57Bl/6 and pTαa.pTα-/- -derived bone marrow are used to reconstitute 
irradiated C57Bl/6 mice. Investigating T cell development in these reconstituted 
animals should allow us to confirm that this altered DP-to-SP transition is cell 
intrinsic.  
 
In summary, we propose a model where the strength of signal at the β-selection 
checkpoint subsequently affects positive/negative selection of αβ T cells at the 
DP stage (Figure 7.1). This supports our original hypothesis that signalling 
events at the DN stage of T cell development may be responsible for 
establishing heterogeneity in the DP subset.  
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Figure 7.1 A possible model: Signal strength at the DN stage finely tunes DP cell sensitivity and subsequently impacts on the 
positive/negative selection of DP cells in the DP-to-SP transition. We propose that DN3 cells (that are CD5low) expressing pTαa at 
the β-selection checkpoint would express lower CD5 levels than cells expressing stronger signalling TCR complexes such as TCRαβ, 
which then finely tunes their sensitivity to subsequent T cell selection. Low-CD5 expressing cells interacting with agonist self-
peptide/MHC complex would undergo negative selection and die by apoptosis while interactions with weaker affinity peptide/MHC 
should drive DP cells to adopt a conventional T cell fate. By contrast, high CD5-expressing cells, which should be less sensitive to 
strong signals, should now be positively selected on agonist-selecting ligands and thus adopt an unconventional T cell fate. Altogether, 
this hypothesis suggests that signalling events occurring at the DN stage of T cell development would participate in the establishment of 
a heterogenous DP subset. 
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7.6 PreTCRa signalling may be dominant to that of preTCRb 
Interestingly, despite expressing the same level of pTαb transcripts as C57Bl/6 
DN3 cells, FVB/n cells express lower levels of CD5 similar to pTαa.pTα-/- mice. 
This suggests that over-expression of pTαa leads to a dominant phenotype 
when co-expressed with pTαb. These data are in agreement with those from 
Juliet Mahtani-Patching showing that co-expression of pTαa and pTαb in FTOC 
promoted accumulation of ISPs to a similar extent as FTOC with pTαa only. 
These results suggest that pTαb may need to be expressed alone or in excess 
to be able to exert its effect. If revealed to be true, it also raises the question of 
how weak signals can be dominant over stronger ones. This may be due to the 
high endocytosis rate of pTαa over pTαb. Once paired with TCRβ, the whole 
preTCRa complex is likely to be endocytosed resulting in a lower cell surface 
expression and thus a reduced signal strength.  
7.7 Signal strength at the DN stage may influence T cell 
proliferation, which may subsequently affect T cell 
development  
Recent transcriptional analysis of pre- and post-β-selected DN3 cells revealed 
that progression through the β-selection checkpoint was associated with a 
dramatic shift in the thymocyte transcriptome with most of the identified genes 
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implicated in metabolism and proliferation (>48% of upregulated genes were 
linked to proliferation) (Mingueneau et al., 2013). Indeed, signalling through the 
preTCR together with notch and IL-7Rα signalling triggers a c-myc-dependent 
burst of proliferation important for subsequent T cell development (Ciofani et al., 
2004; Kreslavsky et al., 2012; Maillard et al., 2006; Sicinska et al., 2003).  
The significantly reduced thymic cellularity (and thus DP cell numbers) 
described in this thesis for the pTαa.pTα-/- mice does not appear to result from 
an inability of the pTαa transgene to signal as part of the preTCR, as pTαa.pTα-/- 
mice have a reduced proportion of γδ T cells, a substantial pool of DP cells, and 
mature thymic and peripheral CD4(+) and CD8(+) T cells compared to 
pTα-deficient mice. An altered ability for T cell precursors to undergo 
proliferation may thus be an explanation for the reduced thymic cellularity of 
pTαa.pTα-/- mice. Indeed, cyclin D3-deficient mice have an impaired proliferation 
of immature DN4 and ISP cells resulting in reduced thymic cellularity, 
reminiscent of the phenotype observed in pTαa.pTα-/- mice (Sicinska et al., 
2003). Interestingly, Kreslavsky et al. recently demonstrated that differentiation 
and proliferation were actually two intertwined processes triggered at the β-
selection checkpoint through preTCR signalling (Kreslavsky et al., 2012). In this 
study, only DN3 cells that had undergone four or more rounds of division in the 
presence of the preTCR efficiently progressed to the DP stage of T cell 
development in a OP9-DL1 system (Kreslavsky et al., 2012). Based on this 
study, the presence of DP cells and mature SP cells in pTαa.pTα-/- mice 
suggests at least in some DN cells the pTαa transgene successfully induced 
proliferation (at least four rounds). The transferrin receptor, CD71, is up-
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regulated in a c-myc dependent manner when cells increase their metabolism, 
for example during proliferation (Brekelmans et al., 1994). We show that 
proportions of CD71(+)i.c.TCRβ(+)DN3 cells are similar between C57Bl/6 and 
pTαa.pTα-/- mice suggesting that the pTαa transgene successfully enhanced 
metabolism and proliferation (Janas et al., 2010; O'Donnell et al., 2006). 
However, we show that FVB/n and pTαa.pTα-/- mice have a higher DN3/DN4 
ratio than C57Bl/6 mice that could illustrate a lack of proliferation in DN4 cells. 
Consistent with this idea, some preliminary data suggest that there is a lower 
proportion of DN4 CD71(+) cells in FVB/n and pTαa.pTα-/- mice compared to 
C57Bl/6 mice. This is likely to reflect a reduced proliferative state of certain DN4 
cells. Thus, further investigation of the proliferation state of post-β-selected DN3 
and DN4 pTαa.pTα-/- cells compared to C57Bl/6 cells using a CFSE assay, or 
by measuring Ki67 expression should be considered.    
Importantly, pTαa.pTα-/- mice lack a substantial proportion of unconventional 
TCRαβ(+)CD8αα(+) IELs. Thus, one could hypothesise that pTαa transgene-
induced proliferation is insufficient to generate DP cells that can subsequently 
differentiate into unconventional TCRαβ(+)CD8αα(+) IELs. Increasing TCR signal 
strength with increasing doses of anti-CD3 cross-linking antibody or by using 
increasing doses of OVA in OT-II mice, was recently shown to positively 
correlate with the burst of proliferation (Au-Yeung and Zikherman, 2014). Thus, 
greater TCR signal appears to trigger greater proliferation. β-selected DN3 cells 
from pTαa.pTα-/- mice express significantly lower CD5 than C57Bl/6 mice 
suggesting that preTCR signalling was weaker in these animals. Thus, one 
could consider that weak signalling through the preTCRa transgene induces less 
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proliferation that is sufficient for development of conventional T cells but not for 
unconventional TCRαβ(+)CD8αα(+) IEL development. By contrast, stronger 
signalling could induce greater proliferation allowing DN and subsequently DP 
cells to acquire a certain phenotype that permits unconventional 
TCRαβ(+)CD8αα(+) IEL development (Au-Yeung and Zikherman, 2014). Data 
obtained with FVB/n mice support this hypothesis as DN3 cells also express 
lower CD5 levels than C57Bl/6 DN3 thymocytes. Thus, we propose a model 
where the proliferative state of DN cells subsequently affects their ability to 
adopt a conventional versus unconventional T cell fate.  
7.8 pTαb transgenic mice  
One of the aims of this thesis was to investigate the role of pTαb in T cell 
development using BAC-transgenic mice. Although the pTαb transgenic animals 
were generated towards the end of my PhD, it took significant time to backcross 
these mice onto a background that was deficient for the two endogeneous 
pTα alleles. Thus, preliminary results were obtained from pTαb BAC transgenic 
animals onto a pTα-/+ background. Based on our initial hypothesis, “stronger” 
signalling at the DN stage of T cell development, potentially delivered by pTαb, 
should have skewed T cell development towards an unconventional T cell fate 
resulting in a reduced ratio of TCRαβ(+)CD8αβ(+) to TCRαβ(+)CD8αα(+) IELs. 
Unfortunately, this was not the case as pTαb.pTα-/+ mice had a phenotype very 
similar to pTα-/+ controls in terms of thymic cellularity, proportion of γδ T cells, 
the efficiency of the DN to DP transition and proportion of TCRαβ(+)CD8αβ(+) 
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and TCRαβ(+)CD8αα(+) IELs. This is likely due to the presence of WT-
pTα allele.  These animals will be further investigated once the strains have 
been backcrossed onto a “pure” pTα-deficient background.  
7.9 C57Bl/6, BALB/c and FVB/n mice have different ratios of 
conventional TCRαβ (+)CD8αβ (+) IELs to unconventional 
TCRαβ (+)CD8αα (+) IELs 
One of the aims of this thesis was to use different strains of WT mice, here 
C57Bl/6, BALB/c and FVB/n, to shed light on unconventional TCRαβ(+)CD8αα(+) 
IEL development.  We show in this thesis that FVB/n mice have an increased 
ratio of conventional TCRαβ(+)CD8αβ(+) IELs to unconventional 
TCRαβ(+)CD8αα(+) IELs compared to C57Bl/6 and BALB/c mice, whereas this 
ratio is largely reduced in BALB/c mice compared to C57Bl/6 and FVB/n mice. 
Importantly, no differences were observed for TCRγδ(+) IELs. This gut 
phenotype was mirrored in the thymus with a decrease or increase of CD4(-
)CD8(-)TCRβ(+)CD5(+) IEL progenitors for FVB/n and BALB/c mice respectively 
(compared to C57Bl/6 mice). Due to time constraints, we principally used FVB/n 
mice to understand the role of “weak” signalling at the DN stage of T cell 
development and its impact on conventional versus unconventional 
TCRαβ(+)CD8αα(+) IEL development, but future work should further focus on 
BALB/c mice. Importantly, these data were unpredicted and demonstrate that 
different strains of WT mice are different to one another and may be useful tools 
when studying immunopathologies of the gut. Despite all three strains being 
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purchased from Charles River, one could hypothesise that this phenotype 
occurs because of differences in gut microbiota rather than differences in 
TCRαβ(+)CD8αα(+) IEL development. To investigate this idea, two WT strains 
could be bred together (e.g. C57Bl/6 and BALB/c) and the gut IEL populations 
analysed. A similar experiment where offspring from one strain could be “cross-
fostered” with the mother of the other strain would allow us to assess the role of 
microbiota on TCRαβ(+)CD8αα(+) IEL proportions and maintenance as it is 
thought that the mother is responsible for shaping the microbiota of her pups 
(Daft et al., 2015). 
The developmental pathway of unconventional TCRαβ(+)CD8αα(+) IELs has 
been the source of lengthy debate. Thus, FVB/n, BALB/c and C57Bl/6 mice 
may be useful models to understand the developmental requirements for 
unconventional TCRαβ(+)CD8αα(+) IELs by, for instance, carrying out a 
microarray assay on the newly described IEL progenitor DPdull 
TCRαβ(+)CD5(+)PD1(+)CD69(+)CD122(+) cells from these three strains. This 
experiment would allow the identification of genes that are differently expressed 
and that may be implicated in unconventional TCRαβ(+)CD8αα(+) IEL 
development. 
7.10 Conclusion part I 
Here, we show that single DN3 and DN4 cells can express pTαa-only, pTαb-only 
or both isoforms simultaneously suggesting that each isoform might have a 
non-redundant role at the β-selection checkpoint. We also show that β-selected 
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DN3 thymocytes from FVB/n and pTαa.pTα-/- mice express lower levels of CD5 
compared to C57Bl/6 cells, suggesting that they have received a “weaker” 
signal at the β-selection checkpoint. This is associated in the gut with a reduced 
TCRαβ(+)CD8αα(+) IEL compartment. By contrast, premature expression of 
TCRαβ complexes at the DN stage, generates a “stronger” signal as depicted 
by greater CD5 expression on DN thymocytes and is associated with an 
increased TCRαβ(+)CD8αα(+) IEL compartment. Thus, quantitative different 
signals at the DN stage of T cell development appears to differently affect the 
development of conventional TCRαβ(+)CD8αβ(+) IELs or unconventional 
TCRαβ(+)CD8αα(+) IELs. We present two possible models to explain these 
observations: In the first model, we propose that the strength of signal recorded 
by developing DN cells positively correlate with CD5 levels, which in turn finely 
tunes the cell sensitivity to subsequent T cell selection events at the DP stage 
of T cell development, thus affecting development of conventional versus 
unconventional T cells. Our second model propose that the strength of signal 
delivered at the DN stage of T cell development is responsible for triggering 
different burst of proliferation which in turn imprint T cells to adopt a 
conventional or unconventional T cell fate. In sum, the data presented in this 
thesis support our initial idea that signalling events at the DN stage of T cell 
development may have fundamental consequences on subsequent T cell 
selection and development. 
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Part II – γδ  T cell development  
7.11 Introduction  
αβ and γδ T cells share the immature DN stages of T cell development. 
Commitment to an αβ or γδ T cell fate occurs at around the DN3 stage and is 
generally accepted to be driven by quantitatively different signals delivered by 
preTCR or TCRγδ complexes, respectively (Hayes et al., 2005, Zarin et al., 
2014). Indeed, the current consensus view suggests that “weak” signalling 
through the preTCR promotes αβ T cell development whereas “stronger” 
signalling through TCRγδ triggers DN3 progenitors to adopt a γδ T cell fate. 
Strong signals are generally thought to be the consequence of ligand 
recognition, exemplified during αβ T cell selection, but very few TCRγδ ligands 
have yet been identified, questioning their requirements for γδ T cell 
development. Indeed, The higher surface expression of TCRγδ compared to the 
preTCR, which is highly endocytosed and thus signals more weakly, could 
account for its increased signal strength even in the absence of ligand 
recognition (Azzam et al., 1998; Panigada et al., 2002). Moreover, it has 
remained unclear how a strong signal at the DN3 stage could first drive γδ T cell 
lineage commitment, but then have a differential influence of subsequent γδ T 
cell developmental outcome with respect to commitment to IL-17A versus IFN-γ-
production (Prinz et al., 2013). Because investigation of these questions has 
been partially impeded by the lack of a very defined sequence of γδ T cell 
developmental stages, the lab has proposed a new combination of cell-surface 
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markers that precisely distinguishes the IL-17A- versus IFN-γ-specific γδ T cell 
developmental pathways, which we have subsequently used to provide novel 
insight on the TCRγδ signalling requirements for driving IL-17A versus IFN-γ-
secreting γδ T cell development.  
7.12 IL-17A- versus IFN-γ-commited γδ  T cell developmental 
pathways can be identified through the combinatorial use of 
CD24, CD44 and CD45RB. 
The lack of a consensus methodology to define thymic γδ T cell subsets has 
partially impeded investigations into understanding the role of TCRγδ at  
different stages of γδ T cell development. Indeed, although cell surface 
expression of CD27 has widely been used to distinguish IL-17A or IFN-γ 
secreting γδ T cells, some CD27(-) γδ T cells do produce some IFN-γ upon 
stimulation (Ribot et al., 2009). Using new conbinations of previously published 
markers, the data in this thesis demonstrate the identification of two clear 
pathways of γδ T cell development where CD24(-)CD44(-)CD45RB(-) γδ T cell 
progenitors diverge by either up-regulating CD44 or CD45RB. This generates 
either CD24(-)CD44(+)CD45RB(-) or CD24(-)CD44(-)CD45RB(+) γδ T cells, which 
clearly segregate with IL-17A or IFN-γ secreting potential, respectively. 
Consistent with IL-17A-secreting potential, CD24(-)CD44(+)CD45RB(-) cells but 
not CD24(-)CD44(-)CD45RB(+) cells express IL-7Rα (Michel et al., 2012). 
Conversely, consistent with an IFN-γ-secreting phenotype,                        
CD24(-)CD44(int)CD45RBhigh γδ T cells express NK1.1 (Haas et al. 2009).  Other 
  
256 
 
studies have suggested that IL-17-producing γδ T cells can be defined by the 
transcription factors RORγt, and SOX13 whereas IFN-γ-producing γδ T cells 
express T-bet (Gray et al., 2013; Turchinovich and Hayday, 2011). Thus, it 
would be interesting to investigate RORγt, SOX13 and T-bet expression in 
CD24(-)CD44(+)CD45RB(-) and CD24(-)CD44(-)CD45RB(+) γδ T cells. Moreover, 
the B cell specific Src kinase, B lymphoid kinase (Blk) was recently implicated in 
IL-17-producing γδ T cell development, and thus future work should confirm that 
its expression is confined to CD24(-)CD44(+)CD45RB(-) γδ T cells (Laird et al JI. 
2010). Finally, cell surface expression of CD73 was recently suggested to 
correlate with ligand engagement by γδ T cells and CD73(+) γδ T cells have been 
shown to principally secrete IFN-γ. Thus, CD73 expression could be analysed 
on CD24(-)CD44(int/-)CD45RBhigh cells (Coffey et al., 2014).  
Analysis appears to suggest that both CD24(-)CD44(+)CD45RB(-) and          
CD24(-)CD44(-)CD45RB(+) γδ T cell subsets develop from a common          
CD24(-)CD44(-)CD45RB(-) progenitor and that an IL-17-A-secreting potential is 
gradually acquired following CD44 up-regulation whereas acquisition of an IFN-
γ- secreting potential occurs through up-regulation of CD45RB and then 
(partially) CD44 following a CD24(-) CD44(-) CD45RB(-) à CD24(-) CD44(-) 
CD45RB(+) à CD24(-) CD44(int) CD45RBhigh pathway. Development through 
these sequential steps should be further investigated and confirmed by 
analysing γδ T cell subsets at different time points in mouse embryonic 
development or by culturing these different subsets on OP9-DL1 cells to follow 
their development (Holmes and Zuniga-Pflucker, 2009). OP9-DL1 cells are 
bone-marrow-derived stromal cells expressing delta like ligand 1 (DL1) and that 
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support T cell differentiation and development in vitro. Although further work is 
required to fully characterise these subsets (e.g. at the transcriptional level), a 
novel methodology has been developed using CD24, CD44 and CD45RB that 
precisely identifies the developmental pathways of IL-17A- versus IFN-γ 
producing γδ T cells.  
7.13 Strong TCRγδ  signalling does not favour commitment to 
an IL-17A-secreting γδ  T cell fate 
It was suggested that thymic γδ T cell progenitors that do not engage a thymic 
TCRγδ ligand adopt an IL-17A-producing fate, whereas “ligand-experienced” γδ 
T cell progenitors principally develop to secrete IFN-γ (Jensen et al., 2008). 
Consistent with this, we show that cross-linking of TCRδ with the anti-TCRδ 
antibody GL3, that is widely considered to increase signal strength and mimic 
TCRγδ ligand engagement, inhibited development of IL-17A-secreting γδ T cells, 
while favouring the CD45RB developmental pathway. Importantly, the few 
CD44(+)CD45RB(-) cells that did develop under these conditions secreted 
significantly less IL-17A than controls further suggesting that cross-linking of 
TCRγδ does not favour an IL-17A-secreting γδ T cell fate. A possible 
explanation for the appearance of some CD44(+)CD45RB(-) cells could be that 
FTOC were set up with thymic lobes dissected from E15 embryos, in which 
some IL-17A-producing γδ T cells have already undergone some degree of 
development that renders them unresponsive to GL3. To investigate this idea, 
the E15/GL3 experiment should be repeated using thymuses from E14 
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embryos. One could also hypothesise that increasing concentrations of GL3 
should correlate with progressively reduced appearance of IL-17A-secreting γδ 
T cells, which could be investigated by supplementing FTOCs with increasing 
doses of GL3. Moreover, because Vγ4- and Vγ6-expressing γδ T cells are the 
main IL-17A-producers (Carding and Egan, 2002), future work should confirm 
that these two populations are mainly found in the CD24(-) CD44(+) CD45RB(-) 
subset and that they are reduced under these cultures condition. Thus, 
development of IL-17A-secreting γδ T cells appears largely impeded by 
increased signalling through TCRγδ, suggesting perhaps that they instead 
develop using a ligand-independent pathway. In agreement with this, the lab 
previously published that a trunctated TCRγδ was sufficient to generate some γδ 
T cells when transfected into RAG-deficient DN2 thymocytes. This suggests 
that inititiation of TCR signalling can result from the simple oligomerization of 
the two TCR subunits and may not require ligand engagement.  
7.14 Development of IL-17A-secreting γδ  T cells is dependent 
on Lck/Zap-70 and PI3K signalling 
The data from GL3-supplemented FTOCs suggest that IL-17A-producing γδ T 
cell development is not favoured by strong signalling through TCRγδ (discussed 
above). Unexpectedly, weakening of TCRγδ signal strength through a gradual 
increase in PP2, a src kinase inhibitor that would inhibit Lck, was associated 
with the gradual disappearance of IL-17A-producing γδ T cells. Although one 
could conclude that weak TCRγδ signalling is incompatible with their 
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development, this would directly contradict the conclusion from the GL3-treated 
FTOCS (above). Thus, we propose instead that it illustrates simply their Lck- 
dependence. In line with this, Wencker et al. recently showed that SKG mice, 
which harbor a mutation in Zap-70 resulting in reduced Zap-70 activity 
(Sakaguchi et al., 2003), had a highly reduced compartment of     
CD44(+)CD27(-)IL-7Rα(+) IL-17-secreting γδ T cells, which corresponds to our 
CD24(-)CD44(+)CD45RB(-) subset. However, the authors concluded that strong 
Zap-70-mediated signalling, likely resulting from TCRγδ ligand engagement, 
was responsible for driving IL-17(+) γδ T cell development. To reconcile these 
data with ours, we propose simply that commitment to an IL-17-producing γδ 
fate is both Lck and Zap-70-dependent, but that this does not necessarily imply 
that high activity of thee kinases is required. Instead we proposed that IL-17A-
secreting γδ T cells may required weak Lck/Zap-70 activity that may support 
signalling through another signalling pathway. It is possible that TCRγδ may 
simply act as a scaffold in this case, providing Lck/zap-70 to another receptor 
such as the IL-7 receptor. Indeed, IL-7 has been demonstrated to be required 
for IL-17A-producing γδ T cell development in an independent study (Michel et 
al., 2012) and IL7Rα subunits were shown to cluster with the preTCR:CD3ζ 
complex upon signalling in human T cells suggesting a possible cooperative 
role (Patel S., et al 2012). Recently, the spleen tyrosine kinase, Syk, a src 
kinase belonging to the same family as Zap-70, was shown to deliver signals 
emanating from the B-cell activating factor receptor (BAFFR) during B cell 
development, highlighting a previously unknown crosstalk between the B cell 
receptor (BCR) and BAFFR (Schweighoffer E., 2013). Importantly, stimulation 
of BAFFR was shown to result in greater phosphorylation of the PI3K signalling 
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pathway including protein kinase B (AKT). We show in this thesis that inhibiting 
PI3K signalling impedes development of IL-17A-producing γδ T cells. Thus, we 
propose a model where IL-17A-secreting γδ T cell development is driven by a 
Lck/Zap-70/PI3K axis triggered by an alternative receptor to TCRγδ. To further 
implicate a role for PI3K signalling in IL-17A but not IFN-γ secreting γδ T cells, 
levels of phosphorylated ribosomal protein S6 (pS6) and AKT should be 
investigated in CD44(+)CD45RB(-) versus CD45RB(+) cells and specific inhibitors 
to AKT (such as MK-2206 which prevents AKT auto-phosphorylation) could be 
supplemented in FTOC. The class I PI3K signalling family includes the subunits 
PI3Kα, PI3Kβ, PI3Kδ and PI3Kγ that were shown to play different role in B cell 
development (Okkenhaug and Vanhaesebroeck, 2003; Ramadani et al., 2010). 
Thus, future work should use isoform-targeting inhibitors in FTOC in order to 
dissect which isoform is implicated in IL-17A-producing γδ T cell development. 
These data could also be further confirmed by using PI3K-deficient mice. Thus, 
we propose a new model where an alternative receptor would have access to 
Lck and Zap-70 downstream of TCRγδ to signal through PI3K and support IL-
17A-producing γδ T cell development  (Figure 7.2).  
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Figure 7.2 A schematic diagram to illustrate the current hypothesis that we 
propose to explain IL-17A- versus IFN-γ-secreting γδ  T cell commitment. We 
propose that Lck/Zap-70 are used by an alternative receptor, possibly IL-7Rα, to signal 
through PI3K and support IL-17A-producing γδ T cell development. Conversely, we 
propose that IFN-γ-secreting γδ T cell development is supported by strong signals from 
TCRγδ that recruit a currently unknown signalling axis.  
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7.15 Commitment to an IFN-γ-secreting γδ  T cell fate is 
supported by strong TCRγδ  signalling that activates a currently 
unknown signalling pathway 
Here we show that augmenting TCRγδ signal strength through the use of anti-
TCRδ cross-linking antibody GL3 principally favour CD45RB(+) γδ T cell 
development. This development did not appear to occur through PI3K, as 
inhibiting PI3K signalling did not affect IFN-γ-secreting γδ T cells. Moreover, 
supplementing FTOC with GL3 in the presence of PI3K inhibitor drove 
CD45RB(+) γδ T cell development, suggesting that an alternative signalling 
pathway is implicated.  We also show using PP2 that CD45RBhigh cells were the 
only remaining cells at higher PP2 concentrations, suggesting that they 
survived because they are receiving the strongest signals (and are thus least 
affected). Nevertheless, these data suggest that an alternative signalling 
pathway activated by strong signals is likely to be supporting IFN-γ-secreting γδ 
T cell development. This should undoubtedly constitute a future area of 
research. The Hayday laboratory implicated the NFKB/NFAT/egr3 signalling 
pathway in the development of CD45RB(+)Vγ5(+) γδ T cells (Turchinovich and 
Hayday, 2011) whereas inhibiting ERK signalling did not impede their 
development. Thus, future work could focus on using specific inhibitors of 
NFAT/NFKB and ERK to investigate their requirements for IL-17A- versus    
IFN-γ-secreting γδ T cell development.   
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7.16 Conclusion - part II 
Here we propose a model in which strong TCRγδ signalling would favour 
CD45RB(+) γδ T cell development through a currently unknown signalling 
pathway, impeding IL-17A-secreting γδ T cell development. Alternatively, if 
TCRγδ signalling is weak, for example in the absence of TCR-ligand, signalling 
from an alternative receptor, such as the IL-7 receptor, could “hijack” TCRγδ-
associated Lck/Zap-70 to activate PI3K and promote commitment to an  IL-17A-
secreting γδ T cell fate (Figure 7.2).  
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